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 Abstract  
Within the human body, microorganisms reside as part of a complex and varied 
ecosystem, where they rarely exist in isolation. Bacteria and fungi have co-
evolved to develop elaborate and intricate relationships, utilising both physical 
and chemical communication mechanisms. Mucorales are filamentous fungi that 
are the causative agents of mucormycosis in immunocompromised individuals. 
Key to the pathogenesis is the ability to germinate and penetrate the surrounding 
tissues, leading to angioinvasion, vessel thrombosis, and tissue necrosis. It is 
currently unknown whether Mucorales participate in polymicrobial relationships, 
and if so, how this affects the pathogenesis. This project analyses the relationship 
between Mucorales and the microorganisms they may encounter. Here we show 
that Pseudomonas aeruginosa culture supernatants and live bacteria inhibit 
Rhizopus microsporus germination through the sequestration of iron. Therefore, 
treatment of P. aeruginosa in a patient could result in the release of this inhibition, 
leaving the patient more susceptible to an underlying fungal infection. However, 
P. aeruginosa responds to the presence of R. microsporus by enhancing 
siderophore production, which increases host mortality in a zebrafish co-infection 
model. This project highlights the complex competition between these organisms 
and the possible enhanced disease pathology when R. microsporus and P. 
aeruginosa meet in a host.
  
Happiness does not come from doing easy work 
but from the afterglow of satisfaction that comes  
after the achievement of a difficult task that  
demanded our best.  
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Chapter 1 : GENERAL INTRODUCTION
Chapter 1: General Introduction 
2 
 
1.1 Fungi. 
1.1.2 Fungi: friend or foe? Amongst the Kingdoms of Life, fungi represent a 
particularly vast, diverse group of organisms which range from single-celled 
microorganisms to enormous, multicellular structures spanning thousands of 
square metres (Smith, Bruhn and Anderson, 1992). There are up to an estimated 
3.8 million species of fungi, though only around 120,000 of these are defined 
(Hawksworth and Lucking, 2017). Fungi are important in the production of staple 
foods, such as cheese and bread, and beverages, such as beer and wine 
(Deacon, 2006). They play direct roles in the production of important medicines, 
including steroids (Christy Hunter et al., 2009), anti-cholesterol drugs (Endo, 
Kuroda and Tsujita, 1976), and antibiotics e.g. penicillin (Alexander Fleming, 
1929). In the environment, fungi are important for carbon recycling during the 
decomposition of dead matter. They also form mutualistic relationships with 
plants, where they receive nutrients and, in turn, help the roots acquire water 
(Money, 2016a). Furthermore, the presence of mycorrhizal fungi is essential for 
proper ecosystem plant diversity (Van Der Heijden et al., 1998). However, their 
saprophytic nature causes major economic loss through food spoilage. 
Approximately 25% of food produced is wasted due to microbial spoilage, globally 
(Fisher et al., 2012). 
 
In the human host, fungi are members of the microbiota, where Candida spp. are 
the most prevalent colonisers (Hallen-Adams and Suhr, 2017). While the 
presence of fungi can protect hosts against bacterial overgrowth and infection, 
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colonisation with Candida albicans can exacerbate diseases, such as ulcerative 
colitis and Crohn’s disease (Balzola et al., 2011).  
 
Of the thousands of identified fungal species, only 300 are known to cause 
disease in humans (Taylor, Latham and Woolhouse, 2001). Fungal infections can 
range from mild superficial infections to life-threatening systemic diseases. More 
than 1 billion people suffer from fungal infections annually, with 1.6 million being 
fatal (Bongomin et al., 2017). These infections are usually related to 
immunocompromising conditions, such as HIV/AIDS, cancer, corticosteroid 
therapy, and organ transplantation. The most common causative agents include 
Candida, Aspergillus, and Cryptococcus (Bongomin et al., 2017). Annual 
incidence and mortality rates for opportunistic invasive fungal infections are found 
in Table 1.1 (Brown et al., 2012).  
 
Table 1.1 Incidence and mortality rates of representative opportunistic invasive 
fungal infections. (Brown et al., 2012) 
Disease Location Life-threatening 
infections per 
year 
Mortality rates 
(%) 
Aspergillosis Worldwide >200,000 30-95 
Candidiasis Worldwide >400,000 46-75 
Cryptococcosis Worldwide >1,000,000 20-70 
Mucormycosis Worldwide >10,000 30-90 
Pneumocystis Worldwide >400,000 20-80 
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Key to the successful control of fungal infections involves early diagnosis, and 
delayed treatment is associated with poor prognosis (Antinori et al., 2009). 
However, diagnostic techniques are currently lacking, with culture-based 
methods being the gold standard of fungal diagnostics despite low sensitivities 
(Kozel and Wickes, 2014). A combination of antigen detection and polymerase 
chain reaction (PCR)-based diagnostics techniques have a higher sensitivity and 
specificity than culture-based methods, but their use is not yet widespread 
(Nguyen et al., 2012). Due to difficulties in diagnosis, many fungal infections are 
not diagnosed until autopsy; for example, only 15% of aspergillosis cases are 
diagnosed ante-mortem (Denning, 2015).  
 
1.1.3 Importance of studying pathogenic fungi. Antimicrobial resistance is a 
major health threat, with a recent widespread initiative to combat over-prescribing 
of antibiotics and to develop novel antimicrobial therapy. While public awareness 
regarding bacterial resistance to antimicrobials is rising, less focus has been on 
the problem of antifungal resistance and the development of novel antifungals 
(WHO, 2014). Mortality rates associated with fungal infections are rising, and 
more people die from fungal infections every year than from breast cancer and 
malaria (Brown et al., 2012). Resistance has been documented for all three 
classes of antifungals: the echinocandins, polyenes, and azoles (Robbins, 
Caplan and Cowen, 2017). Over prescription of antifungals and the widespread 
use of azoles in agricultural have contributed to the development of antifungal 
resistance (Snelders et al., 2009; Berger et al., 2017). Candida auris is an 
emerging multi-drug resistant global outbreak pathogen that has gained recent 
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publicity (Lockhart et al., 2017; Forsberg et al., 2019), though many strains of 
Lomentospora (Scedosporium) prolificans and Fusarium solani are also resistant 
to most known antifungals (McCarthy et al., 2018). There are currently no global 
surveillance programmes for antifungal resistance. However, the World Health 
Organisation (WHO) has recently made the addition of global antifungal 
surveillance programmes for Candida infections a priority within the Global 
Antimicrobial Resistance Surveillance System (GLASS) (WHO, 2018). Together, 
these highlight the growing issue of antifungal resistance and the need to develop 
novel antifungals. 
 
Mucoralean fungi are resistant to many available antifungals, infections are rising 
in prevalence, and they are associated with high mortality rates (Roden et al., 
2005; Katragkou, Walsh and Roilides, 2014; Dannaoui, 2017). Little is known 
about the pathogenesis of mucormycosis in comparison to other invasive fungi, 
and almost nothing is known about the impact of other opportunistic pathogens 
on virulence. For these reasons, this study focuses on gaining an understanding 
of the impact of polymicrobial relationships on Mucorales.  
 
1.2 Mucorales. 
Mucorales are ubiquitous, filamentous fungi that mainly reside as saprophytes on 
decaying organic matter and in the soil. These basal fungi are important causes 
of post-harvest food spoilage and contribute to economic loss due to crop 
wastage (Saito, Michailides and Xiao, 2016). They are also the causative agents 
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of fatal mucormycosis in immunocompromised individuals. Mucorales and 
Entomophthorales were previously grouped into a single phylum, Zygomycota, 
though they have been separated following molecular genotyping and 
Entomophthorales has risen to its own  phylum (Humber, 2012). The Order 
Mucorales comprises a group of distinct potentially pathogenic fungi that are 
linked based on their morphology (broad, aseptate hyphae), rapid growth, and 
ability to form zygospores during sexual reproduction (Hoffmann et al., 2013). 
Rhizopus, Mucor, and Lichtheimia are the most common etiological agents of 
mucormycosis, causing 70-80% of infections, with other genera including 
Cunninghamella, Rhizomucor, Apophysomyces, Saksenaea, Cokeromycetes, 
Actinomucor, and Syncephalastrum being rare sources of infection (Roden et al., 
2005). The phylogenetic relationships between several species have been 
established following genome sequencing, indicating that Mucorales are an 
evolutionarily diverse group of fungi (Chibucos et al., 2016).  
 
1.2.1 Mucoralean lifecycle. 
1.2.1.1 Asexual reproduction. The Mucoralean lifecycle involves both sexual 
and asexual reproduction (Figure 1.1), though asexual spores are the main mode 
of dispersal (Richardson, 2009). Asexual reproduction begins under favourable 
conditions (i.e. moisture, temperature, and nutrients) when an aerial hypha, or 
sporangiophore, sprouts from the lateral mycelium. Nutrients, cytoplasm, and 
nuclei accumulate at the tip of the sporangiophore, forming a bulbous 
sporangium. Within the thin-walled sporangia, multinucleated spores form around 
the tip of the stalk, called the columella. The sporangium burst, and spores are 
Chapter 1: General Introduction 
7 
 
released and passively dispersed through the air until they land on a suitable 
substrate. The spores will then undergo germination (Section 1.2.3), form 
sporangiophores, and the cycle continues (Deacon, 2006). This study involves 
the investigation of asexual spores. 
 
1.2.1.2 Sexual reproduction. Mucorales have two distinct mating types, (+) and 
(-). Sexual reproduction (Figure 1.1) begins when two hyphae of complimentary 
mating types meet adjacently. The hyphae release pheromones (trisporic acid) 
which trigger hyphal branches (progametangia) to form and grow toward each 
other (Mesland, Huisman and Van Den Ende, 1974; Money, 2016a). Nutrients, 
cytoplasm, and nuclei migrate toward the ends and cause swelling. Septa form 
at the end of each branch, trapping nuclei at the tips and forming gametangia. 
These gametangia fuse, pairs of opposite nuclei fuse, and a multinucleated, 
diploid zygospore is formed (Deacon, 2006; Money, 2016a). Following a variable 
period of dormancy, meiosis occurs within the zygospore, and a new aerial 
promycelium grows. Sporangia are formed at the tip of the promycelium, and 
spores develop within. Spores are later released to continue the lifecycle 
(Deacon, 2006; Lee and Heitman, 2014). 
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Figure 1.1 Reproductive life cycles of Zygomycetes. In the asexual cycle, spores 
germinate and form hyphae. Upon adequate conditions, sporangiophores form, with 
spore-filled sporangia on top. Spores are then dispersed, and cycle continues. Sexual 
reproduction begins with hyphae of opposite mating types meeting and hyphae 
(progametangia) branching toward each other. Swollen gametangia fuse and form a 
zygospore. After dormancy, a sporangiophore sprouts from the zygospore and the cycle 
continues. (Adapted from Deacon, 2006).  
 
1.2.2 The cell wall. For most pathogenic fungi, the structure of the fungal cell 
wall is well-characterised. For example, in Candida albicans the cell wall is 
comprised of a chitin and β-glucan inner layer, with an outer layer containing 
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mannosylated glycoproteins (Shibata et al., 2007; Wheeler et al., 2008; Gow, 
Latge and Munro, 2017). In Aspergillus spp. conidia, α-1,3-glucan, melanin, and 
hydrophobic proteins cover the inner chitin and β-1,3-glucan (Wessels, 1996; 
Paris et al., 2003; Beauvais et al., 2005; Gow, Latge and Munro, 2017). The outer 
cell wall of A. fumigatus hyphae is comprised of α-1,3-glucan, galactomannan, 
galactosaminoglycan, and proteins, with the inner cell wall being chitin and β-1,3-
glucan (Fontaine et al., 2000; Gow, Latge and Munro, 2017).  
 
The cell wall of Mucorales is less defined as compared to C. albicans and 
Aspergillus spp., and the exact structure is not known (Figure 1.2). However, it is 
understood to be mainly compromised of chitosan (26-28%) and chitin (10-15%) 
(Compos-Takaki G.M, Dietrich and Beakes, 2014). β-glucan makes up a very 
small proportion of the Mucoralean cell wall, and mucormycosis is not easily 
diagnosed through β-glucan detection tests (Karageorgopoulos et al., 2011). 
Mucorales secrete very small amounts of β-glucan in culture supernatants 
(Odabasi et al., 2006), and this polysaccharide likely does not make up a major 
part of the cell wall, is not readily shed, and/or is only present in dormant spores. 
The un-germinated Mucor circinelloides spore has an outer melanin layer and an 
inner component containing chitin, chitosan, glucan, and mannan (Bartnicki-
Garcia and Reyes, 1964; Bartnicki-Garcia, Nelson and Cota-Robles, 1968).  The 
hyphal cell wall is made of chitin, chitosan, mucoran, and mucoric acid (Bartnicki-
Garcia, Nelson and Cota-Robles, 1968). According to Bartnicki-Garcia et al. 
(1968), hyphae contain little β-glucan, which is probably be due to the decrease 
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in glucan synthase and de novo cell wall synthesis during the germination 
process, though the mechanism of restructuring is unknown.  
 
 
Figure 1.2 Cell wall of Mucorales. The cell wall structure of Mucorales is largely 
undefined. The components of the un-germinated spore and hyphal cell wall are distinct. 
Spores have an outer layer comprised of melanin and an inner layer with chitin, chitosan, 
glucan, and mannan. Hyphae contain chitin, chitosan, mucoran, and mucoric acid. 
(Adapted from Lecointe et al., 2019). 
 
1.2.3 Spore swelling and germination. Key to the pathogenesis of Mucorales 
is the ability of spores to transition from a dormant, resting state to metabolically 
active swelling spores and eventual germination (Figure 1.3). Fungal germination 
is a virulence determinant, which leads to angioinvasion, vessel thrombosis, 
tissue necrosis, and death (Ibrahim, Spellberg, et al., 2005). Exposure to acidic 
pH, water, and nutrients (such as glucose and nitrogen) activates two pH-
dependent aquaporins (RdAQP1 and RdAQP2) on the surface of R. delemar 
spores (Figure 1.3A) (Turgeman et al., 2016). This induces an active isotropic 
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growth, where the spores swell approximately 3-fold, allowing the acquisition of 
water and necessary nutrients to begin germinating (Figure 1.3B) (Turgeman et 
al., 2016).  While dormant spores exhibit very little chitin, swelling enhances the 
surface chitin (Sephton-Clark et al., 2018). Molecularly, swelling involves cell well 
biogenesis, protein synthesis, sugar metabolism, and an increase in intracellular 
reactive oxygen species (ROS) (Sephton-Clark et al., 2018).  
 
Isotropic growth provides nutrients necessary for driving germination. Following 
this, the spores become polarised and germ tubes emerge at polarised regions 
prior to hyphal elongation (Figure 1.3C) (Money, 2016b). Mechanisms for 
germination are less defined in Mucorales than in other filamentous fungi, though 
Rhizopus delemar has been shown transcriptionally to enhance cytoskeleton 
regulation, cell wall remodelling, and stress response genes during germination 
(Sephton-Clark et al., 2018). In Aspergillus nidulans, germination is triggered by 
available carbon sources, which activate RasA and initialise protein synthesis 
(Osherov and May, 2000). While C. albicans filamentation is regulated by the 
cyclic adenosine monophosphate (cAMP) / Protein Kinase A (PKA) and mitogen-
activated protein kinase (MAPK) pathways (Stoldt et al., 1997; Alonso Monge et 
al., 2006), A. fumigatus germination is not PKA dependent (Osherov and May, 
2000).  
 
Rather than restructuring the cell wall for hyphal protrusion, M. circinelloides 
synthesises a new cell wall underneath the existing one during swelling before 
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the germ tube breaks through (Figure 1.3D and E) (Bartnicki-Garcia, Nelson and 
Cota-Robles, 1968). During filamentation, cell membrane synthesis, migration of 
the cytoplasm, and maintenance of hyphal turgor pressure also occur (Steinberg, 
2007; Money, 2016b). Germination involves the delivery and accumulation of 
vesicles from the Golgi apparatus to the growing hyphal tip along microfilaments 
(Johnston, Prendergast and Singer, 1991). In most fungi, these vesicles form a 
dark body, known as the Spitzenkörper which facilitates hyphal elongation via the 
delivery of essential nucleic acids, F-actin, and other components of the cell wall 
that fuse to the growing tip (Howard and Aist, 1979; Bartnicki-Garcia et al., 1995). 
Mucorales hyphae also utilise a vesicle-based delivery service, termed the apical 
vesicle crescent (AVC), which is essential for proper germination (Figure 1.3F) 
(Fisher and Roberson, 2016b). In contrast to the Spitzenkörper, the AVC has an 
unorganised structure and does not strongly control directional growth (Fisher 
and Roberson, 2016b). The exact contents of the AVC are unknown, and it is 
currently debated whether the AVC is a type of Spitzenkörper or if they are 
completely different structures (Fisher and Roberson, 2016a).  
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Figure 1.3 Spore swelling and germination of Mucorales. (A) When resting spores 
are exposed to water, acidic pH, and nutrients, the aquaporins RdAQP1 and RdAQP2 
are activated. (B) These allow for the influx of water and nutrients necessary to drive 
germination, resulting in swollen spores. Swelling involves cell wall biogenesis and 
increased chitin. Germination is initiated through (C) polarisation and (D) de novo cell 
wall synthesis under existing cell wall. (E) Germ tube protrudes at polarised point. (F) 
Hyphal elongation is mediated by delivery of vesicles to the growing tip, called the apical 
vesicle crescent. Within a host, germination results in (G) angioinvasion, vessel 
thrombosis, and tissue necrosis. Created with Biorender (www.biorender.com). 
 
1.2.4 Mucormycosis. Mucorales are the etiological agents of mucormycosis, a 
fatal infection occurring in immunocompromised patients. This includes 
individuals with cancer, neutropenia, chronic renal failure, and burn, blast, or 
traumatic wounds. Mucormycosis also occurs post-transplantation, post-
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tuberculosis, and following corticosteroid therapy (Roden et al., 2005; Prakash 
and Chakrabarti, 2019). The most common underlying condition is uncontrolled 
diabetes, which accounts for 38% of cases (Roden et al., 2005). Different to other 
fungal infections, such as candidiasis and cryptococcosis, HIV/AIDS is not a 
major risk factor for mucormycosis, and co-infection with the virus is rare (Moreira 
et al., 2016). This is likely because of the necessity of innate immune cells, rather 
than T-cells, to control Mucorales (Ibrahim et al., 2012). Mucormycosis does 
occur in late-stage AIDS, in patients with median CD4+ counts of 47, and it is 
usually associated with neutropenia or intravenous drug use (Moreira et al., 
2016).   
 
The most frequent manifestations of Mucorales infections are rhinocerebral, 
cutaneous, and pulmonary mucormycosis (Jeong et al., 2019). Mortality is 
exceptionally high, and mortality rates are 54% overall though outcome varies 
based on location of infection. Death occurs in 46% of rhinocerebral, 76% of 
pulmonary, and 96% of disseminated mucormycosis, where 13-23% of infections 
become disseminated (Roden et al., 2005; Jeong et al., 2019).   
 
Mucormycosis is classically considered to be a rare disease. However, 
epidemiological studies have reported rising incidences of infection, and it is now 
considered the second most common invasive mould infection and the third most 
prevalent cause of angioinvasive fungal disease (Kennedy et al., 2016; Trieu et 
al., 2017; Prakash and Chakrabarti, 2019). A 10-year retrospective study in 
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France reported an elevated incidence of mucormycosis from 0.7 to 1.2 cases 
per million hospitalised persons, rising 7.3% each year (Bitar et al., 2009). In the 
United States, approximately 0.12 per 10,000 patients are hospitalised with 
mucormycosis (Kontoyiannis et al., 2016).  This rise is likely due to enhanced 
awareness, improved diagnostic methods, and increases in diabetes and age-
associated immunocompromising diseases. Global prevalence is estimated to be 
less than 10,000 cases per year (Bongomin et al., 2017), but some regions are 
more prone to mucormycosis, with India and Pakistan seeing 140 cases of 
mucormycosis per million patients (Chakrabarti and Dhaliwal, 2013; Jabeen et 
al., 2017).  
 
1.2.5 Pathogenesis and infection. Spores enter the body through inhalation, 
exposure to mucosal surfaces, ingestion of contaminated food, or contamination 
of wounds. In a healthy individual, phagocytes engulf spores and inhibit 
germination, though resting spores are resistant to killing (Waldorf, Ruderman 
and Diamond, 1984). However, swollen spores are susceptible to killing by 
macrophages and neutrophils (Levitz et al., 1986). More recently, swollen 
Rhizopus microsporus spores were shown to inhibit macrophage phagocytosis 
and survive within macrophages, which is dependent on the presence of the 
bacterial endosymbiont, Ralsonia pickettii (Itabangi et al., 2019, preprint). 
Intracellular inhibition of spore swelling and germination through iron restriction 
maintains melanin on the cell wall, which inhibits phagosome maturation and 
prevents killing (Andrianaki et al., 2018). Some virulent M. circinelloides strains 
can survive and germinate within macrophages in vitro. This process is 
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dependent on ROS response pathways and is regulated by the transcription 
factors Atf1 and Atf2 (activating transcription factor) (Pérez-Arques et al., 2019).  
 
Following infection, neutrophils exhibit delayed recruitment to infection sites, 
possibly due to the lack of neutrophil chemoattractants produced by resting 
spores. Once swollen, spores then produce chemotactic molecules (Waldorf and 
Diamond, 1985). Mucorales activate Toll-like receptor 2 on polymorphonuclear 
neutrophils and stimulate the immune system through the NF-κB pathway 
(Chamilos et al., 2008). Despite this, neutrophils cannot kill resting spores, though 
they are able to damage and kill the hyphae of germinated Rhizopus oryzae 
through oxidative stress, defensins, and neutrophil extracellular traps (NETs) 
(Ibrahim et al. 2012; Diamond & Clark 1982). However, neutrophil damage to 
Mucoralean hyphae is still attenuated when compared with A. fumigatus 
(Chamilos et al., 2008).  
 
Immunodeficiency results in decreased lymphocyte numbers, insufficient 
chemotaxis, and/or depressed phagocytosis, and the immune system is unable 
to effectively control infection (Waldorf, Ruderman and Diamond, 1984). 
Adherence and invasion of epithelial cells is key for the pathogenesis of 
mucormycosis, and the initial adherence is mediated by the host’s epithelial 
growth factor receptor (EGFR). Inhibition of EGFR signalling decreases virulence 
of R. oryzae in mouse models (Watkins et al., 2018).  Angioinvasion is a hallmark 
of mucormycosis, and attachment to endothelial cells is mediated by the binding 
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of the spore cell wall ligand CotH to glucose-regulated protein 78 (GRP78) on the 
surface of endothelial cells (Gebremariam et al., 2014). Binding of CotH by 
GRP78 only occurs in germlings, rather than un-germinated spores (Liu et al., 
2010). Copies of CotH in the genome is associated with prevalence of infection, 
with the most common etiological agent, R. delemar, containing 6-7 copies of 
CotH and the rarer species, C. bertholletiae, only containing 1-2 copies (Baldin 
et al., 2018). In diabetic patients, increased glucose, ketone bodies (such as β-
hydroxy butyrate), and iron enhance the expression of GRP78 and CotH, which 
explains why diabetes is a major risk factor for mucormycosis (Liu et al., 2010).  
 
1.2.6 Iron dependency, uptake, and storage. While iron is essential for the 
pathogenesis of all microorganisms, Mucorales have a uniquely strong 
dependence on available iron. In comparison to C. albicans and A. fumigatus, the 
virulence of R. oryzae is highly regulated by iron availability (Abe et al., 1990). 
Mucorales are unable to grow in human serum and supplementation with 
exogenous iron recovers germination, suggesting their inability to scavenge iron 
from host proteins (Artis et al., 1982). Consistent with this, conditions where iron 
overload occurs, such as during blood transfusions or renal failure, are risk 
factors for mucormycosis (Ibrahim, Spellberg and Edwards, 2008). In patients 
with diabetic ketoacidosis (DKA), where blood pH is between 7.3-6.8, the 
hydrogen bonds connecting iron to transferrin are weakened, increasing the 
levels of free iron (Figure 1.4). The normal concentration of serum iron in healthy 
individuals is 10-18 M (1 x 10-13 µg/dl) (Bullen, Rogers and Griffiths, 1978). 
However, acidotic individuals have levels between 13 µg/dl to 69 µg/dl, and 
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exposure of R. oryzae to these conditions allows for germination (Artis et al., 
1982). Iron is also essential for spore survival, and extended periods of iron 
starvation induces apoptosis (Shirazi, Kontoyiannis and Ibrahim, 2015).  
 
Most fungi produce hydroxamate siderophores; however, Mucorales produce a 
carboxylate siderophore called rhizoferrin, which has a much lower affinity for iron 
than the hydroxamates (Thieken and Winkelmann, 1992). Unlike many bacterial 
and fungal siderophores, rhizoferrin is unable to extract iron from host 
sequestering proteins and is therefore not currently believed to play a role in 
fungal pathogenicity (Ibrahim, Spellberg and Edwards, 2008).   
 
The main route for Mucorales to acquire iron is via the high affinity iron permease, 
Ftr1 (Figure 1.4) (Fu et al., 2004; Ibrahim et al., 2010). FTR1 is expressed in iron-
deprived conditions and works in cooperation with ferric reductases on the cell 
wall. These reduce ferric to ferrous iron in preparation for intracellular transport. 
After being transported through the cell wall, a copper oxidase converts ferrous 
iron to ferric iron, before further transport into the cytoplasm (Stearman et al., 
1996). Iron is bound to ferritin for storage, and Mucorales are the only fungi which 
synthesise ferritin (Figure 1.4) (Matzanke, 1994; Ibrahim et al., 2012). FTR1 is 
necessary for virulence of R. oryzae in vivo, providing further evidence of the 
essentiality of iron for pathogenesis (Ibrahim et al., 2010). 
 
Chapter 1: General Introduction 
19 
 
While rhizoferrin is ineffective in human infections, Mucorales utilise 
deferoxamine as a xenosiderophore. Deferoxamine is a siderophore produced by 
Streptomyces pilosis (Yamanaka et al., 2005) and is an iron chelation drug for 
patients with risk of iron-overload (Windus et al., 1987). Mucorales bind 
ferrioxamine (the iron rich form of deferoxamine) through Fob1 and Fob2 
receptors that allow the spores to extract, reduce, and absorb the bound iron 
(Figure 1.4) (Liu et al., 2015).  
 
Figure 1.4 Iron acquisition mechanisms in Mucorales. In a diabetic host, DKA 
weakens hydrogen bonds, allowing for the scavenging of iron from transferrin. Ferric 
(Fe3+) iron is reduced to its ferrous (Fe2+) form via a reductase on the cell surface. Fe2+ 
is then oxidised by a copper-oxidase and transferred into the cytoplasm via Ftr1. Iron is 
bound to ferritin for storage. Deferoxamine is a xenosiderophore, and ferrioxamine (the 
iron-rich form of deferoxamine) binds to Fob1/Fob2 on the spore surface. Reductive 
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uptake continues as previously described. (Adapted from Ibrahim, Spellberg and 
Edwards, 2008). 
 
1.2.7 Diagnosis. While early diagnosis is essential for the effective treatment of 
mucormycosis, diagnostic methods are currently lacking. Clinical characteristics 
are generic and are often confused with other fungal infections, such as 
aspergillosis and fusariosis, or bacterial infections, like P. aeruginosa (Katragkou, 
Walsh and Roilides, 2014). Pulmonary infections manifest as a high fever, non-
productive cough, chest pain, and difficulty breathing. Radiographical diagnosis 
is difficult, as chest images also provide non-specific results that are often 
confused with aspergillosis (Petrikkos et al., 2012). The most common form of 
mucormycosis, rhinocerebral mucormycosis, presents as pain and blurred vision, 
and is usually identified by black, necrotic tissue on the face or hard palate 
(Petrikkos et al., 2012). However, after infection has progressed to this extent, 
survival is unlikely. 
  
Biopsy and histopathology are used as diagnostic techniques and can be 
accurate if performed by highly trained personnel familiar with distinguishing 
between aspergillosis and mucormycosis (Baldin et al., 2018). Microscopically, 
Mucorales present as irregular, broad, aseptate hyphae (Frater, Hall and Procop, 
2001), while Aspergillus spp. have thin, septate hyphae that are regularly 
branched at acute angles (Hope, Walsh and Denning, 2005).  
 
Chapter 1: General Introduction 
21 
 
There are currently no serological diagnosis tests used for mucormycosis. 
However, assays have been developed for the diagnosis of C. albicans and 
Aspergillus spp., based on the detection of circulating β-1,3-D-glucan (BG tests) 
(Richardson and Page, 2018). However, these are generally ineffective for 
diagnosing mucormycosis as Mucorales contain very little cell wall glucans 
(Mélida et al., 2015; Richardson and Page, 2018). However, this is a source of 
contention in the field, as there have been reports of positive BG tests in patients 
with confirmed mucormycosis (Angebault et al., 2016), and β-glucan synthetase 
can be found in the genome (Ibrahim, Bowman, et al., 2005).   
 
Mycological culture remains the gold standard, even though Mucorales are poorly 
culturable from active, necrotic lesions. Sensitivity of culture is low, with only one-
third of mucormycosis cases detected this way (Lackner, Caramalho and Lass-
Flörl, 2014). Molecular diagnostic approaches are in its infancy, though there has 
been recent progress in developing a non-invasive PCR-based assay. Here, the 
antigen CotH could be accurately detected in the urine of infected mice, with a 
sensitivity of 90% and specificity of 100%. This was effective for all Mucorales 
tested and was negative for mice infected with A. fumigatus as a control (Baldin 
et al., 2018). Therefore, future diagnostic methods will likely involve PCR 
identification for rapid, non-invasive, specific detection.   
 
1.2.8 Treatment. Extensive necrosis makes this infection difficult to treat, with 
necrotic tissue preventing leukocytes and antifungals from reaching the infection 
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site (Ibrahim et al., 2012). Effective therapy involves intensive antifungal 
treatment, surgical debridement, and reversal of underlying condition. Antifungal 
therapy alone is rarely effective and surgical debridement of the affected tissue 
is usually required. This leads to extensive, permanent disfiguration and high 
patient morbidity (Kontoyiannis and Lewis, 2011). Despite therapeutic 
interventions, mortality can reach 96% in disseminated mucormycosis even with 
rigorous antifungal administration (Katragkou, Walsh and Roilides, 2014). 
Treatment of mucormycosis is expensive, with each patient costing 
approximately $112,000 in the United States (Kontoyiannis et al., 2016).  
 
1.2.8.1 Antifungals. Mucorales are inherently resistant to short-tail azoles, such 
as fluconazole and voriconazole. Azoles’ main mode of action is through 
destabilisation of the cell membrane through the inhibition of ergosterol 
biosynthesis, as ergosterol is the major component of the fungal cell membrane 
(Hitchcock et al., 2015). Azoles specifically act on the lanosterol 14α-
demethylase in the ergosterol biosynthesis pathway, and Mucoralean resistance 
to short-tailed azoles is due to an amino acid substitution in this enzyme 
(Caramalho et al., 2017). However, mid- and long-tail azoles can be effective in 
mucormycosis, as isavuconazole and posaconazole are used as salvage 
therapies (van Burik et al., 2006; Graves et al., 2016).  
 
Due to the limited efficacy of the azoles against Mucorales, the polyene 
amphotericin B is the first-line treatment for mucormycosis. Like the azoles, 
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amphotericin B disrupts the fungal cell membrane. However, instead of inhibiting 
biosynthesis, amphotericin B binds to ergosterol and creates pores in the cell 
membrane (Finkelstein and Holz, 1973). While mostly effective, some strains of 
Mucorales display resistance to amphotericin B, and high doses are necessary 
to impact fungal growth, often resulting in renal failure (Ibrahim, Spellberg and 
Edwards, 2008). Because of this, lipid formulations of amphotericin B (also known 
as AmBisome) are utilised to reduce nephrotoxicity, though damage still occurs 
in prolonged treatment with high doses (Personett et al., 2019). For patients with 
haematological malignancies, amphotericin B treatment leads to 39% survival, 
while liposomal amphotericin increases survival rates to 62% (Gleissner et al., 
2004). Distribution of the antifungals into necrotic tissue is difficult, though 
utilisation of polymethylmethacrylate beads loaded with amphotericin B as a 
delivery system within a soft-tissue necrotic wound reduced fungal burden in a 
patient with cutaneous mucormycosis (Heller et al., 2017). Mucorales exhibit high 
variability of antifungal susceptibility between species, with minimum inhibitory 
concentrations of amphotericin B for Cunninghamella being significantly higher 
than for Rhizopus and Mucor. Further, R. oryzae tends to be resistant to 
pozaconazole, while M. circinelloides is generally susceptible (Katragkou, Walsh 
and Roilides, 2014). 
 
Echinocandins alone are not effective against Mucorales. These drugs inhibit cell 
wall synthesis, and the lack of activity against Mucorales could be caused by an 
upregulation of chitin synthase in response to the induced cell wall stress, as 
found with C. albicans (Walker et al., 2008).  However, studies have found a 
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combination of amphotericin B and caspofungin to synergise against R. delemar 
(Reed et al., 2008; Kazak et al., 2013).  
 
1.2.8.2 Alternative strategies. As iron is essential for the pathogenesis of 
mucormycosis, iron chelators have been explored as adjunct therapies. When 
administered alongside amphotericin B, deferasirox (also known as Exjade) 
synergises and improves survival of infected mice (Ibrahim et al., 2007). 
Furthermore, deferasirox used as a salvage therapy following liposomal 
amphotericin B treatment in a patient with rhinocerebral mucormycosis led to 
complete recovery (Reed et al., 2006). Because of this, a clinical trial known as 
the DEFEAT Mucor (Deferasirox–AmBisome Therapy for Mucormycosis) study 
was performed, but unfortunately more patients in the deferasirox treated arm 
died than in the control (Spellberg et al., 2012).  
 
Recently, anti-CotH antibodies have been shown to protect mice against 
mucormycosis and synergize with antifungals (Gebremariam et al., 2019). This 
indicates a potential use for immunotherapy in treating human infection in the 
future. 
Taken together, this highlights the necessity for novel therapeutic targets and 
investigation into unknown regulators of pathogenesis, including the impact of 
polymicrobial interactions on fungal virulence.  
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1.3 Polymicrobial interactions. 
Microbiological research has historically been approached from a mono-
pathogen perspective, and many clinical diseases were originally thought to be 
caused by a single etiological agent. However, in recent years there is an 
increase in the understanding that no organism lives in isolation, and that to fully 
understand the pathogenesis of an individual microbe, the influence of others 
must be recognised. Bacteria, fungi, and viruses have co-evolved to develop 
elaborate and intricate relationships, which are present in both healthy and 
diseased states. These relationships can strongly influence the pathogenesis of 
each organism, the progression of infection, and the overall patient prognosis. 
For example, while mono-infections with C. albicans or S. aureus in a murine 
model of peritonitis were not life-threatening, co-infection resulted in a 40% 
mortality rate, increased inflammation, and greater microbial burden (Peters and 
Noverra, 2013). Polymicrobial interactions can occur throughout the body (Figure 
1.5) and can be more resistant to antimicrobial therapy, resulting in poorer host 
prognosis (Carlson, 1982; Harriott and Noverr, 2009).  
 
As Mucorales are naturally environmental saprophytes, they have evolved 
alongside microbes within the soil, on decaying plants and animals, and while 
colonising plant roots.  In a clinical setting, mucormycosis can occur in blast, burn, 
and traumatic wounds, where 70% of infections are polymicrobial (Akers et al., 
2014; Warkentien et al., 2015). Furthermore, mucormycosis can emerge post-
transplantation in patients with Cystic Fibrosis (CF) whose lung environment is 
usually polymicrobial even post-transplantation (Hunstad, Cohen and St. Geme, 
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1999; Brugière et al., 2005; Rabin and Surette, 2012; Syed et al., 2016). The 
impact of other microorganisms on Mucorales virulence is largely unknown, 
though polymicrobial interactions play a definitive role in the pathogenicity of 
other microbes (Peters et al., 2012). 
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Figure 1.5 Sites of polymicrobial infections. Polymicrobial interactions can occur in 
various sites throughout the body and can impact overall disease outcome (This figure 
has been published in Microbiology Today, Kousser, Alam and Hall, 2019).  
 
1.3.1 Mechanisms of intra- and inter-species interactions. Microorganisms 
can interact through a variety of different methods. The most well-studied 
mechanisms include physical cell-to-cell contact, such as biofilm formation or 
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attachment of bacteria to fungal hyphae (Hogan and Kolter, 2002; Harriott and 
Noverr, 2009; Schlecht et al., 2015); and chemical interactions, where the 
production of toxins, secondary metabolites, or other molecules influences the 
growth and development of the other microbe (Holcombe et al., 2010; Mowat et 
al., 2010). Another method of interaction is through the alteration of host immune 
responses. For example, C. albicans can prime the immune system upon initial, 
sub-lethal exposure, and enhance immune response to secondary P. aeruginosa 
infection. This leads to more effective clearing of the bacterial burden (Quintin et 
al., 2012; Mear et al., 2014).  
 
1.3.2 Competitive vs. cooperative relationships. Polymicrobial interactions 
can manifest in the form of cooperative or competitive relationships. Cooperative 
interactions result in the individual organisms working together to survive within 
a host. The result of cooperation can be additive, where the impact of each 
organism combines. Additive effects are usually found within multi-species 
biofilms, for example in periodontal disease, where a myriad of Gram-negative 
and Gram-positive bacteria and C. albicans form complex biofilms in the oral 
cavity (Kolenbrander, 2002). Some cooperative relationships can also be 
synergistic, where the relationships between microbes enhance their respective 
virulence. This results in effects greater than additive and can promote more 
aggressive infections. C. albicans and S. aureus have been found to work 
synergistically together, where co-infections lead to enhanced microbial burden 
of each organism in the vaginal epithelium (Pidwill et al., 2018). The binding of S. 
aureus to C. albicans hyphae promotes deeper penetration of bacteria into the 
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host and can lead to systemic infection (Schlecht et al., 2015). Furthermore, 
Group B Streptococcus promotes the survival of E. coli in a urinary tract infection, 
resulting in more aggressive, reoccurring infections (Kline et al., 2012).  
 
However, not all microbes work together. Some relationships are antagonistic, 
where they compete for resources and space. Organisms can either actively fight 
against their competition or they can make colonisation difficult by creating a 
hostile niche. Competition between organisms usually results in the death or 
inhibition of virulence of one or both organisms. P. aeruginosa is implicated in a 
variety of antagonistic relationships with both bacteria and fungi. For example, P. 
aeruginosa and A. fumigatus form a mutually antagonistic relationship within the 
CF lung (Reece et al., 2018). In this case, P. aeruginosa induces apoptosis of A. 
fumigatus, while A. fumigatus can inhibit biofilm formation of P. aeruginosa 
(Shirazi et al., 2016; Reece et al., 2018). P. aeruginosa can also inhibit 
filamentation of C. albicans, while C. albicans can reduce the virulence of P. 
aeruginosa by suppressing virulence factor secretion (Hogan, Vik and Kolter, 
2004; Lopez-Medina et al., 2015). Bacteria can also compete against each other. 
For instance, there is an inverse association between individuals who test positive 
as carriers for Streptococcus pneumoniae and those who carry S. aureus, 
presumably due to competition (Regev-Yochay et al., 2004; Chao et al., 2015).  
 
1.3.3 Mucorales and C. albicans. C. albicans is the most well-characterised and 
commonly implicated fungus participating in polymicrobial interactions. As it is 
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part of the microbiome and present in numerous niches, interactions between C. 
albicans and Mucorales likely occur. Because standard diagnostic techniques for 
identifying mucormycosis have a low sensitivity and the incidence of fungi is 
under-reported in general, there is limited data regarding co-isolation with other 
fungi. Therefore, it is not currently known whether C. albicans interacts with any 
Mucorales. However, both fungi are present in burn and post-traumatic wounds, 
diabetic-associated infections, and CF-associated lung transplantations (Kubak, 
2012; Neto et al., 2014; Mendoza et al., 2015). Furthermore, Candida glabrata 
and Rhizopus microsporus were co-isolated in a case of peritonitis (Monecke et 
al., 2006). It is possible to extrapolate the potential interaction between R. 
microsporus and C. albicans in this context, as C. albicans is also isolated in 
peritonitis and associated with high mortality rates (Cheng et al., 2013). 
Interestingly, fungal chitosan extracted from Rhizomucor miehei and Mucor 
racemosus was shown to have anti-fungal properties on C. albicans and C. 
glabrata, which could indicate a potential contact-dependent interaction (Tajdini 
et al., 2010). C. albicans inhibits other filamentous fungi via secreted factors 
(Semighini et al., 2006; Semighini, Murray and Harris, 2008), therefore it is 
reasonable to hypothesize that C. albicans will have similar inhibitory effects on 
Mucorales. 
 
1.3.4 Mucorales and bacteria. As immunocompromised individuals are at high 
risk for polymicrobial infections involving both opportunistic bacteria and fungi, it 
is likely that Mucorales come into contact with several bacterial species. For 
instance, Rhizopus spp. and Klebsiella pneumoniae have been co-isolated in 
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cases of pulmonary gangrene (Chougule et al., 2015). Mucormycosis was also 
found in a patient with uncontrolled diabetes who originally suffered from K. 
pneumoniae infection and tuberculosis (Dogra et al., 2015). Moreover, Dimaka et 
al. (2014) explain that chronic rhinocerebral mucormycosis may present as a co-
infection with other organisms, and they specifically highlight P. aeruginosa. The 
majority of wound infections are polymicrobial (Akers et al., 2014; Warkentien et 
al., 2015) and 19% of mucormycosis cases are cutaneous (Roden et al., 2005; 
Jeong et al., 2019). P. aeruginosa, S. aureus, and Escherichia coli are the most 
commonly isolated bacterial species from chronic wounds (Gjødsbøl et al., 2006; 
Kalan et al., 2016), and are therefore likely to interact with Mucorales spores. 
Furthermore, fungal chitosan extracted from R. miehei and M. racemosus is not 
only antimicrobial against C. albicans, but also against P. aeruginosa and 
Escherichia coli (Tajdini et al., 2010). Serratia marcescens interacts with R. 
oryzae by binding to, migrating along, and killing the hyphae of R. oryzae (Hover 
et al., 2016). This is most likely not a S. marcescens-specific phenomenon and it 
is probable that other bacteria are able to interact in a similar way.   
 
Mucormycosis presents with non-specific symptoms and is commonly 
misdiagnosed as being caused by other infectious agents. Sometimes the 
presence of commensal bacteria or a bacterial infection will mask mucormycosis, 
a situation known as “Green Herring Syndrome” (Peixoto et al., 2014). This 
delays diagnosis of mucormycosis and leads to poorer patient outlook and 
increased mortality. Examples of this occurring in mucormycosis patients with 
concurrent E. coli or P. aeruginosa infections have been reported, and P. 
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aeruginosa infection is one of the differential diagnoses for mucormycosis 
(Katragkou, Walsh and Roilides, 2014; Peixoto et al., 2014).  
 
Mucormycosis has been associated with the use of antibiotics, and it is suggested 
that treatment with broad spectrum antibiotics can lead to fungal infections 
(Ribes, Vanover-Sams and Baker, 2000). Early speculation regarding the 
emergence of mucormycosis was attributed to the growing widespread use of 
antibiotics (Baker, 1957). Furthermore, another early study found a 10-fold 
increase in aseptate fungal burn wound infections following the advent of topical 
antibiotics (Nash et al., 1971). This could indicate that antibiotics kill inhibitory 
bacteria, removing pressures and allowing for secondary mucormycosis.  
 
Increasing evidence suggests that most species of Mucorales harbour 
endosymbiotic bacteria, usually Burkholderia or Ralstonia spp., that influence 
fungal reproduction and virulence (Mondo et al., 2017; Itabangi et al., 2019, 
preprint) though there has been conflicting results (Ibrahim et al., 2008). In terms 
of plant pathogenesis, the endosymbionts Burkholderia rhizoxinica and 
Burkholderia endofungorum secrete rhizoxin, a chemical which causes rice 
seedling blight (Partida-Martinez et al., 2007).  
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1.4 Aim of this study.  
Mucormycosis is a debilitating infection with limited treatment options and a high 
mortality rate. While the presence of other microorganisms is known to impact 
the growth and development of fungi such as Aspergillus spp. and C. albicans 
(Kerr et al., 1999; Hogan and Kolter, 2002; Hogan, Vik and Kolter, 2004; Ferreira 
et al., 2015), little is known about the impact of polymicrobial interactions on 
Mucoralean pathogenesis. As bacteria and fungi rarely exist in isolation, the 
progression of mucormycosis is likely affected by these organisms. This study 
aims to investigate whether Mucorales are influenced by polymicrobial 
interactions, the mechanisms surrounding these relationships, and how the host 
could be affected.  
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2.1 Strains and culture conditions.  
All media and chemicals were purchased from Sigma-Aldrich unless stated 
otherwise. For details of fungal and bacterial strains used, please see (Table 1). 
Mucorales were routinely sub-cultured (1 x 104 spores/ml, Section 2.1.2), 
maintained on Sabouraud 4% dextrose agar (SAB, Merck Millipore, Germany), 
and incubated for 10-14 days before use (25˚C). Candida albicans was 
maintained on Yeast Extract Peptone Dextrose (YPD) with 2% agar. Bacteria 
were maintained on Lysogeny broth (LB) with 2% agar.  
 
Table 2.1 Strains used in this project.  
Strain Characteristics Source 
Rhizopus microsporus 
12.6652333 
Clinical isolate, non-
invasive 
(Trzaska et al., 2015) 
Queen Elizabeth Hospital  
Cunninghamella 
bertholletiae 182 
Clinical isolate, lungs (Simitsopoulou et al., 
2010) 
University of Kentucky 
College of Medicine 
Lichtheimia corymbifera Clinical isolate, wound (Trzaska et al., 2015) 
Queen Elizabeth Hospital 
Candida albicans 
SC5314 
Wild type (Meyers et al., 1968) 
 
R. microsporus var. 
microsporus 
Clinical isolate Westerdijk Fungal 
Biodiversity Institute 
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CBS 699.68 
R. microsporus var. 
chinensis 
CBS 631.82 
Clinical isolate Westerdijk Fungal 
Biodiversity Institute 
R. delemar RA 99-880 Clinical isolate Fungal Genetics Stock 
Centre 
Mucor circinelloides 
NRRL3631  
Clinical isolate ARS Culture Collection 
(NRRL) 
Burkholderia 
cenocepacia K56-2 
Clinical isolate from 
Cystic Fibrosis 
(Darling et al., 1998) 
Klebsiella pneumoniae 
ATCC43816R  
Spontaneously 
rifampicin-resistant. 
Derived from clinical 
isolate ATCC43816 
(Bakker-Woudenberg et 
al., 1985) 
Staphylococcus aureus 
USA300 
Wild type (Hawley et al., 2013) 
Escherichia coli 
MG1655 
Wild type (Stones et al., 2017) 
Pseudomonas 
aeruginosa PAO1 
ATCC15692 
Wild type American Type Culture 
Collection (ATCC) 
P. aeruginosa PAO1 Wild type (Holloway, 1955; Ghysels 
et al., 2004) 
P. aeruginosa ΔpchEF PAO1, deleted 
pyochelin 
(Ghysels et al., 2004) 
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P. aeruginosa ΔpvdD PAO1, deleted 
pyoverdine 
(Ghysels et al., 2004) 
P. aeruginosa 
ΔpchEFΔpvdD 
PAO1, deleted 
pyochelin and 
pyoverdine 
(Ghysels et al., 2004) 
P. aeruginosa PA14 Wild type (Rahme et al., 1995) 
P. aeruginosa:mCherry PA14 with 
PME6032:mcherry 
plasmid 
This study 
P. aeruginosa CHA Clinical isolate, Cystic 
Fibrosis 
(Delic-Attree et al., 1996) 
Centre Hospitalier 
Universitaire of Grenoble 
P. aeruginosa MID Clinical isolate, Cystic 
Fibrosis 
(Scott and Pitt, 2004) 
Heartlands Hospital 
P. aeruginosa LIV Clinical isolate, Cystic 
Fibrosis 
(Cheng et al., 1996) 
Heartlands Hospital 
P. aeruginosa blood Clinical isolate, blood Queen Elizabeth Hospital 
Birmingham 
P. aeruginosa 985 Clinical isolate, burn 
wound 
(Quick et al., 2014) 
P. aeruginosa 1008 Clinical isolate, burn 
wound 
(Quick et al., 2014) 
P. aeruginosa 1009 Clinical isolate, burn 
wound 
(Quick et al., 2014) 
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2.1.2 Maintaining and sub-culturing Mucorales. Fungal spores were 
maintained on SAB agar (25°C) and routinely sub-cultured onto fresh SAB agar 
plates once per week to maintain active stocks. A 100 μl droplet of sterile 
phosphate buffered saline (PBS) was added to each new agar plate. A small 
sample of spores were scraped from a parent plate using a sterile pipette tip, 
added to the PBS, and spread using an L-shaped spreader. Every two months, 
the active spore stock was replaced with spores from a freezer stock, stored in 
CryoTubes (Fisher-Scientific, Pro-Lab Diagnostics Microbank Bacterial and 
Fungal Preservation System) at -80°C.  
 
2.1.3 Harvesting sporangiospores. After at least 10 days of growth on SAB 
agar, plates containing fungi were flooded with 10 ml PBS. Hyphae were carefully 
broken to release spores by gently using an L-shaped spreader, and spores were 
collected into a 15 ml falcon tube. The spore solution was centrifuged (3000 rpm, 
3 minutes), washed and resuspended in PBS. Spores were counted using a 
haemocytometer, adjusted to desired concentration, and kept on ice until needed 
to prevent swelling and metabolic activity.  
 
2.1.4 Creating frozen spore stocks. After 10-14 days of growth, spores were 
harvested as above, centrifuged (3000 rpm, 3 minutes), and resuspended in 800 
μl PBS. Concentrated spore stocks were added to CryoTubes (Fisher-Scientific, 
Pro-Lab Diagnostics Microbank Bacterial and Fungal Preservation System) in 
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duplicate and mixed well. One vial was stored in liquid nitrogen and the other in 
a -80°C freezer. 
 
2.2 Elucidating the effect of supernatants on Mucorales.  
2.2.1 Exposing Mucorales to Candida albicans supernatant.  YPD broth (5 
ml) was inoculated with C. albicans and incubated for 24 hours (37˚C, 200 rpm) 
in 50 ml falcon tubes. Cultures were centrifuged (4000 rpm, 4 minutes) and 
sterilised using 0.22 μm syringe filters. Sterile supernatants were stored at -80˚C 
until required. R. microsporus (n=4), L. corymbifera (n=3), and C. bertholletiae 
(n=3) spores (1 x104 spores/ml) were added to a well plate containing either 50% 
SAB and 50% YPD broth or 50% SAB and 50% supernatant. Fungal germination 
was monitored over 18 hours using live cell imaging (37°C with humidity), and 
the percent of spores germinated in each field of view was quantified (Section 
2.7.3). Two-way Repeated Measures ANOVA with Tukey’s multiple comparisons 
test was used on arcsine transformed data to analyse significance (Section 
2.13.1). 
 
2.2.2 Exposing Mucorales to bacterial supernatants. LB broth (10 ml) was 
inoculated with bacteria (P. aeruginosa, B. cenocepacia, E. coli, K. pneumoniae, 
or S. aureus) and incubated for 24 hours (37˚C, 200 rpm) in 50 ml glass conical 
flasks until absorbance (OD600) reached at least 3.0. Cultures were separated 
into 10 ml aliquots and centrifuged (4500 rpm, 10 minutes) and the resulting 
supernatant was sterilised using 0.22 μm syringe filters. Sterile supernatants 
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were stored at -80˚C until required. Spores (1 x104 spores/ml) were added to a 
well plate containing either 50% SAB and 50% LB, or 50% SAB and 50% 
supernatant. Fungal germination and growth were determined by endpoint 
analysis after 24 hours using absorbance (OD600) as a quantifier of growth 
(FLUOstar Omega plate reader) and/or percent of spore germination in each field 
of view was analysed following live cell imaging. Absorbance was analysed using 
Kruskal Wallis with Dunn's multiple comparisons test. For percent germination, 
Two-way Repeated Measures ANOVA with Tukey’s multiple comparisons test 
was used on arcsine transformed data (Section 2.13.1) to analyse significance.  
  
2.2.3 Testing the effect of pH change and nutrient starvation on 
germination. SAB broth (5 ml) was added to 5 ml of sterile supernatant and 
thoroughly mixed. The pH was measured using a bench-top pH meter (Mettler 
Toledo). Fresh SAB and LB were mixed 50:50, and the pH was adjusted to match 
the pH of the supernatant mixture using 5 M sodium hydroxide (NaOH) and filter 
sterilised. To model nutrient depletion, PBS and SAB were mixed 50:50 and pH 
was adjusted to match normal SAB/LB control. Two-way Repeated Measures 
ANOVA with Tukey’s multiple comparisons test was used on arcsine transformed 
data (Section 2.13.1) to analyse significance (n=3). 
 
2.2.4 Exposure of pre-germinated R. microsporus spores to P. aeruginosa 
supernatant. Spores were harvested and added to 500 µl of SAB broth at a 
concentration of 1x106 spores/ml in triplicate in a 24 well plate. Spores were 
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incubated statically for 4 to 5 hours at 37˚C until germlings emerged and then 
either 500 µl of sterile P. aeruginosa supernatant or 500 µl LB was added. The 
plate was incubated for 18 hours at 37˚C, and the endpoint absorbance (OD600) 
of each well was measured (n=4, Mann-Whitney U test). 
 
2.2.5 Observing the effect of P. aeruginosa supernatant on R. microsporus 
antifungal susceptibility. Stock solutions of amphotericin B, posaconazole, and 
fluconazole were prepared in dimethyl sulfoxide (DMSO, 5 mg/ml), aliquoted, and 
stored at -20°C. Stocks were diluted in 50:50 SAB:LB or 50:50 SAB:supernatant 
(64 μg/ml) and doubling dilutions were prepared in a 96-well plate to a final 
concentration of 0.0625 μg/ml for posaconazole and fluconazole and 0.00775 
μg/ml for amphotericin B. R. microsporus spores (1 x 104 spores/ml) were added 
to each well and incubated for 24 hours at 37°C. Endpoint measurement of fungal 
growth was analysed via absorbance (OD600, n=3, Kruskal Wallis test with Dunn’s 
multiple comparisons test). 
 
2.3 Quantifying the effects of microbial secreted molecules on 
fungal germination.  
Resting Mucorales spores (1 x 104 spores/ml) were added to SAB broth with the 
addition of the below chemicals. Endpoint absorbance (OD600) readings were 
measured after 24 hours incubation at 37°C to determine overall fungal growth 
for all chemicals, except farnesol and dodecanol, which were imaged via time 
lapse microscopy. 
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2.3.1 Fungal quorum sensing molecules. Farnesol was prepared in 100% 
methanol to a final concentration of 200 µM in SAB broth. This solution (200 μl) 
was added to 96 well plates in duplicate, Rhizopus microsporus, Cunninghamella 
bertholletiae, and Lichtheimia corymbifera spores (1 x 104 spores/ml) were 
added, and 2 positions per well were imaged via time lapse microscopy (37°C). 
Controls included SAB only and SAB + methanol, as solvent control. Two-way 
Repeated Measures ANOVA on arcsine-transformed data (Section 2.13.1) with 
Tukey’s multiple comparisons test was used to analyse data (n=3). 
 
2.3.2 Bacterial quorum sensing molecules. The quorum sensing molecule 
(QSM) mimic, dodecanol, was prepared in 100% methanol to a final 
concentration of 200 µM in SAB broth.  This (200 μl) was added to 96 well plates 
in duplicate, R. microsporus, C. bertholletiae, and L. corymbifera spores were 
added (1 x 104 spores/ml), and 2 positions per well were imaged via time lapse 
microscopy (37°C). Controls included SAB only and SAB + methanol. Two-way 
Repeated Measures ANOVA on arcsine-transformed data with Tukey’s multiple 
comparisons test was used to analyse data (n=3). 
 
Stock solutions of the P. aeruginosa QSMs N-butanoyl-l-homoserine lactone (C4 
HSL), N-hexanoyl-DL-homoserine lactone (C6 HSL), N-octanoyl-L-homoserine 
lactone (C8 HSL), and N-(3-oxododecanoyl)-L-homoserine lactone (C12 HSL) 
were made in DMSO to a total concentration of 50 mM. Working concentrations 
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were 10, 50, 100, and 200 µM diluted in 1 ml SAB broth. The diluted QSMs (200 
μl) were added to 96 well plates in duplicate and R. microsporus spores were 
added (1 x 104 spores/ml). Controls included SAB only and SAB + DMSO, (n=3, 
Kruskal-Wallis test with Dunn’s multiple comparisons test). 
 
2.3.3 Bacterial toxins. Pyocyanin (ready-made solution; 5 mg/ml in DMSO) was 
diluted to 12.5, 25, and 50 µM in SAB broth. Controls include SAB broth only and 
SAB + DMSO, (n=3, Kruskal-Wallis test with Dunn’s multiple comparisons test). 
 
2.4 Characterising the inhibitory compound. 
2.4.1 Denaturation of proteins in P. aeruginosa supernatant. To determine if 
the inhibitory substance is proteinaceous, P. aeruginosa supernatants were 
collected, filter sterilised, and a 1 ml sample was boiled at 100˚C for 1 hour to 
denature proteins. To remove the effect of any heat-stable proteins, Proteinase 
K (20 µg/ml stock, New England Biolabs) was added to 1 ml of supernatant at a 
concentration of 150 µg/ml and incubated at 37˚C for 2 hours. The Proteinase K 
was inactivated by heating at 100°C for 1 hour. Spores were added to 50% 
treated supernatants and 50% SAB at a total volume of 200 µl/well in a 96 well 
plate. Controls included 50:50 SAB + LB, and 50:50 SAB + untreated 
supernatant. Well plates were incubated for 18 hours at 37°C and endpoint 
absorbance (OD600) was measured, (n=6, Kruskal-Wallis test with Dunn’s 
multiple comparisons test).   
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2.4.2 Organic extraction of P. aeruginosa supernatant. To determine whether 
the inhibitory molecule is hydrophilic or hydrophobic, chloroform extractions were 
performed on P. aeruginosa supernatants. P. aeruginosa supernatant (40 ml) 
was collected, sterilised and placed in a glass extraction funnel with the addition 
of chloroform (50% volume). This was mixed thoroughly and allowed to settle into 
aqueous and organic phases. The organic phase was removed, and the process 
was repeated two more times. Sodium sulphate was added to the organic phase 
until any remaining water was removed, and dried using a rotary evaporator. The 
resulting powder was reconstituted in 1 ml DMSO and further resuspended with 
LB to a total volume of 40 ml. The aqueous phase was also placed on a rotary 
evaporator to remove any remaining chloroform. As a procedural control, this 
chloroform extraction was also performed on fresh LB, (n=5, Kruskal-Wallis test 
with Dunn’s multiple comparisons test). 
 
2.4.3 Removal of R. microsporus endosymbiont. To determine whether the 
resident bacterial endosymbiont is mediating R. microsporus inhibition, the 
endosymbiont was removed via antibiotic treatment.  R. microsporus spores were 
harvested and sub-cultured for at least 10 generations onto SAB agar plates + 
60 μg/ml ciprofloxacin to kill bacterial endosymbiont. Loss of endosymbiont was 
confirmed through SYTO9 staining and microscopy. Cured spores were exposed 
to P. aeruginosa supernatant as previously described for parent spores in Section 
2.2.2 (n=3, Kruskal-Wallis test with Dunn’s multiple comparisons test). 
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2.5 Investigating the role of metal restriction on supernatant-
dependent growth inhibition. 
2.5.1 Addition of iron, zinc, copper, and manganese to R. microsporus 
spores following exposure to P. aeruginosa supernatant. To determine 
whether micronutrient depletion was inducing the germination defect, spores 
were exposed to ferric chloride (FeCl3), zinc chloride (ZnCl2), cupric sulphate 
(CuSO4), and manganese sulphate (MgSO4). Metal stocks (100 mM in dH2O) 
were diluted to 1, 10, 50, 100, 200, and 500 µM (2x concentrated) in P. 
aeruginosa supernatants (500 μl). The metals were allowed to associate with any 
chelating molecules for 15 minutes before the addition of an equal volume of SAB 
broth. Wells containing the SAB/supernatant mixture without metals were 
included as controls. R. microsporus spores (1 x 104 spores/ml) were added to 
each well and incubated for 24 hours. Absorbance (OD600) was used to measure 
fungal growth (n=3, Kruskal-Wallis test with Dunn’s multiple comparisons test). 
 
2.5.2 Exposure of R. microsporus var microsporus, R. microsporus var 
chinensis, R. delemar, and M. circinelloides to P. aeruginosa supernatant 
+/- iron. To determine if P. aeruginosa supernatant had the same effect on 
closely related Mucorales (Chibucos et al., 2016), ferric chloride (100 mM stocks) 
was diluted to 100 µM (2x concentrated) in P. aeruginosa supernatants (500 μl). 
The metals were allowed to associate with any chelating molecules for 15 
minutes before the addition of an equal volume of SAB broth. Wells containing 
the SAB/supernatant mixture without metals were included as controls. R. 
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microsporus spores (1 x 104 spores/ml) were added to each well and incubated 
for 24 hours. Absorbance (OD600) was used to measure fungal growth (n=3, 
Kruskal-Wallis test with Dunn’s multiple comparisons test). 
 
2.5.3 Exposure of R. microsporus to purified, exogenous bacterial 
siderophores.  
2.5.3.1 Pyoverdine. To determine whether the major siderophore produced by 
P. aeruginosa, pyoverdine, is capable of inhibiting R. microsporus growth, spores 
were exposed to exogenous pyoverdine. Pyoverdine (10 mg/ml in dH2O) was 
diluted to 15 μM (17.4 μg/ml) in SAB broth before the addition of spores (1 x 104 
spores/ml) and subsequent incubation for 24 hours (37°C, n=6, Mann-Whitney U 
test).  
 
2.5.3.2 Enterobactin. To determine if siderophore-mediated inhibition is a 
universal effect, R. microsporus spores were exposed to a high-affinity 
siderophore produced by E. coli, enterobactin (Carrano and Raymond, 1979). A 
stock solution of enterobactin was made in DMSO to a concentration of 50 mM. 
Working concentrations of 10, 50, and 100 μM were made in SAB broth before 
the addition of spores (1 x 104 spores/ml) and subsequent incubation for 24 hours 
(37°C, n=3, Kruskal-Wallis with Dunn’s multiple comparisons test). 
 
To determine if enterobactin can enhance R. microsporus germination when 
exposed to P. aeruginosa supernatant, 50 μM enterobactin was added to 50% P. 
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aeruginosa supernatant + 50% LB. R. microsporus (1 x 104 spores/ml) were 
incubated in solutions at 37°C for 24 hours before images were taken using a 
Zeiss AxioObserver inverted microscope (x20 magnification). 
 
2.5.4 Viability of spores exposed to P. aeruginosa supernatant. Iron 
starvation has been shown to induce apoptosis in Rhizopus oryzae (Shirazi, 
Kontoyiannis and Ibrahim, 2015). To determine the impact of P. aeruginosa 
supernatant on R. microsporus viability, spores (1 x 106 spores/ml) were exposed 
to 100% P. aeruginosa supernatant for 96 hours (statically, 37˚C). Every 24 
hours, 100 spores were plated on SAB agar and incubated at 25˚C for 24 hours. 
Following incubation, the number of viable spores were counted and compared 
to 0-hour control plates (n=3, Kruskal-Wallis test with Dunn’s multiple 
comparisons test). 
 
2.6 Quantification of bacterial virulence factor production.  
To determine the overall secretion of toxins and siderophores in this system, 
supernatants from either mono- or co-cultured P. aeruginosa PAO1 were 
analysed using the following methods:  
 
2.6.1 Pyocyanin secretion. P. aeruginosa was grown in LB (24 hours, 37°C, 200 
rpm), and supernatants were prepared by centrifugation (4500 rpm, 10 minutes) 
and sterilisation using a 0.22 μm syringe filter. Absorbance (690 nm) was 
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measured using a FLUOstar Omega plate reader and compared to a pyocyanin 
standard curve.  
 
2.6.2 Overall siderophore production. Siderophore concentration in bacterial 
supernatants or co-culture supernatants (Section 2.9.2) were quantified by using 
the SideroTec Assay Kit (Emergen Bio) according to the manufacturer 
recommendations (n=3, Mann-Whitney U test).   
 
 2.6.3 Pyoverdine secretion. P. aeruginosa and R. microsporus (1 x 106 
spores/ml) were co-cultured in 1 ml RPMI-1640 (Thermo-Fisher) at multiplicity of 
infection (MOI) ratios of 1:1, 1:10, 1:50, and 1:100 in a 24 well plate (statically, 24 
hours, 37˚C). Plates were centrifuged (4000 rpm, 5 minutes) and 200 µl from 
each well was transferred to a 96 well plate in duplicate. Pyoverdine production 
was measured at 405 nm (Stintzi et al., 1996). Absorbance of co-culture 
supernatant was compared to absorbance of supernatants from P. aeruginosa 
alone, with the same starting concentration of bacteria (n=4, Kruskal-Wallis test 
with Dunn’s multiple comparisons test). 
 
2.7 Microscopy. 
Mucoralean virulence is dependent on the ability to germinate and penetrate 
surrounding tissues (Ibrahim et al., 2012). Microscopy was used to visualise the 
germination of spores following exposure to desired conditions.  
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2.7.1 Live-cell imaging. To observe fungal growth and germination over time, 
live-cell imaging was performed for 12-18 hours at 37˚C with humidity using a 
Zeiss AxioObserver inverted microscope (20x magnification). Images were taken 
every 10 minutes to create a time-lapse movie, and spore germination was 
quantified as described in Section 2.7.3.  
 
2.7.2 Endpoint imaging. Following 18-24 hours of spore exposure to 
experimental conditions, at least four images per condition were captured using 
a Zeiss AxioObserver inverted microscope (20x magnification). Images were 
analysed as described below.  
 
2.7.3 Quantifying spore germination. For both live-cell imaging and endpoint 
microscopy, the percentage of germinated spores compared to total spores in 
each field of view was determined. Germination was defined as the point in which 
the germ tube reached the same size as the spore diameter. Fiji Image J software 
(Schindelin et al., 2012) was used to count germinated spores. Data was 
analysed using a Two-way ANOVA performed on arcsine transformed data 
(Section 2.13.1).  
 
2.7.4 Spore swelling. To compare the isotropic growth of Mucorales spores in 
the presence of microbial secreted factors, the area of resting versus swollen 
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spores were measured using Fiji Image J software (Schindelin et al., 2012) 
following live-cell imaging. Spores were considered resting at the first time point 
imaged and maximum isotropic growth was measured for all non-germinated 
spores at the final time point before 50% of the spores in the field of view have 
germinated.  
To convert spore area to volume, the radius was first calculated according to 
Equation 1 and the volume was calculated according to Equation 2: 
Equation 1: Calculating radius from the area of a sphere 
radius =  √
𝑎𝑟𝑒𝑎
𝜋
 
Equation 2: Calculating the volume of a sphere 
Volume = 4
3
𝜋𝑟3 
Statistical significance was calculated using Kruskal Wallis with Dunn's multiple 
comparisons test.  
 
2.7.5 Time to first germ tube. To determine whether the presence of microbial 
secreted factors impacts the initiation of germination on an individual, rather than 
population level, the time point (minutes) in which the first spore germinated was 
recorded following live-cell imaging (Kruskal Wallis with Dunn's multiple 
comparisons test). 
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2.7.6 Hyphal width. As a marker for nutrient starvation (Turgeman et al., 2014), 
hyphal width of germinated spores was measured using Fiji Image J software 
(Schindelin et al., 2012). One hour after the first germ tube protruded, the average 
width of each hyphae was measured at three different points for at least 100 
hyphae per condition per experiment (n=3). (Kruskal Wallis with Dunn's multiple 
comparisons test). 
 
2.8 Quantifying chitin. 
To determine if P. aeruginosa impacts R. microsporus cell wall chitin, spores were 
harvested (Section 2.1.3) and exposed to 15 ml of either 50:50 SAB:LB to 
promote swelling, or 50% P. aeruginosa supernatant for 4 hours (200rpm, 37°C). 
Resting spores were maintained in PBS on ice to prevent swelling. 
 
2.8.1 Staining spores. Spores were washed three times with PBS and stained 
with 250 μg/ml calcofluor white (CFW) for 45 minutes (37°C, 200 rpm). Stained 
spores were washed three times with PBS (centrifuged at 3000 rpm, 3 minutes), 
wet mounted onto glass slides, and imaged on a Zeiss AxioObserver at 63x 
magnification. Four images per condition were captured. Relative fluorescence 
intensity was measured through image analysis of at least 50 spores per 
condition per experiment (Section 2.8.2). 
 
Chapter 2: Materials and Methods 
 
52 
 
2.8.2 Measuring fluorescence. The fluorescence intensity of CFW stained 
spores correlates to the chitin content of the fungal cell wall (Monheit, Cowan and 
Moore, 1984). Endpoint images were analysed using Fiji ImageJ software 
(Schindelin et al., 2012). A circle was drawn around each spore, and the 
corrected total cell fluorescence (CTCF) was measured according to Equation 3: 
Equation 3: Calculating fluorescence intensity 
CTCF = Integrated Density – (Cell area X Mean fluorescence of background)  
Data was analysed using Kruskal Wallis with Dunn's multiple comparisons test 
(n=4). 
 
2.9 Live co-cultures of R. microsporus and P. aeruginosa. 
2.9.1 Determining colony forming units from bacterial absorbance. LB (5 
ml) was inoculated with bacteria and incubated for at least 18 hours (37°C, 200 
rpm). Bacteria were washed two times with PBS by centrifugation (8000 rpm, 2 
minutes), and absorbance (OD600) was measured by spectrophotometer. 
Samples were diluted to an OD600 of 0.01, 0.02, 0.04, and 0.05 and serially diluted 
to 10-4. Dilutions (10 μl of 10-2, 10-3, and 10-4) were plated onto LB agar, incubated 
for 18 hours (37°C) and colonies were counted to determine correlation between 
absorbance and colony forming units (CFUs). 
 
2.9.2 Investigating the impact of live bacteria on Rhizopus microsporus 
germination. To determine whether there is any contact-dependent inhibition of 
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bacteria on R. microsporus germination, LB was inoculated with P. aeruginosa, 
K. pneumoniae, B. cenocepacia, E. coli, or S. aureus and incubated for 24 hours 
(37˚C, 200 rpm). Bacteria were washed three times with PBS. R. microsporus 
spores (1 x 104 spores/ml) were added to 50% SAB, 50% LB in a 96-well plate. 
Bacteria were added to each well at a multiplicity of infection (MOI) ratio of 1:1, 
1:10, 1:50, and 1:100 and incubated for 24 hours (static, 37˚C). Wells were 
imaged using an inverted Zeiss AxioObserver microscope (20x magnification). 
The number of germinated spores per field of view were quantified for spores 
exposed to P. aeruginosa (n=4, Two-way ANOVA performed on arcsine 
transformed data).  
 
2.9.3 Addition of enterobactin to live co-cultures. Enterobactin was added to 
live co-cultures of R. microsporus and P. aeruginosa (MOI 1:100) to determine 
whether the addition of enterobactin can aid fungal growth. Co-cultures were 
prepared as described above (Section 2.9.2). A 50 mM stock of enterobactin was 
prepared in DMSO. Enterobactin was diluted to 50 μM in 50:50 SAB:LB before 
the addition of spores (1 x 104 spores/ml) and bacteria (1 x 106 CFUs/ml) and 
subsequent incubation for 24 hours (static, 37°C). Endpoint images were taken 
using a Zeiss AxioObserver inverted microscope (20x magnification) (n=3). 
 
2.9.4 Investigating the ability of live P. aeruginosa to decrease spore 
viability, in an iron-dependent manner. R. microsporus (1 x 104 spores/ml) and 
P. aeruginosa (1 x 106 CFUs/ml) were added to 1 ml of 50:50 SAB:LB +/- 100 μM 
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FeCl3 in a 24 well plate and incubated for 24 hours (statically, 37°C). Following 
incubation, each well was mixed thoroughly, and 100 spores were spread onto 
SAB agar containing 100 μg/ml tetracycline. Agar plates were incubated for 24 
hours (25˚C) before the number of viable spores were counted and compared to 
0 hour control plates (n=3, Two-way ANOVA with Sidak's multiple comparisons 
test).  
 
2.10 Molecular biology 
2.10.1 Gel Electrophoresis. For visualisation of nucleic acids following RNA 
extraction, DNA extraction, plasmid isolation, or polymerase chain reaction 
(PCR), agarose gels (1%) were prepared in 1x TAE (Tris-acetate-EDTA) buffer 
with SYBER Safe DNA gel stain (2 μl per 40 ml agarose, Thermo-Fisher 
Scientific). A GeneRuler 1 kb Plus DNA Ladder (5 μl, Thermo-Fisher Scientific) 
was run alongside the samples. Electrophoresis was carried out at 75 volts for 35 
minutes, and RNA or DNA were observed by ultraviolet (UV) trans-illumination 
on a Bio Rad ChemiDoc MP imaging system using Image Lab 4.1 software. 
 
2.10.1.1 DNA Gel Electrophoresis. To visualise concentration and quality of 
DNA, 5 μl of PCR products, plasmid isolates, or extracted DNA were mixed with 
1 μl gel loading dye (6x concentrated, New England Biolabs) before gel 
electrophoresis as described in Section 2.10.1.  
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2.10.1.2 Non-denaturing RNA Gel Electrophoresis. RNA quality was 
confirmed by separating the RNA via electrophoresis. RNA samples (5 μl) were 
mixed with 1 μl gel loading dye (6x concentrated, New England Biolabs) and 
heated at 70°C for 5 minutes to denature the RNA. Samples were centrifuged 
briefly and 5 μl was loaded onto the agarose gel and run as previously described 
(Section 2.10.1). 
 
2.10.2 Genomic DNA extraction from Mucorales. R. microsporus spores were 
harvested, washed in PBS, and counted. Genomic DNA was extracted using a 
Qiagen DNeasy PowerSoil kit according to manufacturer instructions. Pelleted 
spores (at least 1 x 107) were resuspended in Solution C1 (500 μl), transferred 
into 2 ml tubes containing 0.5 mm glass beads (Precellys, VWR, Product code 
VK05), and homogenised using a Precellys 24 tissue homogeniser (Berlin 
Instruments, 2 x 20 seconds, 6500 rpm, 2 cycles). Tubes were placed on ice 
between cycles and before centrifugation (10000 rpm, 30 seconds). Supernatant 
was removed and transferred to a new 2 ml collection tube. Following a series of 
washes using an MB spin column with the provided solutions as per manufacturer 
instructions, 100 μl of Solution C6 (elution buffer) was added directly to the 
membrane before centrifugation (10000 rpm, 30 seconds). DNA quality was 
confirmed through gel electrophoresis and imaging using UV trans-illumination 
(Section 2.10.1.1). Concentration of DNA was quantified by diluting 1:100 in dH2O 
and using a spectrophotometer, where an OD260 of 1 equals 50 μg/ml of double 
stranded DNA. Purity was measured through absorbance wavelength ratios of 
260/280 and 260/230. 
Chapter 2: Materials and Methods 
 
56 
 
 
2.10.3 Genomic DNA isolation of bacteria. Genomic DNA was extracted from 
P. aeruginosa cultures following incubation in LB (18 hours, 37°C, 200 rpm). A 
sample (200 μl) of the culture was heated (100°C, 10 minutes) to lyse the cells 
and denature DNases. This was centrifuged (13000 rpm, 30 seconds), the 
supernatant was collected, and stored at -20°C until needed.   
 
2.10.4 RNA extraction of Mucorales. Extraction of fungal RNA involved 
modification of the Qiagen RNeasy Plus Mini kit manufacturer protocol.  R. 
microsporus spores (2.5 x 106 spores/ml) were exposed to 50:50 SAB:LB or 50% 
P. aeruginosa supernatant, 50% SAB (10 ml total volume in 50 ml glass conical 
flasks). Flasks were incubated statically at 37˚C for 7 hours. Spores were 
centrifuged (3000 rpm, 3 min), pellets were snap frozen in liquid nitrogen, and 
stored at -80˚C. When ready to extract RNA, 1 ml of TRIzol (Invitrogen) was 
added to each sample and thawed on ice. Samples were transferred into 2 ml 
tubes containing 0.5 mm glass beads (Precellys, VWR), and homogenised using 
a Precellys 24 tissue homogeniser (Berlin Instruments, 2 x 20 seconds, 6500 
rpm, 2 cycles). Tubes were placed on ice between cycles and before centrifuging 
at 13000 rpm, 4°C for 1 minute. Chloroform (200 µl) was added to each sample, 
vortexed thoroughly, and centrifuged at 13000 rpm, 4˚C, for 15 minutes. The 
aqueous layer was collected and run through the gDNA (genomic DNA) 
eliminator column (10000 rpm, 1 minute). An equal volume of 100% ethanol was 
added to the resulting flow-through. This solution, including precipitates, was 
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transferred to the RNeasy column, and centrifuged for 30 seconds, 10000 rpm. 
The membrane was washed with RW1 buffer (350 μl, 10000 rpm, 30 seconds) 
before the addition of RNase-Free DNase (Qiagen) directly to the membrane 
according to manufacturer recommendations. The column was incubated at room 
temperature for 20 minutes before washing once with RW1 buffer (350 μl, 10000 
rpm, 30 seconds), and twice with RPE buffer (10000 rpm for 30 seconds, followed 
by 2 minutes). RNA was eluted from the membrane by adding 50 μl dH2O, 
incubating for 1 minute (room temperature), centrifuging for 1 minute (10000 rpm) 
and repeating with 30 μl dH2O.  
 
RNA quality was confirmed through gel electrophoresis and imaging of using UV 
trans-illumination (Section 2.10.1.2). The concentration was measured by diluting 
RNA 1:100 in dH2O and using a spectrophotometer, where an OD260 of 1 equals 
40 μg/ml of double stranded RNA. Purity was measured through absorbance 
wavelength ratios of 260/280 and 260/230. RNA was stored at -80°C until 
required. 
 
2.10.5 RNA extraction of bacteria. P. aeruginosa (1x108 CFUs/ml) was exposed 
to 50:50 SAB:LB (+/- 100 μM FeCl3) or R. microsporus spores (1 x 106 spores/ml, 
+/- 100 μM FeCl3). Flasks were incubated at 37°C and 50 rpm for 7 hours. 
Samples (1 ml) from each culture were centrifuged (8000 rpm, 3 minutes), snap 
frozen in liquid nitrogen, and stored at -80°C. The RNeasy Mini Plus Kit (Qiagen) 
protocol for purification of total RNA from bacteria was followed. Following 
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addition of 700 μl of RLT buffer + β-mercaptoethanol (10 μl β-mercaptoethanol 
per 1 ml RLT buffer) to each frozen sample, suspensions were transferred into 2 
ml tubes containing 0.5 mm glass beads (Precellys, VWR), and homogenised 
using a Precellys 24 tissue homogeniser (Berlin Instruments, 2 x 20 seconds, 
6500 rpm, 2 cycles). Tubes were placed on ice between cycles and before 
centrifuging at 13000 rpm for 1 minute. The supernatant was removed and run 
through the gDNA eliminator column (10000 rpm, 1 minute) before an equal 
volume of 70% ethanol was added. 700 μl of mixture was transferred to RNeasy 
spin columns and centrifuged for 30 seconds, 10000 rpm. The membrane was 
washed with RW1 buffer (350 μl, 10000 rpm, 30 seconds) before the addition of 
RNase-Free DNase (Qiagen) directly to the membrane according to 
manufacturer recommendations. The column was incubated at room temperature 
for 20 minutes before washing once with RW1 buffer (350 μl, 10000 rpm, 30 
seconds), and twice with RPE buffer (10000 rpm for 30 seconds, followed by 2 
minutes). RNA was eluted from the membrane by adding 50 μl dH2O, incubating 
for 1 minute (room temperature), centrifuging for 1 minute (10000 rpm) and 
repeating with 30 μl dH2O.  
 
RNA quality was confirmed through gel electrophoresis and imaging of gel using 
UV trans-illumination (Section 2.10.1.2). The concentration was measured by 
diluting RNA 1:100 in dH2O and using a spectrophotometer, where an OD260 of 1 
equals 40 μg/ml of double stranded RNA. Purity was measured through 
absorbance wavelength ratios of 260/280 and 260/230. RNA was stored at -80°C 
until required. 
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2.10.6 Designing Primers. DNA sequences were obtained through the National 
Center for Biotechnology Information (NCBI) database. Primers were designed 
using the NCBI Primer-BLAST tool or used from previous studies (Table 2.2) and 
validated via PCR (Section 2.10.7).  
 
Table 2.2 Primers used in this study.  
Name Organism Sequence Source 
FTR1 
forward  
R. microsporus  GTG-GTG-TCT-CCT-TGG-GTG-
TT 
This study 
FTR1 
reverse  
R. microsporus  CCA-CCA-CGG-TAG-ATG-
AGG-A 
This study 
18s 
forward  
R. microsporus  GGC-GAC-GGT-CCA-CTC-
GAT-TT 
This study 
18s 
reverse  
R. microsporus  TCA-CTA-CCT-CCC-CGT-GTC-
GG 
This study 
rpoD 
forward  
P. aeruginosa GGG-CGA-AGA-AGG-AAA-
TGG-TC 
(Lopez-
Medina et al., 
2015) 
rpoD 
reverse  
P. aeruginosa CAG-GTG-GCG-TAG-GTG-
GAG-AA 
(Lopez-
Medina et al., 
2015) 
pchA 
forward 
P. aeruginosa CTG-CCT-GTA-CTG-GGA-ACA-
GC 
(Lopez-
Medina et al., 
2015) 
pchA 
reverse 
P. aeruginosa GCA-GAG-CAA-TTG-CCA-GTT-
TT 
(Lopez-
Medina et al., 
2015) 
pvdS 
forward 
P. aeruginosa ACC-GTA-CGA-TCC-TGG-TGA-
AG 
(Lopez-
Medina et al., 
2015) 
pvdS 
reverse 
P. aeruginosa TGA-ACG-ACG-AAG-TGA-TCT-
GC 
(Lopez-
Medina et al., 
2015) 
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2.10.7 Polymerase Chain Reaction (PCR). To test primers and to check for 
DNA contamination of extracted fungal and bacterial RNA (Section 2.10.4 and 
2.10.5), a PCR was performed. Master mixes were made using 125 μl MyTaq 
Red (Bioline), 1 μl forward primer (diluted 1:10), 1 μl reverse primer (diluted 1:10), 
1 μl of DNA or 2 μl RNA, and dH2O for a total volume of 50 μl. PCR conditions 
are detailed in Table 2.3, using a Sensoquest Labcycler. PCR products were 
visualised following gel electrophoresis (Section 2.10.1). 
 
Table 2.3 PCR conditions.  
 
Step Temperature 
(°C) 
Time # 
passes 
Other 
1 Initial 
denaturation 
95 5 min 1 
 
2 Denaturation 95 30 sec 30 
 
3 Annealing 55 30 sec 30 
 
4 Initial extension 72 3 min 30 Repeat from 
step 2 
5 Final Extension 72 10 min 1 
 
6 Hold 10 ∞ n/a 
 
 
2.10.8 Checking RNA for DNA contamination. To confirm that RNA samples 
were free of any contaminating genomic DNA, a PCR amplifying 18s rRNA for R. 
microsporus and rpoD for P. aeruginosa was used. RNA spiked with genomic 
DNA was used as a PCR procedural control. See Table 2.2 for primers and 
Section 2.10.7 for PCR details.  
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2.10.9 Removing DNA from contaminated RNA. For RNA contaminated with 
genomic DNA, an RNA clean-up procedure was performed using an RNase-free 
DNase kit (Qiagen) and RNeasy Mini Plus kit (Qiagen). RNA (50 μl), RDD buffer 
(10 μl), DNase (2.5 μl) and dH2O (37.5 μl) were mixed thoroughly and incubated 
at room temperature for 15 minutes. 350 μl of RLT buffer + β-mercaptoethanol 
(10 μl β-mercaptoethanol per 1 ml RLT buffer) were added to each sample, 
transferred to the gDNA eliminator columns, and centrifuged (10000 rpm, 1 
minute). 250 μl of 100% ethanol was added to the flow-through and samples were 
transferred to the RNeasy spin columns. The protocol was continued according 
to manufacturer guidelines. RNA quality and concentration were measured via 
spectrophotometer and gel electrophoresis (Section 2.10.1.2). A PCR was used 
to determine whether any residual DNA remained in the samples (Section 
2.10.7).  
 
2.10.10 Quantitative Reverse Transcriptase PCR (qRT-PCR). A qRT-PCR 
was performed to determine the expression of iron-related genes in both R. 
microsporus and P. aeruginosa. An iTaq Universal SYBR Green One-Step Kit 
(Bio Rad) was used with 10 ng/μl RNA and a total reaction volume of 20 μl. 
Reactions were prepared with 10 μl iTaq universal SYBR green reaction mix (2x), 
1 μl iScript reverse transcriptase, 0.8 μl forward primer, 0.8 μl reverse primer, and 
both primers were diluted 1:10 in dH2O. Controls with no reverse transcriptase 
were included to ensure DNA was completely removed from RNA during the 
extraction process. Conditions for qRT-PCR are detailed in Table 2.4, using a Bio 
Rad CFX Connect Real Time System and Bio Rad CFX Manager 3.1 software.  
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qRT-PCR data for FTR1 was analysed via 2-∆CT and presented as gene 
expression relative to 18S mRNA. Significance was analysed using a Mann-
Whitney U test (n=4). qRT-PCR for pchA and pvdS were analysed via 2-∆∆CT 
analysis, and presented as fold change compared to housekeeping gene (rpoD). 
Significance was analysed using a 2-way ANOVA with Tukey's multiple 
comparisons test.  
 
 
Table 2.4 Quantitative Reverse Transcriptase PCR conditions.  
 
Step Temperature  Time # passes 
 
1 cDNA synthesis 
(reverse transcription) 
45 10 min 1 
 
2 Polymerase activation 95 2 min 1 
 
3 Denaturation 95 5 sec 39 
 
4 Annealing 59 30 sec 39 
 
5 Denaturation 95 10 sec 39 
 
6 Annealing/Extension 65 5 sec 39 Repeat 
from step 3 
7 Dissociation gradient  65-95 30 sec 1 
 
 
2.10.11 Creating fluorescent P. aeruginosa. 
2.10.11.1 E. coli plasmid extraction. A Qiagen Miniprep kit was used to purify 
mCherry (PME6032:mcherry) and GFP (PME6032:gfp) plasmids from overnight 
cultures (5 ml) of fluorescent E. coli DH5α according to manufacturer guidelines. 
Integrity of DNA was confirmed through gel electrophoresis and stored at -20°C 
until needed.  
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2.10.11.2 Transformation of P. aeruginosa. P. aeruginosa PAO1 and PA14 
were grown overnight in LB at 37°C and 200 rpm. Bacteria (2 x 1 ml) were made 
electrocompetent by washing twice in 300 mM sucrose (8000 rpm, 3 minutes). 
Plasmid DNA (5 μl) was added to the bacteria, with one sample of each strain 
acting as plasmid-negative control. Both positive and negative samples were 
placed into electrocuvettes and transformed via electroporation. Fresh LB was 
immediately added to cuvettes, mixed thoroughly, transferred to 1.5 ml Eppendorf 
tubes, and incubated for 1 hour (37°C, 200 rpm) to allow for recovery. Both 
plasmid-positive and plasmid-negative bacteria (neat and diluted 1:10) were 
streaked onto LB agar (+/- 100 μg/ml tetracycline) and grown overnight at 37°C. 
Positive colonies were re-streaked onto LB agar + 100 μg/ml tetracycline and 
again incubated overnight. Cultures (5 ml) were prepared in LB broth + 100 μg/ml 
tetracycline, incubated overnight (37°C, 200 rpm), and fluorescence was 
confirmed via microscopy. 
 
2.11 Zebrafish infections. 
2.11.1 Ethics. Zebrafish care and experiments were performed under Home 
Office project license P51AB7F76 and personal license I5B923969 in accordance 
with the Animal Scientific Procedures Act 1986.  
 
2.11.2 Maintenance. Adult wild type (AB) Danio rerio zebrafish were maintained 
at the University of Birmingham Aquatic Facility in recirculating tanks with 14 
Chapter 2: Materials and Methods 
 
64 
 
hours light/10 hours dark cycles at 28˚C. Adult zebrafish naturally spawned 
overnight in groups of 11 fish (six females, five males). Embryos were transferred 
to E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 
7) with 0.3 µg/ml methylene blue and 0.003% 1-phenyl-2-thiourea (PTU) for the 
first 24 hours post fertilisation (hpf) and maintained at 28˚C. Sample sizes for 
injections were calculated via power analysis using an alpha value of 0.05, power 
of 80%, mean effect size of 4.2%, and standard deviation of 8%, based on 
preliminary data and standards accepted by the zebrafish infection community.  
 
2.11.3 Preparation of inoculum. Mucorales hyphae are fragile and 
sporangiophores tend to clump, causing needles to readily clog during micro-
injections. Because of this, R. microsporus spores were gently harvested for 
injections by slowly dropping 10 ml of PBS onto each plate of fungi and carefully 
swirling before collecting into falcon tubes, repeating plate wash with fresh PBS, 
and washing pellets once. After resuspending in PBS (5 ml), heavier clumps of 
spores were allowed to settle to the bottom of the falcon tube for approximately 
1 minute and the upper 4 ml were removed and counted. If microscopic 
visualisation of R. microsporus spores was necessary, spores were stained as 
described in Section 2.8 before counting. P. aeruginosa PA14 (1 ml) from an 
overnight LB culture was washed twice in PBS via centrifugation (8000 rpm, 2 
minutes), and absorbance (OD600) was measured. 
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R. microsporus spores or P. aeruginosa PA14 were resuspended in 25 μl 
polyvinylpyrrolidone (PVP, 10% in PBS + 0.05% phenol red) to achieve desired 
infection dose. Specific infection doses varied between experiments and are 
explicitly stated below. Samples were kept on ice until needed to prevent spore 
swelling and bacterial growth.  
 
2.11.4 Hindbrain injections. Hindbrain injections were performed as previously 
described (Voelz, Gratacap and Wheeler, 2015). At 24 hpf larvae were manually 
dechorionated and anaesthetised (160 µg/ml Ethyl 3-aminobenzoate 
methanesulfonate salt [Tricaine]). Samples (2 nl) were injected into the hindbrain 
via the otic vesicle. Any fish that did not survive the injection process were 
removed. Following injections, survival was recorded every 24 hours until larvae 
were sacrificed at 5 dpf (96 hours post infection) through 10x overdose of 
Tricaine. 
 
2.11.4.1 R. microsporus and P. aeruginosa hindbrain mono-injections. 
Embryos were injected into the hindbrain with PVP only, PVP + R. microsporus, 
or PVP + P. aeruginosa PA14 to achieve a desired dose of 10, 50, or 100 
spores/fish and 10, 50, 100, 500, or 1000 bacterial CFUs/fish. P. aeruginosa 
injections with 10000 bacterial CFUs/fish were completed separately, with 
separate controls. For R. microsporus experiments, data were pooled from two 
independent experiments with a total of 32, 40, 38, and 42 fish for control, 10, 50, 
and 100 spores, respectively. For P. aeruginosa experiments, data were pooled 
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from four independent experiments with a total of 70, 80, 80, 80, 79, and 79 fish 
for controls, 10, 50, 100, 500, and 1000 CFUs/fish. For P. aeruginosa with 10000 
CFUs/fish, data were pooled from two independent experiments with 31 control 
and 35 treated fish. 
 
2.11.4.2 R. microsporus hindbrain mono-injections with pyoverdine or 
enterobactin. Embryos were injected into the hindbrain with PVP + R. 
microsporus only, R. microsporus + 60 μM (69.6 μg/ml) pyoverdine, or R. 
microsporus + 50 μM (33.5 μg/ml) enterobactin, with a desired dose of 50 
spores/fish. Control embryos were injected into the hindbrain with either PVP 
only, PVP + 60 μM pyoverdine, PVP + DMSO, or PVP + 50 μM enterobactin. For 
the pyoverdine experiment, data were pooled from four separate experiments 
with a total of 87, 80, 80, and 81 fish for control, pyoverdine only, spores only, 
and spores + pyoverdine, respectively. For the enterobactin experiment, data 
were pooled from two separate experiments with a total of 42, 44, 46, 43, and 50 
fish for control, DMSO, enterobactin only, spores only, and spores + enterobactin, 
respectively.  
 
2.11.4.3 R. microsporus and P. aeruginosa hindbrain co-infections. Embryos 
(24 hpf) were injected into the hindbrain with PVP only, R. microsporus only (100 
spores), P. aeruginosa PA14 only (10000 CFUs), or R. microsporus + P. 
aeruginosa. Data were pooled from three separate experiments with 51, 61, 60, 
and 61 fish per condition, respectively. 
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2.11.5 Yolk sac injections. At 48 hpf, zebrafish embryos were anaesthetised 
(160 μg/ml Tricaine). Samples (2 nl) were injected into the dorsal end of the yolk 
sac to avoid circulation. Any fish that did not survive the injection process were 
removed. Following injections, survival was recorded every 24 hours until larvae 
were sacrificed at 5 dpf (72 hours post infection) through 10x overdose of 
Tricaine. 
 
2.11.5.1 R. microsporus and P. aeruginosa yolk sac mono infections. 
Embryos were injected into the yolk sac with PVP only, PVP + R. microsporus, 
or PVP + P. aeruginosa PA14 to achieve a desired dose of 10, 50, or 100 
spores/fish and 10, 50, 100, 500, or 1000 bacterial CFUs/fish. For R. microsporus 
experiments, data were pooled from two independent experiments with a total of 
26, 34, 35, and 34 fish for control, 10, 50, and 100 spores, respectively. For P. 
aeruginosa experiments, data were pooled from two independent experiments 
with a total of 35, 40, 40, 35, 40, and 40 fish for controls, 10, 50, 100, 500, and 
1000 CFUs/fish. 
 
2.11.6 Swim bladder injections. Swim bladder injections were performed as 
previously described (Gratacap, Bergeron and Wheeler, 2014). Zebrafish larvae 
(96 hpf) were anaesthetised (160 μg/ml Tricaine) and samples (4 nl) were injected 
into the swim bladders. Any fish that did not survive the injection process were 
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removed. Following injections, survival was recorded after 24 hours, after which 
larvae were sacrificed through 10x overdose of Tricaine. 
 
2.11.6.1 R. microsporus and P. aeruginosa swim bladder co-infections. 
Based on the literature, mono-infections with P. aeruginosa and R. microsporus 
were unlikely to reduce viability at low concentrations (Voelz, Gratacap and 
Wheeler, 2015; Bergeron et al., 2017). Therefore, instead of performing mono-
injections to determine concentration curve, co-infections were attempted first 
with high concentrations. Zebrafish larvae (96 hpf) were injected into the swim 
bladder with PVP only, R. microsporus only (100 spores), P. aeruginosa PA14 
only (10000 CFUs), or R. microsporus + P. aeruginosa. Data were pooled from 
two separate experiments with 40, 40, 42 and 42 fish per condition, respectively. 
 
2.11.6.2 Spore viability following zebrafish infection. Zebrafish (4 dpf) were 
injected into the swim bladder with 4 nl of R. microsporus spores (50) or R. 
microsporus + P. aeruginosa (MOI 1:100).  To quantify R. microsporus survival 
at 0 hours and 24 hours, at each timepoint 3 larvae per condition were euthanised 
with 1600 μg/ml Tricaine and placed into 1.5 ml Eppendorf tubes. E3 media was 
replaced with 200 μl Trypsin EDTA (0.25%) and fish were homogenised with a 
motorised pestle until dissociation was complete. PBS (800 μl) was added, mixed 
thoroughly, and 500 μl was plated onto SAB agar + antibiotic cocktail (60 μg/ml 
tetracycline, 30 μg/ml gentamycin, 30 μg/ml chloramphenicol). Plates were 
incubated at 25°C overnight before CFUs were counted. After counting CFUs, 
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one plate was statistically recognised as an outlier using the ROUT method 
(Robust regression and Outlier removal) and was removed. Data was pooled 
from 3 individual experiments with 3 fish per experiment, tested for normality 
using the D'Agostino & Pearson omnibus normality test, and analysed for 
significance using a T-test (n=9).  
 
2.11.7 Imaging of zebrafish. Following hindbrain or swim bladder injections, 5 
fish per condition were anaesthetised with Tricaine and positioned in 6 well plates 
containing 5 ml of low-gelling temperature agarose (1% in 1x E3 + 160 μg/ml 
Tricaine). For real time microscopy, images were taken every 10 minutes for 16 
hours using a Zeiss AxioObserver inverted microscope (28°C, 10x magnification).  
 
2.11.8 Statistical analysis of zebrafish survival experiments. Survival data 
was inputted and analysed using Graphpad Prism 6 software. A Kaplan-Meyer 
curve was created and statistical significance between curves were calculated by 
using a Mantel-Cox log-rank test with the Bonferroni method for multiple 
comparisons.  
 
2.12 Statistical analysis.  
In most cases, experiments were performed with at least two technical and two 
biological replicates. Microsoft Excel 2016 and GraphPad Prism 6 were used to 
record and analyse data. Statistical tests used are indicated in individual sections. 
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All analyses were performed on non-normalised raw data or arcsine transformed 
data where appropriate. A p-value of p < 0.05 was considered statistically 
significant. Statistical significance is indicated by * = p < 0.05, ** = p < 0.01, and 
*** = p < 0.001. 
 
2.12.1 Arcsine transformations. As data with percentages are non-normal and 
on a fixed scale, proportions were transformed using arcsine transformations to 
stabilise the variance and normalise the data (Sokal and Rohlf, 1995). 
Transformations were performed on Microsoft Excel 2016 using Equation 4: 
Equation 4: Arcsine transformations for percentage data 
=DEGREES(ASIN(SQRT(xx))) 
Parametric statistical tests were performed on arcsine transformed data, as they 
are considered normal following transformation. 
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3.1 Introduction 
While the presence and influence of polymicrobial communities are becoming 
increasingly acknowledged, research into the dynamics of these interactions is 
still incomplete, and focus tends to remain on a few key organisms. There is a 
distinct lack of understanding about polymicrobial interactions involving fungi, 
though the gap in knowledge is slowly being addressed. The majority of fungal 
polymicrobial research has focused on the more common invasive fungi, such as 
Candida albicans and Aspergillus spp. However, there is not much known about 
relationships involving Mucorales.  To thoroughly understand the pathogenesis, 
it is important to consider the impact of surrounding microorganisms on the 
virulence of Mucorales. 
 
Mucormycetes are most commonly associated with pulmonary, rhinocerebral, or 
cutaneous infections, which are known to host a plethora of bacteria and fungi 
(Torres-Narbona et al., 2007). Candida albicans, Burkholderia cenocepacia, 
Klebsiella pneumoniae, and Pseudomonas aeruginosa were studied in this 
chapter initially as they are commonly associated with polymicrobial infections 
and are isolated in similar niches as Mucorales. Staphylococcus aureus and 
Escherichia coli were added to later experiments due to their prevalence in 
polymicrobial research.  
 
3.1.1 Organisms studied in this chapter.  
3.1.1.1 Candida albicans. C. albicans is a polymorphic fungus that can grow as 
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yeast, pseudohyphae, true hyphae and chlamydospores (Kabir, Hussain and 
Ahmad, 2012). C. albicans is routinely isolated from the skin, oral, vaginal and 
gastrointestinal tracts. Approximately 70% of the human population is naturally 
colonised with C. albicans, with over 80% of women testing positive for C. 
albicans genital-flora (Vermitsky et al., 2008; Mayer, Wilson and Hube, 2013), C. 
albicans can cause superficial mucosal infections including oral and genital 
thrush, or life-threatening systemic candidiasis in severely immunocompromised 
individuals (Kabir, Hussain and Ahmad, 2012). The ability of C. albicans to switch 
morphology is critical to its virulence, with yeast- or hyphal-locked strains 
displaying a significant reduction of virulence in animal models (Murad et al., 
2001).  During colonisation and dissemination, C. albicans mainly resides as 
yeast, but many host and environmental factors induce a morphological switch to 
the invasive hyphae form. These triggers include alkaline pH, increased 
temperature, presence of serum, change in concentration of quorum sensing 
molecules (QSMs), and the presence of other microorganisms (Brown et al., 
1999). This ability to switch between morphologies is key to the virulence of C. 
albicans and factors that alter this mechanism can strongly impact pathogenesis. 
 
C. albicans is known to participate in many different polymicrobial relationships, 
and is the most commonly studied fungus in polymicrobial research, along with 
Aspergillus spp. C. albicans produces the QSM, farnesol, which prevents 
morphological switch and biofilm formation (Hornby et al., 2001; Ramage et al., 
2002). This molecule also affects viability and biofilm formation in bacterial and 
fungal species. For example, the presence of farnesol decreases the ability of S. 
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aureus and Streptococcus mutans to form biofilms; for the former, farnesol also 
weakens the cell membrane integrity and enhances the efficacy of antimicrobials 
(Koo et al., 2003; Jabra-Rizk et al., 2006). This molecule has also been shown to 
increase the susceptibility of Burkholderia pseudomallei and Acinetobacter 
baumannii to antibiotics, which indicates a potential therapeutic application 
(Kostoulias et al., 2015; Castelo-Branco et al., 2016). Farnesol also affects other 
fungal pathogens, and inhibits the growth of Cryptococcus neoformans (Cordeiro 
et al., 2012) and induces apoptosis in Aspergillus nidulans (Semighini et al., 
2006), Aspergillus flavus (Wang et al., 2014), and Fusarium graminerum 
(Semighini, Murray and Harris, 2008). C. albicans has been identified in many 
polymicrobial diseases such as CF, ventilator-associated pneumonia, oral 
infections, trauma-associated wounds, peritonitis, and burn wounds (Tsang and 
Samaranayake, 2000; Peleg, Hogan and Mylonakis, 2010; Mallick and Bennett, 
2013; Rapisarda et al., 2015).  
 
3.1.1.2 Burkholderia cenocepacia. B. cenocepacia is a Gram-negative 
opportunistic pathogen and member of the Burkholderia cepacia complex, a 
group of 22 environmental bacteria that can cause potentially fatal complications 
in CF lungs. Burkholderia spp. are typically resistant to multiple classes of 
antibiotics, such as polymyxins, β-lactams, fluoroquinolones, tetracyclines, and 
trimethoprims (Rhodes and Schweizer, 2016). This resistance is due to the 
production of modified lipopolysaccharides, decreased membrane permeability, 
over-expression of efflux pumps, production of β-lactamases, and drug target 
modification (Loutet and Valvano, 2011; Rhodes and Schweizer, 2016).  B. 
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cenocepacia is particularly harmful and typically leads to high mortality in infected 
CF patients (Jones et al., 2004). 
 
B. cenocepacia is isolated in the CF lung alongside other fungi, bacteria, and 
viruses such as Aspergillus spp., C. albicans, Haemophilus influenzae, S. aureus, 
P. aeruginosa, and respiratory syncytial virus (Rogers et al., 2003; Etherington et 
al., 2014). B. cenocepacia has been found to work synergistically with Aspergillus 
niger, and co-cultures increase biomass and phosphate solubilisation (Braz and 
Nahas, 2012). Conversely, a QSM produced by B. cenocepacia, Cis-2-
dodecenoic acid (BDSF), inhibits filamentation, biofilm formation, and attachment 
of C. albicans (Boon et al., 2008; Zhang et al., 2011; Tian et al., 2013). This 
indicates that B. cenocepacia can participate in diverse polymicrobial 
relationships with fungi.  
 
3.1.1.3 Klebsiella pneumoniae. K. pneumoniae is a Gram-negative commensal 
of the gastrointestinal system and nasopharynx, and becomes an opportunistic 
pathogen following host immune suppression (Heitman and Brasher, 1971; 
Struve and Krogfelt, 2004). This bacterium is a major nosocomial pathogen, 
causing urinary tract infections, ventilator-associated pneumonia, diarrhoea, 
wound infections, bacteraemia, and septicaemia (Balestrino et al., 2005). Many 
strains of multi-drug-resistant carbapenemase- and β- lactamase-producing K. 
pneumoniae have emerged, making these infections particularly difficult to treat 
(Podschun and Ullmann, 1998; Patel et al., 2008). The prevalence of antibiotic-
resistant K. pneumoniae is dramatically increasing, with incidences of 
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carbapenem-resistant isolates rising from 2.4% to 52% in 10 years (Datta et al., 
2012). 
 
The main virulence factor of K. pneumoniae is its thick, acidic polysaccharide 
capsule (Podschun and Ullmann, 1998). K. pneumoniae is able to avoid 
phagocytosis by utilising this capsular protection and activating phosphoinositide 
3-kinase to inhibit phagosome maturation (Cano et al., 2014). Virulence is also 
mediated through siderophores, adhesins, lipopolysaccharide, and urease 
(Rosen et al., 2016).  
 
K. pneumoniae is frequently found within polymicrobial environments, as it is a 
member of the gut microbiome and is commonly isolated in urinary tract infections 
(Garcia de la Torre et al., 1985; Behzadi et al., 2010; Lin et al., 2012). Catheter-
associated urinary tract infections are usually caused by multi-species biofilms. 
(Frank et al., 2009). Moreover, K. pneumoniae has been co-isolated with C. 
albicans, E. coli, Staphylococcus epidermidis, and Enterococcus faecium in 
patients with abdominal peritonitis (Hwang et al., 2014). 
 
3.1.1.4 Pseudomonas aeruginosa. P. aeruginosa is a Gram-negative, motile, 
opportunistic pathogen that is found in soil and as a member of the human skin 
flora (Hogan and Kolter, 2002). This bacterium can cause potentially fatal 
infections in immunocompromised individuals, and in catheters, ventilators, 
burns, traumatic wounds, or the CF lung (Gonzalez et al., 2016). Overall mortality 
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rates for P. aeruginosa infections reach around 60% for hospitalised patients 
(Kang et al., 2003). This infection is particularly prevalent in CF, where it infects 
64% of adult CF patients and increases the risk of mortality (Parad et al., 1999; 
Crull et al., 2016). The WHO has recently prioritised P. aeruginosa as one of the 
top three pathogens requiring focus for antibiotic development, highlighting the 
importance of this bacterium on a global scale (WHO, 2017).  
 
The pathogenesis of P. aeruginosa involves direct contact and adherence with 
the epithelium. Secretion systems play a major role in host infection, especially 
Type II, III, and VI. The Type II secretion system is not contact-dependent and 
involves the extracellular release of toxins such as elastase, phospholipase C, 
exotoxin A, and phosphatases (Kipnis, Sawa and Wiener-Kronish, 2006). The 
Type III secretion system (T3SS) is activated after binding to host cells, where a 
needle-like appendage injects several specific effector proteins into host cells, 
leading to cell death and bacterial dissemination (Yahr, Goranson and Frank, 
1996). The Type VI secretion system (T6SS) is another contact-dependent 
delivery system, with machinery that resembles bacteriophages (Cascales and 
Cambillau, 2012). Similar to the T3SS, the T6SS facilitates virulence and injects 
prey cells with toxins (Mougous et al., 2006). This system has been found to act 
against other bacteria (Hood et al., 2010), and the Serratia marcescens T6SS 
can kill C. albicans (Trunk et al., 2018).  
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The most commonly implicated extracellular chemicals involved in polymicrobial 
relationships include QSMs, phenazines, and siderophores. P. aeruginosa 
secretes several QSMs, which are mechanisms for communication between 
cells, both intra- and inter-species (Nealson and Hastings, 1979; Waters and 
Bassler, 2005). This density-dependent mechanism allows bacteria to sense 
other organisms and coordinate appropriate responses as a population. This 
includes the secretion of virulence factors, swarming, bioluminescence, 
apoptosis, and the induction of biofilm formation (Kipnis, Sawa and Wiener-
Kronish, 2006). They have been found to depress host immune response and 
inhibit the growth of other organisms (Telford et al., 1998). 3-oxo-C12 homoserine 
lactone (C12 HSL) is the major QSM, and inhibits filamentation of C. albicans and 
sporulation of A. fumigatus (Hogan, Vik and Kolter, 2004; Mowat et al., 2010). 
 
The phenazine pyocyanin is a blue-pigmented toxin that causes deleterious 
effects on both the host and neighbouring microorganisms. Pyocyanin damages 
host cells by enhancing intracellular ROS and decreasing catalase and 
superoxide dismutase (Muller, 2002; Rada et al., 2011). The toxin also depresses 
the host immune response by disrupting lysosome formation and inducing 
apoptosis in neutrophils, promoting P. aeruginosa survival (Allen et al., 2005; 
Prince et al., 2013). Pyocyanin can exacerbate infections during CF, and this 
phenazine can reach concentrations of 130 µM in sputum (Wilson et al., 1988). 
Concentrations of pyocyanin can be up to 8 µM in infected wounds, and the 
presence of burn wound exudate increases the production of pyocyanin, thus 
perpetuating the cellular damage in these patients (Gonzalez et al., 2016; Hall et 
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al., 2016). Phenazines can also negatively impact other microorganisms, for 
instance pyocyanin and 1-hydroxy-phenazine can inhibit the growth of C. 
albicans and A. fumigatus (Kerr et al., 1999; Morales et al., 2013). Phenazine-1-
carboxylic acid has been explored as a potential biocontrol agent to inhibit 
germination of Botrytis cinereal, the causative agent of grey mould in soft fruits 
(Simionato et al., 2017).  
 
P. aeruginosa also produces potent siderophores, which are important secreted 
virulence factors. Siderophores are low molecular weight chelators that 
specifically bind iron (Braud, Hoegy, et al., 2009). P. aeruginosa produces 
pyoverdine and pyochelin, which have affinity constants for iron of 1036 M-1 and 
105 M-1, respectively (Cox and Graham, 1979; Albrecht-Gary et al., 1994). 
Pyoverdine is the major siderophore produced by P. aeruginosa, as it has the 
highest affinity for iron and can acquire iron from host transferrin (Xiao and 
Kisaalita, 1997). Pyoverdine is essential for P. aeruginosa virulence, and deletion 
of pyoverdine synthesis reduces pathogenicity in vivo (Meyer et al., 1996). 
Though the major role for pyoverdine is iron acquisition, it also participates in 
cellular communication, regulates biofilm formation, and mediates the secretion 
of virulence factors, such as exotoxin A, endoproteases, and pyoverdine itself 
(Lamont et al., 2002; Cézard, Farvacques and Sonnet, 2015). Pyoverdine 
chelates ferric iron, binds to the P. aeruginosa ferripyoverdine outer membrane 
transport receptor FpvA and enters the bacterial periplasm (Poole et al., 1993). 
Iron is dissociated from pyoverdine through a reductive process (Schalk, 
Abdallah and Pattus, 2002) involving the FpvCDEF ABC-transporter and enters 
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the cytoplasm via FpvDE transporter. The apo-siderophore (iron-free) is recycled 
after iron removal and secreted again through the PvdRT-OmpQ efflux pump 
(Brillet et al., 2012; Cézard, Farvacques and Sonnet, 2015). 
 
3.1.1.5 Staphylococcus aureus. S. aureus is a common commensal of the skin 
and nasal cavities, with 20-30% of individuals being chronically colonised 
(Kluytmans, Van Belkum and Verbrugh, 1997). A person’s own colonising strains 
are generally the cause of infection, though transmission of commensal bacteria 
between healthy and susceptible individuals is also a common route of infection 
(von Eiff et al., 2001). This opportunistic pathogen is a major cause of 
antimicrobial resistant community- and hospital- associated infections, causing 
over 50,000 deaths per year and costing billions of dollars annually in the United 
States (Goetghebeur et al., 2007; Lee et al., 2013). S. aureus attaches to the 
surface of host cells and medical devices where they readily form persistent, 
difficult to eradicate biofilms (Foster and Höök, 1998). These bacteria can survive 
and hide within host cells, and are associated with capsule formation and small 
colony variants that promote recurrent infections (Kahl et al., 1998; Tzianabos, 
Wang and Lee, 2001). Host damage occurs through the secretion of degrading 
enzymes (proteases, lipases, and elastases), toxins (such as α-toxin, leukocidins, 
delta-hemolysin, and enterotoxins) and superantigens that can lead to further 
dissemination, chronic wounds, and diseases such as toxic shock syndrome or 
food poisoning  (as reviewed in McCormick, Yarwood and Schlievert, 2002; Otto, 
2014). S. aureus has been implicated in polymicrobial relationships with C. 
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albicans (Schlecht et al., 2015; Kong et al., 2016) and A. fumigatus (Granillo et 
al., 2015).  
 
3.1.1.6 Escherichia coli. E. coli is an abundant member of the intestinal flora of 
mammals, and generally lives as a harmless commensal. However, when a host 
becomes immunocompromised, intestinal barriers are breached, or the 
bacterium is transported to other body sites, severe gastroenteritis, urinary tract 
infections, wound infections, meningitis, or bloodstream infections can occur. 
Virulence factors vary based on E. coli pathovar, though all pathogenesis 
includes adherence to the host mucosa by utilising fimbriae or other adhesins, 
multiplication and biofilm formation, and toxin production. Examples of toxins 
include haemoglobin-binding protease, urease, Shiga-toxin, heat-labile and -
stable enterotoxins, and cytolethal distending toxin (as reviewed in Kaper, Nataro 
and Mobley, 2004). The pro-inflammatory compound located on the surface of E. 
coli cell wall, lipopolysaccharide (LPS), can cause septic shock by binding to Toll-
like receptor 4 and inducing an acute inflammatory response (Tapping et al., 
2000).  
 
As E. coli is such a prominent member of the microbiome, it forms diverse 
relationships with fungi. For instance, E. coli can enhance the pathogenicity of C. 
albicans in a rat bladder model (Levison and Pitsakis, 1987) but can also kill C. 
albicans through secretion of a soluble antifungal substance (Cabral et al., 2018). 
It is possible that these relationships vary based on location, where they compete 
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for resources as commensals in the highly populated gut, but they work together 
in a sparse urinary tract infection scenario. Furthermore, E. coli produces a 
protein that was found to have anti-Aspergillus activity (Yadav et al., 2005), while 
LPS produced by E. coli enhances the production of gliotoxin in A. fumigatus 
(Svahn et al., 2014).  
 
3.2 Aim of this chapter.  
Although Mucoralean fungi are ubiquitous in the environment and come into 
contact with countless species of fungi and bacteria, their interaction with other 
organisms is currently uncharacterised. While it is likely that they have evolved 
specific mechanisms to communicate with and respond to neighbouring 
microorganisms, it is unknown whether these relationships impact Mucoralean 
pathogenesis. As virulence of these filamentous fungi is dependent on 
germination, this chapter aims to understand the impact of candidate bacteria 
and fungi on the germination and overall growth of representative Mucoralean 
species.  
 
3.3 Results 
3.3.1 Candida albicans supernatant delays the germination of Rhizopus 
microsporus, Lichtheimia corymbifera, and Cunninghamella bertholletiae. 
To begin investigating the role of opportunistic microorganisms in influencing the 
pathogenesis of Mucorales, we exposed Lichtheimia corymbifera (low virulence, 
35% mortality), Rhizopus microsporus (moderate virulence, 47% mortality), and 
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Cunninghamella bertholletiae (high virulence, 77% mortality) to supernatants 
from opportunistic pathogens (Jeong et al., 2019).  
 
To understand whether C. albicans impacts the growth of Mucorales, spores (1 x 
104 spores/ml) were exposed to 50% C. albicans supernatant. Live-cell imaging 
was used to visualise spore swelling and germination over time. The addition of 
50% C. albicans supernatant induced moderate delays in R. microsporus (Figure 
3.1), L. corymbifera (Figure 3.2) and C. bertholletiae (Figure 3.3) germination. R. 
microsporus germination was decreased by 47.26% (+/- 15.48%) after exposure 
to the supernatant for 8 hours (Figure 3.1B), and germination remained lower 
than the control throughout the time course of the experiment. For L. corymbifera, 
germination was delayed by 39.54% (+/- 15.65%) at 6 hours (Figure 3.2B). C. 
albicans supernatant decreased C. bertholletiae germination by 64.04% (+/- 
24.13%, p = 0.0029) after 5 hours (Figure 3.3B).  
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Figure 3.1 Candida albicans supernatant delays the germination of Rhizopus 
microsporus. R. microsporus spores were exposed to sterile supernatants from 
overnight cultures of C. albicans and (A) representative images were taken. Scale bar = 
50 µm. (B) Percent of spores germinated over 15 hours was calculated (n=3).  Two-way 
Repeated Measures ANOVA on arcsine-transformed data was used to determine 
significance with Tukey’s multiple comparisons test (α = 0.05). Data represent mean and 
standard error of mean (SEM). 
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Figure 3.2 Candida albicans supernatant delays the germination of Lichtheimia 
corymbifera. L. corymbifera spores were exposed to sterile supernatants from overnight 
cultures of C. albicans and (A) representative images were taken. Scale bar = 50 µm. 
(B) Percent of spores germinated over 18 hours was calculated (n=3). Two-way 
Repeated Measures ANOVA on arcsine-transformed data was used to determine 
significance with Tukey’s multiple comparisons test (α = 0.05). Data represent mean and 
SEM. 
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Figure 3.3 Candida albicans supernatant delays the germination of 
Cunninghamella bertholletiae. L. corymbifera spores were exposed to sterile 
supernatants from overnight cultures of C. albicans and (A) representative images were 
taken. Scale bar = 50 µm. (B) Percent of spores germinated over 8 hours was calculated 
(n=3). Two-way Repeated Measures ANOVA on arcsine-transformed data was used to 
determine significance with Tukey’s multiple comparisons test (α = 0.05). Data represent 
mean and SEM. 
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3.3.2 Farnesol delays the growth and germination of R. microsporus, C. 
bertholletiae, and L. corymbifera. R. microsporus, C. bertholletiae, and L. 
corymbifera spores were exposed to commercially purified farnesol and imaged 
for 18 hours via live cell microscopy (Figures 3.4, 3.5, and 3.6). Addition of 
exogenous farnesol to R. microsporus spores resulted in a mild delay in 
germination, with farnesol-treated spores taking 10 hours for over 90% of the 
population to germinate, while solvent control spores reached 100% germination 
within 9 hours (Figure 3.4A and B). To determine whether the presence of 
farnesol delays the initiation of germination, the time when the first spore began 
producing a germ tube was measured (Figure 3.4C). Farnesol slightly delayed 
the time to first germ tube formation, with methanol control spores initialising 
germination after 6.97 hours (+/- 0.23) and farnesol-exposed spores after 8.14 
hours (+/- 0.04). Spores exposed to farnesol swelled more than control spores 
before germination was initiated (Figure 3.4D), suggesting that spores are still 
metabolically active even though germination was delayed. Therefore, farnesol 
imposes a mild stress on R. microsporus, which results in a slight delay in the 
onset of germination. 
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Figure 3.4 Farnesol delays the growth and germination of Rhizopus microsporus. 
R. microsporus spores were exposed to 200 µM farnesol and (A) representative images 
were collected. Scale bar = 50 µm. (B) Percent of R. microsporus spores germinated 
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over time, (C) time to first germ tube emergence, and (D) fold increase of spore volume 
after exposure to farnesol was calculated (n=3). For percent germination, Two-way 
Repeated Measures ANOVA on arcsine-transformed data with Tukey’s multiple 
comparisons test (α = 0.05) was used, comparing farnesol to methanol control. For time 
to first germ tube emergence and spore swelling, Kruskal Wallis with Dunn's multiple 
comparisons test was used. Data represent mean and SEM.  * = p < 0.05, ** = p < 0.01, 
**** = p < 0.0001. 
 
Farnesol also delayed the germination of C. bertholletiae (Figure 3.5A). Here, 
1.59% (+/- 1.59%, p < 0.0001) of spores germinated after 4 hours, while 55.01% 
(+/- 4.77%) of solvent control germinated (Figure 3.5B). However, germination 
reached 93.03% (+/- 6.34%) after 6 hours. While there was an overall delay in 
germination, the time to first germ tube formation was not impacted by the 
presence of farnesol (Figure 3.5C).  
 
L. corymbifera had the least significant delay in growth (Figure 3.6A), and 53.47% 
(+/- 18.70%, p = 0.0341) of farnesol-exposed spores still germinated at 6 hours. 
After 9 hours, 93.40% (+/- 4.57%) of spores germinated (Figure 3.6B), and the 
time to first germ tube formation was not impacted after treatment with farnesol 
(Figure 3.6C),  
In all, this data suggests that C. albicans induces a modest effect on the 
germination of the representative Mucoralean species, R. microsporus, C. 
bertholletiae and L. corymbifera.  
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Figure 3.5 Farnesol delays the germination of Cunninghamella bertholletiae. C. 
bertholletiae spores were exposed to 200 µM farnesol and (A) representative images 
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were collected. Scale bar = 50 µm. (B) Percent of C. bertholletiae spores germinated 
over time and (C) time to first germ tube emergence after exposure to farnesol were 
calculated (n=3). For percent germination, Two-way Repeated Measures ANOVA on 
arcsine-transformed data with Tukey’s multiple comparisons test (α = 0.05) was used, 
comparing farnesol to methanol control. For time to first germ tube emergence, Kruskal 
Wallis with Dunn's multiple comparisons test was used. Data represent mean and SEM.  
* = p < 0.05, ** = p < 0.01, **** = p < 0.0001. 
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Figure 3.6 Farnesol delays the germination of Lichtheimia corymbifera. L. 
corymbifera spores were exposed to 200 µM farnesol and (A) representative images 
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were collected. Scale bar = 50 µm. (B) Percent of L. corymbifera spores germinated over 
time and (C) time to first germ tube emergence after exposure to farnesol were calculated 
(n=3). For percent germination, Two-way Repeated Measures ANOVA on arcsine-
transformed data with Tukey’s multiple comparisons test (α = 0.05) was used, comparing 
farnesol to methanol control. For time to first germ tube emergence, Kruskal Wallis with 
Dunn's multiple comparisons test was used. Data represent mean and SEM.  * = p < 
0.05, ** = p < 0.01, **** = p < 0.0001. 
 
3.3.3 Bacterial supernatants significantly impact the growth of R. 
microsporus, L. corymbifera, and C. bertholletiae. To determine whether the 
presence of P. aeruginosa, K. pneumoniae, and B. cenocepacia would impact 
the pathogenicity of Mucorales, R. microsporus, L. corymbifera, and C. 
bertholletiae were exposed to 50% supernatants from overnight cultures of these 
bacteria. Live cell imaging was used to monitor spore swelling and germination 
(Figure 3.7A and 3.8A).  
 
While B. cenocepacia supernatant had a very mild impact on R. microsporus, K. 
pneumoniae delayed germination by 2 hours (Figure 3.7B). Germination 
eventually reached 100%. On the other hand, the presence of P. aeruginosa 
supernatant resulted in almost total inhibition of R. microsporus germination, with 
only 6.7% (+/- 3.8, p < 0.0001) of spores germinating after 18 hours.  
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The time in which the first spore produced a germ tube was also recorded (Figure 
3.7C). Controls began germinating at 6.72 hours (+/- 0.073). While K. 
pneumoniae delayed the first germ tube protrusion by 2.31 hours (+/- 0.083), P. 
aeruginosa supernatant significantly delayed the onset of hyphal formation, with 
the first spore germinating at 13.13 hours (+/- 0.99, p = 0.0288). This indicates 
that P. aeruginosa secretes a substance that inhibits the cue for R. microsporus 
to begin producing hyphae. 
 
To determine the impact of bacterial supernatants on spore swelling, the average 
volume of spores immediately before germ tube protrusion was measured and 
compared to the earliest imaged timepoint (Figure 3.7D). The fold increase of R. 
microsporus spore volume after exposure to P. aeruginosa supernatant 
increased by 21.17-fold (+/- 7.07), while control spores increased 13.36-fold (+/- 
0.43), indicating that the spores continue to swell without germinating. The fold-
increase upon treatment with K. pneumoniae (9.57-fold +/- 1.34) and B. 
cenocepacia 6.06-fold (+/- 0.43) supernatants is lower than controls, suggesting 
that full swelling is not necessary for germination. In all, this indicates that spores 
can swell without producing hyphae or germinate without reaching maximum 
isotropic growth.  
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Figure 3.7 Bacterial supernatants significantly impact the growth of R. 
microsporus. R. microsporus spores were exposed to 50% P. aeruginosa (P.a.), K. 
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pneumoniae (K.p.) or B. cenocepacia (B.c.) supernatants and (A) representative images 
were taken. Scale bar = 20 µm (B) Percent of spores germinated over time was 
calculated (n=4). (C) Time to first germ tube emergence (n=3) and (D) fold increase of 
the average spore volume was measured after exposure to 50% supernatants (n=3). For 
percent germination, Two-way Repeated Measures ANOVA on arcsine-transformed 
data with Tukey’s multiple comparisons test (α = 0.05) was used. For time to first germ 
tube emergence and spore swelling, Kruskal Wallis with Dunn's multiple comparisons 
test was used. Data represent mean and SEM.  * = p < 0.05, ** = p < 0.01, **** = p < 
0.0001.   
 
Exposure to B. cenocepacia, K. pneumoniae, and P. aeruginosa supernatants 
induced a surprising response from L. corymbifera and C. bertholletiae. Instead 
of inhibiting germination, as seen with R. microsporus, all three supernatants 
promoted early germination and led to the production of thin, misshapen hyphae 
(Figures 3.8A and 3.8B). Germination of L. corymbifera spores increased by 
34.92% (+/- 11.40%) with B. cenocepacia supernatant, 58.04% (+/- 7.56%) with 
K. pneumoniae, and 49.07% (+/- 6.06%) with P. aeruginosa, as compared to the 
control at 5 hours (Figure 3.8B). C. bertholletiae filamentation increased by 
69.83% (+/- 12.88%, p = 0.0004) with B. cenocepacia, 75.80% (+/- 4.88%, p < 
0.0001) with K. pneumoniae, and 54.68% (+/- 20.99%, p = 0.0039) with P. 
aeruginosa at 4 hours (Figure 3.8C). 
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Figure 3.8 Bacterial supernatants promote early overall germination of L. 
corymbifera and C. bertholletiae. Spores were exposed to 50% P. aeruginosa (P.a.), 
K. pneumoniae (K.p.) or B. cenocepacia (B.c.) supernatants and (A) representative 
images were taken. Scale bar = 20 µm. Percent of (B) L. corymbifera and (C) C. 
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bertholletiae spores germinated over time was calculated (n=4). Two-way Repeated 
Measures ANOVA on arcsine-transformed data with Tukey’s multiple comparisons test 
was used (α = 0.05). Data represent mean and SEM.  * = p < 0.05, ** = p < 0.01, *** = p 
< 0.001. 
 
The time to first germ tube emergence was calculated (Figure 3.9). While early 
filamentation of L. corymbifera was promoted overall when exposed to all three 
supernatants, only K. pneumoniae significantly decreased the time to first germ 
tube emergence (3.75 hours +/- 0.024, p = 0.0485) as compared to control (5.03 
hours +/- 0.16) (Figure 3.9A). For C. bertholletiae, there was no significant 
difference between control spores (4.42 hours +/- 0.024) and B. cenocepacia 
(3.52 hours +/- 0.10), K. pneumoniae (3.31 hours +/- 0.20), or P. aeruginosa (4.76 
hours +/- 1.497) supernatants (Figure 3.9C). This suggests that while overall 
germination is promoted, the initiation of germination of individual spores is not 
always significantly impacted.  
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Figure 3.9 Bacterial supernatants do not promote initiation of L. corymbifera and 
C. bertholletiae germination on an individual spore level. (A) L. corymbifera and (B) 
C. bertholletiae spores were exposed to 50% P. aeruginosa, K. pneumoniae or B. 
cenocepacia supernatants and time to first germ tube emergence was measured (n=3). 
Kruskal Wallis with Dunn's multiple comparisons test was used (α = 0.05). Data represent 
mean and SEM.  * = p < 0.05. 
 
To determine whether spore swelling was also impacted by the presence of the 
supernatants, the average spore volume was measured, comparing the initial 
time point to the final time point before 50% germination (Figure 3.10). The 
volume of L. corymbifera control spores increased by 10.41-fold (+/- 2.23), while 
spores exposed to B. cenocepacia, K. pneumoniae, and P. aeruginosa 
supernatants swelled by 3.94 (+/- 0.86), 3.56 (+/- 0.49), and 2.80 (+/- 0.46, p = 
0.0293) fold, respectively (Figure 3.10A). C. bertholletiae control spores 
increased by 7.05-fold (+/- 0.64), and treatment with B. cenocepacia, K. 
pneumoniae, and P. aeruginosa supernatants resulted in 1.93 (+/- 0.49), 1.75 (+/- 
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0.042), and 1.74 (+/- 0.13) fold increase. Therefore, the presence of the bacterial 
supernatants decreased spore swelling.  
 
 
Figure 3.10 Exposure to bacterial supernatants decreases L. corymbifera and C. 
bertholletiae spore swelling. (A) L. corymbifera and (B) C. bertholletiae spores were 
exposed to 50% P. aeruginosa, K. pneumoniae, or B. cenocepacia supernatants. The 
fold increase of the average spore volume was measured after exposure to 50% 
supernatants (n=3). Kruskal Wallis with Dunn's multiple comparisons test was used (α = 
0.05). Data represent mean and SEM.  * = p < 0.05. 
 
3.3.4 Growth promotion and phenotype alteration of C. bertholletiae by P. 
aeruginosa supernatant is likely caused by pH changes and nutrient 
depletion. Addition of B. cenocepacia, K. pneumoniae, and P. aeruginosa 
supernatants to SAB broth resulted in mild alkalisation of the media (average pH 
of 7.33 vs. 6.45). As fungal germination is dependent on environmental pH and 
nutrient availability (Buffo, Herman and Soll, 1984; Singh et al., 2016), we 
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assessed whether the addition of the supernatants were influencing germination 
through modulation of these parameters. C. bertholletiae was used as a fungus 
that germinated early in response to supernatants, and R. microsporus was 
included as its germination was highly inhibited. Only P. aeruginosa supernatant 
was used in these experiments, as it produced the strongest, most consistent 
results. 
 
Exposure of C. bertholletiae spores to 7.3 pH SAB/LB induced a similar 
phenotype as the addition of P. aeruginosa supernatant, producing deformed, 
thin, fragile hyphae (Figure 3.11A) and promoting early germination (Figure 
3.11B). Filamentation of C. bertholletiae was rapidly enhanced with 7.3 pH 
SAB/LB, increasing germination by 59.13% (+/- 5.15%, p = 0.0005) compared to 
control after only 4 hours. This was similar to the effect of P. aeruginosa 
supernatant, which increased germination by 38.89% (+/- 12.44%, p =0.0391) at 
4 hours compared to control.  
 
To elucidate the role of macronutrient restriction, SAB broth was diluted with 50% 
PBS to mimic the nutrient limitation imposed by the addition of 50% supernatant. 
As with the adjusted pH, nutrient dilution induced early germination, statistically 
similar to P. aeruginosa supernatants at all measured time points (Figure 3.11B). 
At 4 hours, germination was increased by 59.26% (+/- 1.63%, p = 0.0007) with 
the addition of PBS compared to control.  
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Hyphal width is an indicator of nutrient status  and decreased width suggests 
starvation (Turgeman et al., 2014). While the width of control hyphae was 5.30 
μm (+/- 0.15) 1-hour post germination, C. bertholletiae exposed to P. aeruginosa 
supernatant had a decreased hyphal width to 2.82 μm (+/- 0.15, p = 0.0383, 
Figure 3.11C). This was similar to the hyphal width in the nutrient starved 
condition, which was 2.79 μm (+/- 0.14, p = 0.0277). This indicates that the 
unusual hyphal growth in response to supernatants (Figure 3.11A) is likely due 
to nutrient limitation. However, using PBS to dilute the media could also indicate 
osmotic stress due to the high levels of salt in PBS.  
Taken together these results indicate that the early germination of C. bertholletiae 
induced by the presence of bacterial supernatants is likely caused by modulation 
of pH and nutrients, rather than production of hyphae-promoting molecules.  
  
Chapter 3: Impact of Polymicrobial Interactions on Mucorales 
 
103 
 
 
Figure 3.11 Growth promotion and phenotype alteration of C. bertholletiae by P. 
aeruginosa supernatant is likely caused by pH changes and nutrient depletion. To 
determine if alteration of pH or nutrient depletion caused the promotion of fungal 
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germination, C. bertholletiae spores were exposed to 50% P. aeruginosa supernatant 
(P. a.), SAB/LB pH 7.3 (pH), and 50% PBS to mock nutrient starvation conditions and 
(A) representative images were taken. Scale bar = 20 µm. (B) The percent of spores 
germinated over time were calculated (n=3). (C) Average width of C. bertholletiae 
hyphae was measured (n=3).  For percent germination, Two-way Repeated Measures 
ANOVA on arcsine-transformed data was used to determine significance with Tukey’s 
multiple comparisons test. For hyphal width, Kruskal Wallis with Dunn's multiple 
comparisons test was used (α = 0.05). Data represent mean and SEM. * = p < 0.05, ** = 
p < 0.01, *** = p < 0.001, **** = p < 0.0001.  
 
3.3.5 P. aeruginosa supernatant significantly inhibits the germination of R. 
microsporus, while pH changes and nutrient depletion have no impact. In 
contrast to C. bertholletiae, adjusting to pH 7.33 did not affect R. microsporus 
phenotype or germination (Figure 3.12A). While the supernatant inhibited 
germination by 95.19% (+/- 2.49%, p < 0.0001) after 15 hours, the spores were 
still able to germinate normally with both 7.33 pH SAB/LB and 50% PBS (Figure 
3.12B). There was no significant difference between control conditions, as R. 
microsporus reached 99.21% (+/- 0.399%), 97.67% (+/- 1.79%), and 88.76% (+/- 
10.01%) germination with control, pH 7.33, and 50% PBS, respectively, after 9 
hours. This indicates that pH alteration and nutrient starvation in isolation do not 
impact R. microsporus growth. While there could be a combination effect, it is 
likely that P. aeruginosa secretes a molecule(s) that can inhibit R. microsporus 
germination independent of pH changes or macro-nutrient limitation.  
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Figure 3.12 P. aeruginosa supernatant significantly inhibits the germination of R. 
microsporus, while pH changes and nutrient depletion have no impact. To 
determine if alteration of pH or nutrient depletion caused the inhibition of fungal 
germination, R. microsporus spores were exposed to 50% P. aeruginosa supernatant 
(P. a.), SAB/LB pH 7.3 (pH), and 50% PBS (PBS) to mock nutrient starvation conditions 
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and (A) representative images were taken. Scale bar = 20 µm. (B) The percent of spores 
germinated over time were calculated (n=3). Two-way Repeated Measures ANOVA on 
arcsine-transformed data was used to determine significance with Tukey’s multiple 
comparisons test (α = 0.05). Data represent mean and SEM. * = p < 0.05, ** = p < 0.01, 
*** = p < 0.001, **** = p < 0.0001. 
 
3.3.6 P. aeruginosa supernatant halts the growth of pre-germinated R. 
microsporus spores. To deduce whether P. aeruginosa supernatants can inhibit 
fungal growth after germination has begun, spores were pre-germinated, and 
then incubated with 50% supernatant. After 24 hours, fungal growth was reduced 
by 81.4% (+/- 5.252, p = 0.0286) in the presence of the supernatant as compared 
to the media control (Figure 3.13). Therefore, P. aeruginosa supernatant is able 
to halt further germination and growth of R. microsporus.   
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Figure 3.13 P. aeruginosa supernatant halts the growth of pre-germinated R. 
microsporus spores. To determine whether the supernatant also inhibits the 
continuation of growth after germination is initiated, spores were incubated in SAB broth 
for 4-5 hours until germlings emerged, and subsequently exposed to 50% P. aeruginosa 
supernatant for 18 hours (n=4). Growth was measured using absorbance (OD600). A 
Mann-Whitney U test was used to determine significance. Data represent mean and 
SEM. * = p < 0.05. 
 
3.3.7 Inhibition of R. microsporus growth by P. aeruginosa is not specific 
to lab-evolved strains. To determine whether the inhibitory molecule(s) is 
produced by other P. aeruginosa strains, we tested the ability of supernatants 
from a series of P. aeruginosa isolates to inhibit spore germination. R. 
microsporus germination was inhibited in the presence of supernatants from all 
Chapter 3: Impact of Polymicrobial Interactions on Mucorales 
 
108 
 
P. aeruginosa clinical isolates (Figure 3.14), suggesting that the production of this 
inhibitory molecule is a general trait of P. aeruginosa and is not limited to 
laboratory-evolved strains.  
 
Figure 3.14 Inhibition of R. microsporus growth by P. aeruginosa is not specific to 
lab-evolved strains. To test whether the inhibition of fungal growth by P. aeruginosa is 
a lab strain-specific phenomenon, R. microsporus spores were exposed to supernatants 
from P. aeruginosa clinical isolates for 24 hours (n=6). Fungal growth was determined 
through absorbance (OD600). Data was analysed by a Kruskal-Wallis test with Dunn’s 
multiple comparisons test (α = 0.05). CF = Cystic Fibrosis isolate. Data represent mean 
and SEM. * = p < 0.05, ** = p < 0.01. 
 
3.3.8 P. aeruginosa supernatant decreases R. microsporus swelling in early 
times points and reduces cell wall chitin.  R. microsporus spores began 
germinating in control media after about 6 hours (Figure 3.7C). Figure 3.7D 
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determined that P. aeruginosa supernatant does not decrease spore swelling 
when the volume was measured immediately before the initiation of germination 
or at the end of the experiment if no spores germinated. However, decreased 
swelling in earlier time points could limit nutrient acquisition and reduce 
germination. Therefore, spore swelling after 4 hours exposure to 50% P. 
aeruginosa supernatant was compared to spores suspended in PBS on ice to 
reduce metabolic activity or suspended in 50:50 SAB/LB to induce swelling for 4 
hours (Figure 3.15). The majority of PBS-incubated spores (80.54%) were 
between 10 and 15 μm2, while 65.79% of SAB/LB-incubated spores were greater 
than 20 μm2. Upon exposure to P. aeruginosa supernatant, R. microsporus 
spores continued to swell, but overall area was reduced, with only 29.76% of 
spores being greater than 20 μm2 and 53.17% of spores being between 10 and 
15 μm2 (Figure 3.15A). This indicates that the presence of P. aeruginosa 
supernatant reduces swelling at early time points (4 hours). Reduction in isotropic 
could decrease nutrient uptake and influence germination.  
 
Resting spores contain low levels of chitin, and this is increased during spore 
swelling and germination (Sephton-Clark et al., 2018). Chitin can be anti-
inflammatory (Wagener et al., 2014), and decreased levels of this polysaccharide 
could influence the host immune response to R. microsporus by increasing 
inflammation. Because the presence of P. aeruginosa supernatant reduces spore 
swelling (Figure 3.15A), total chitin levels were measured. R. microsporus spores 
were exposed to 50% P. aeruginosa supernatant, PBS, or 50:50 SAB/LB for 4 
hours, stained with 250 μg/ml calcofluor white (CFW), and microscopic images 
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were taken (Figure 3.15B). Fluorescence was manually measured for 200 spores 
in each condition, relative to area. Relative fluorescence of SAB/LB-incubated 
spores was increased, compared to PBS-incubated (p = 0.0513, Figure 3.15C). 
The average relative fluorescence of spores exposed to P. aeruginosa 
supernatant was also increased as compared to PBS-incubated spores, but this 
was less significantly different (p = 0.3033). This indicates that the decreased 
spore swelling after exposure to P. aeruginosa supernatant likely decreases total 
chitin content, which could influence the host immune response during co-
infection. 
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Figure 3.15 P. aeruginosa supernatant decreases R. microsporus spore swelling 
and chitin. R. microsporus spores were exposed to 50% P. aeruginosa supernatant, 
PBS, or 50:50 SAB/LB for 4 hours before images were taken microscopically. (A) The 
average spore area under each condition was measured and grouped into size 
categories (< 10 μm2, 10-15 μm2, 15-20 μm2, and > 20 μm2). Spores were stained with 
calcofluor white (CFW) and (B) representative images are shown. Scale bar = 25 μm. 
(C) The fluorescence of spores under each condition was measured, relative to area. 
Data was analysed by a Kruskal-Wallis test with Dunn’s multiple comparisons test (α = 
0.05). Data represent mean and SEM.  
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3.3.9 Live P. aeruginosa strongly inhibits the germination of R. 
microsporus. R. microsporus spores were co-cultured with live P. aeruginosa, 
K. pneumoniae, B. cenocepacia, S. aureus, and E. coli to further observe cross-
kingdom interactions (Figure 3.16A). Co-culture of R. microsporus with P. 
aeruginosa at MOIs of 1:50 and 1:100 for 24 hours resulted in 56.80% (+/- 8.269, 
p = 0.0023) and 92% (+/- 2.784, p < 0.001) inhibition of fungal germination, 
respectively (Figure 3.16B, quantified by Callum Clark). K. pneumoniae 
completely inhibited the germination of R. microsporus spores at all MOIs tested, 
and this observation is being investigated by other laboratory members. 
Conversely, co-culturing R. microsporus with S. aureus, E. coli, and B. 
cenocepacia did not affect fungal growth at any of the MOIs tested. Taken 
together, the results obtained from live co-cultures between R. microsporus and 
P. aeruginosa indicate that these two microbes undergo a competitive 
relationship resulting in reduced fungal germination.  
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Figure 3.16 P. aeruginosa strongly inhibits the germination of R. microsporus. R. 
microsporus spores were incubated with live P. aeruginosa (P. a.), K. pneumoniae (K. 
p.), B. cenocepacia (B. c.), S. aureus (S. a.), and E. coli (E. c.) at increasing multiplicities 
of infection (MOI) for 24 hours (A) Representative images after 24 hours exposure (37˚C, 
static). Scale bars depict 50 µm. (B) Percent of spores germinated after 24 hours 
exposure to P. aeruginosa. Dotted line represents spore-only control. One-way ANOVA 
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performed on arcsine transformed data (n=6, α = 0.05). *** = p < 0.001. Data represent 
mean and SEM. (Kousser et al., 2019).   
 
3.4 Discussion. 
This chapter highlights the ability of polymicrobial interactions to modulate the 
germination of Mucorales, which is a key virulence determinate (Ibrahim et al., 
2012). Here it was demonstrated that Mucorales have a varying, species-specific 
response to opportunistic bacteria and fungi.  
 
3.4.1 Fungal-fungal interactions. C. albicans has been previously shown to 
modulate the growth and virulence of invasive fungi such as Cryptococcus 
neoformans (Cordeiro et al., 2012), Aspergillus nidulans (Semighini et al., 2006), 
Aspergillus flavus (Wang et al., 2014), Penicillium expansum (P. Liu et al., 2010), 
and Fusarium graminerum (Semighini, Murray and Harris, 2008) through the 
secretion of farnesol. However, C. albicans supernatant and isolated farnesol 
have limited effects on Mucorales germination.  
 
Farnesol is an autoinhibitory molecule that prevents the morphological switch in 
C. albicans from disseminating or commensal yeast to invasive hyphae by acting 
on the cyclic adenosine monophosphate (cAMP) pathway (Hall et al., 2011). As 
farnesol does not completely inhibit spore germination, it is possible that 
filamentation is regulated through a different pathway in Mucorales, though the 
exact pathway is unknown. During hyphal growth, Rhizopus delemar upregulates 
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stress response genes (Sephton-Clark et al., 2018). A. nidulans responds to 
farnesol by enhancing the production of stress response proteins, including 
antioxidant enzymes and the MAPK regulated dehydrin-like protein (Wartenberg 
et al., 2012). Therefore, perhaps R. microsporus, C. bertholletiae, and L. 
corymbifera overcome the farnesol-dependent inhibition by enhancing their 
stress response mechanisms.  
 
3.4.2 Inhibition of R. microsporus germination by P. aeruginosa secreted 
factors. While B. cenocepacia, K. pneumoniae, and P. aeruginosa supernatants 
all significantly inhibited the growth of R. microsporus, P. aeruginosa had the 
most drastic, long-lasting effect. This is similar to observations in plant disease, 
where Pseudomonas fluorescens inhibits apple rot caused by Mucor piriformis 
through secreted molecules (Wallace, Hirkala and Nelson, 2018). P. aeruginosa 
is known to participate in polymicrobial interactions with fungi, frequently acting 
antagonistically and competing against other organisms. The result of these 
interactions usually ends in inhibition or death of the other organism (Hogan and 
Kolter, 2002; Hogan, Vik and Kolter, 2004; Mowat et al., 2010; Filkins et al., 
2015). Because of this dramatic, long-lasting inhibition that is not confounded by 
pH changes or nutrient depletion, the interaction between R. microsporus and P. 
aeruginosa was chosen to study more in-depth.  
 
Diagnosis of mucormycosis usually occurs once disease has already progressed, 
and a successful treatment would halt hyphal growth following the initiation of 
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germination. It has been shown previously that cessation of actively germinating 
Mucorales spores is possible through the addition of acetic acid (Trzaska et al., 
2015). Here we found that supernatants from P. aeruginosa can inhibit further 
growth of pre-germinated R. microsporus spores. This indicates that P. 
aeruginosa secreted factors also inhibit hyphal extension and could impact 
existing infections. This is contrary to work investigating the relationship between 
Rhizopus stolonifer and Enterobacter cloacae, where addition of E. cloacae to 
resting spores inhibited germination, but bacteria had a reduced effect on pre-
germinated R. stolonifer (Wisniewski, Wilson and Hershberger, 1989). 
 
Consistent with results from sterile supernatants, exposure to live P. aeruginosa 
inhibits R. microsporus growth more effectively than other tested bacteria, with 
the exception of K. pneumoniae. This bacterium can interact with C. albicans in 
a contact-dependent manner, where P. aeruginosa binds to fungi hyphae, forms 
a biofilm, and kills via the secretion of cytolytic phospholipase C (Gibson, Sood 
and Hogan, 2009). Therefore, it is possible that the presence of the bacteria also 
reduces viability of R. microsporus, and fungal survival during co-cultures will be 
explored in Chapter 4.  
 
3.4.3 Response variation between distantly related Mucorales following 
exposure to bacterial supernatants. Bacterial supernatants promoted the early 
germination of C. bertholletiae and L. corymbifera. While germination occurred 
earlier than controls, hyphae were thin, fragile, and deformed. Previous studies 
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have found that nutrient starvation can lead to decreased hyphal width 
(Turgeman et al., 2014) and that susceptibility to pH varied based on species 
(Singh et al., 2016). Our observations that an increase of the media’s pH impacts 
the growth of C. bertholletiae is consistent with previously published results that 
this species, along with L. corymbifera, is more sensitive to alkaline pH than 
Rhizopus spp. (Singh et al., 2016). It is possible that secreted molecules from 
these bacteria or live bacteria could impact growth of C. bertholletiae and L. 
corymbifera, but these effects may be masked by the pH response. Aquaporins 
that actively regulate spore swelling are pH dependent. This factor could be 
responsible for the lower fold-increase of C. bertholletiae and L. corymbifera 
spores prior to germination (Turgeman et al., 2016). Therefore, perhaps the 
media alkalisation modulated the pH-dependent aquaporins on the spore 
surface, limiting the swelling and nutrient acquisition of C. bertholletiae and L. 
corymbifera. This may have led to the malformed hyphae and decreased hyphal 
width, which is a characteristic of nutrient deprived spores (Turgeman et al., 
2014).  
In all, this chapter has shown that opportunistic pathogens can impact the 
germination and growth of Mucorales, though there is inter-species variation. The 
next chapter will focus on the interaction between R. microsporus and P. 
aeruginosa to characterise the inhibitory molecule(s) and determine the causative 
agent. 
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Chapter 4 : CHARACTERISATION OF P. 
AERUGINOSA-MEDIATED INHIBITION 
OF R. MICROSPORUS  
 
The majority of this chapter has been previously published: 
Kousser, C., Clark, C., Sherrington, S., Voelz, K. and Hall, R. (2019). 
Pseudomonas aeruginosa inhibits Rhizopus microsporus germination 
through sequestration of free environmental iron. Scientific Reports, 9. 
DOI 10.1038/s41598-019-42175-0 
 
Parts of this chapter were undertaken by MSci student, Callum Clark, who worked 
under my supervision; and Sarah Sherrington, a technician in Rebecca Hall’s 
laboratory: 
• Figures 4.3B, 4.8A, and 4.8B by Callum Clark 
• Figure 4.7A by Sarah Sherrington 
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4.1 Introduction 
In the previous chapter, we established that Pseudomonas aeruginosa inhibits 
the growth of Rhizopus microsporus through secreted factors. As there is a 
general lack of understanding regarding the pathogenesis of mucormycosis, 
dissecting the relationship between these organisms is important in the context 
of patient management and could provide insight into novel treatment options. 
 
4.1.1 Mucorales and P. aeruginosa in the human host. Investigating the 
interaction between Mucorales and P. aeruginosa is medically relevant, as these 
organisms have been co-isolated from the rhinocerebral cavity and 
gastrointestinal system (Akhrass et al., 2011; Martinello et al., 2012), are routinely 
found in the same niches (Crull et al., 2016; Kabulski and MacVane, 2018; Jeong 
et al., 2019), and infect patients with similar underlying conditions (Atreja and 
Kalra, 2015). They are particularly likely to interact in traumatic and burn wounds, 
where bacteria such as P. aeruginosa are isolated in cutaneous mucormycosis 
(Lelievre et al., 2014). As 75% of chronic wounds test positive for P. aeruginosa, 
it is very likely that Mucorales spores from the environment come into contact 
with this bacteria (De Oliveira et al., 2017). However, the inhibitory action of P. 
aeruginosa on R. microsporus could reduce reporting of the fungus, and co-
habitation of these organisms is likely higher than described. 
 
Diabetes is the most common underlying disease leading to mucormycosis 
(Roden et al., 2005). Diabetic patients, especially those with poorly controlled 
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diabetes, are at risk for developing infections with both P. aeruginosa and 
Mucorales. P. aeruginosa causes infections in chronic foot ulcers, Fournier's 
gangrene, and malignant otitis externa in diabetic individuals (Atreja and Kalra, 
2015).  Mucorales have also been documented in cases of diabetic foot wounds, 
Fournier’s gangrene, and necrotising malignant otitis externa (Tuzcu et al., 2006; 
Kumar et al., 2011; Mandal et al., 2013).  
 
Pulmonary infection is one of the most prevalent manifestations of mucormycosis, 
and this can occur following lung transplantations in CF patients (Kabulski and 
MacVane, 2018). As P. aeruginosa commonly infects the lungs of adults with CF, 
even following transplantation (Suhling et al., 2013), it is likely that they meet in 
this niche as well (Oliver et al., 2000). Specific case reports have described co-
isolation of P. aeruginosa and Mucorales. For example, one study presented an 
individual with rhinocerebral and palatal mucormycosis whose cultures also grew 
P. aeruginosa (Akhrass et al., 2011). Another example involves a patient 
successfully treated for Salmonella typhimurium infection who developed 
gastrointestinal mucormycosis with multi-drug resistant P. aeruginosa also 
isolated following fungal diagnosis (Martinello et al., 2012).  
 
It is possible that the inhibitory nature of P. aeruginosa can mask the presence of 
Mucorales, and mucormycosis could emerge following antibiotic treatment. For 
instance, a person who originally tested positive for only P. aeruginosa sinus 
infection developed rhinocerebral mucormycosis following ciprofloxacin 
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treatment, though this could also be evidence for original misdiagnosis (Dimaka 
et al., 2014). Furthermore, 94% of fungal peritonitis is associated with recent 
antibiotic therapy, usually for treatment of bacterial peritonitis. In these cases, P. 
aeruginosa is one of the most common causes of bacterial peritonitis, and non-
Candida fungi such as Aspergillus spp., Cryptococcus spp., and Mucorales make 
up 10% of fungal infections (Cho and Struijk, 2017). 
 
4.1.2 Mucorales and Pseudomonas spp. in the environment. As Mucorales 
are natural colonisers of soil and plants, human infections usually arise from 
exposure to environmental spores, especially following traumatic wounds. 
(Mousavi et al., 2018). It is likely that Mucorales evolved relationships with 
bacteria in environmental niches, and that these relationships carry over into 
human infection. Studies investigating the interaction between Mucorales and 
Pseudomonas spp. in the agricultural sector provide insight into the relationship 
they may have within a medical setting.  
 
Not only is mucormycosis a devastating infection in humans, but Mucorales are 
major causes of food spoilage. These fungi infect post-harvest fruits and 
vegetables such as peaches, apples, pears, sweet potatoes, strawberries, and 
grapes (Zahavi et al., 2000; Northover and Zhou, 2002; Holmes and Stange, 
2007; Zhang et al., 2007; López et al., 2015).  There have been several studies 
investigating the potential use of bacterial biocontrol agents in reducing 
Mucoralean fruit rot, with Pseudomonas spp. being particularly effective. For 
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instance, P. syringae reduces Rhizopus rot caused by R. stolonifer more 
effectively than other bacteria, such as Enterobacter cloacae (Wilson, Franklin 
and Pusey, 1987; Zhou, Northover and Schneider, 1999; Northover and Zhou, 
2002). The effectiveness of Pseudomonas spp. against mould infections of fruit 
is highlighted with the commercial biocontrol agent BioSave®. This product is 
effective against Mucor rot and Rhizopus rot of fruits, and the main active 
ingredient is P. syringae (Droby et al., 2016).  
 
Although our focus is investigating polymicrobial interactions in a medical setting, 
clues regarding their relationship can be drawn from these environmental 
examples. These cases highlight the antagonistic relationship between 
Mucorales and Pseudomonas and the potential medical implications. 
 
4.2 Aim of this chapter.  
While P. aeruginosa and R. microsporus are likely to meet within the environment 
and the human host, the interaction has not been well defined. This chapter aims 
to systematically characterise the inhibitory compound produced by P. 
aeruginosa and dissect the mechanism mediating this interaction. We will also 
begin investigating the clinical repercussions of P. aeruginosa secreted 
molecules on R. microsporus. 
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4.3 Results 
4.3.1 Bacterial quorum sensing molecules (QSMs) do not inhibit R. 
microsporus growth. The major P. aeruginosa QSM, C12 HSL, inhibits C. 
albicans filamentation (Hogan, Vik and Kolter, 2004). This antagonism is not 
specific to C12 HSL, as dodecanol, a 12-carbon molecule that is structurally 
similar to C12 HSL (Figures 4.1A and 4.1B), can also inhibit C. albicans 
filamentation (Hogan, Vik and Kolter, 2004). Therefore, we first tested the ability 
of dodecanol to inhibit the germination of R. microsporus. Dodecanol (200 μM) 
slightly delayed the germination of R. microsporus by 16.66% (+/- 0.57%) at 9 
hours, but 97.39% (+/- 1.29%) of the spores germinated by 10 hours as compared 
to solvent control (Figure 4.1C).  
 
As dodecanol is not a physiological QSM, we tested the ability of the major P. 
aeruginosa QSMs to inhibit R. microsporus growth. Exposure of R. microsporus 
spores to N-butanoyl-l-homoserine lactone (C4 HSL), N-hexanoyl-DL-
homoserine lactone (C6 HSL), and N-octanoyl-L-homoserine lactone (C8 HSL), 
did not affect fungal growth (Figures 4.1D, 4.1E, and 4.1F). At high concentrations 
(200 μM) C12 HSL resulted in 42.1% (+/- 0.1518%) reduction in growth (Figure 
4.1G). Therefore, secreted bacterial QSMs appear to not be the major regulators 
of R. microsporus growth under these conditions. 
 
4.3.2 Pyocyanin does not impact R. microsporus growth. Addition of purified 
pyocyanin resulted in 31.4% (+/- 0.1434) inhibition of R. microsporus growth at 
Chapter 4: Characterisation of P. aeruginosa-Mediated Inhibition 
124 
 
concentrations above 100 μM (Figure 4.1H). To deduce whether these pyocyanin 
concentrations were physiologically relevant, the concentration of pyocyanin in 
the P. aeruginosa supernatants was quantified through absorbance 
measurement (690 nm) and compared to a standard curve of pre-defined 
pyocyanin concentrations. Growth of P. aeruginosa in LB media at 200 rpm, 37°C 
did not result in the secretion of detectable levels of pyocyanin (performed by 
Callum Clark). Therefore, the inhibition of R. microsporus growth in the P. 
aeruginosa supernatant was not due to pyocyanin. 
Chapter 4: Characterisation of P. aeruginosa-Mediated Inhibition 
125 
 
 
Figure 4.1 Bacterial QSMs and pyocyanin do not inhibit R. microsporus growth. 
The chemical structures of (A) dodecanol and (B) C12 HSL are shown to demonstrate 
their structural similarities. R. microsporus spores were exposed to 200 μM dodecanol 
and (C) the percent of spores germinated over time were calculated. R. microsporus 
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spores were incubated with increasing concentrations of (D) C4 HSL, (E) C6 HSL, (F) 
C8 HSL, (G) C12 HSL, and (H) pyocyanin. Fungal growth was quantified by absorbance 
(OD600) and normalised to media control (n=3). For percent germination, Two-way 
Repeated Measures ANOVA on arcsine-transformed data with Tukey’s multiple 
comparisons test was used (α = 0.05). For all other data, Kruskal Wallis with Dunn's 
multiple comparisons test was used on non-normalised raw data (α = 0.05). Data 
represent mean and SEM. 
 
4.3.3 Inhibitory substance secreted by P. aeruginosa is a hydrophilic, heat-
stable non-protein. To determine whether the secreted factor responsible for 
inhibiting spore germination is proteinaceous, P. aeruginosa supernatants were 
boiled or treated with Proteinase K to degrade any secreted proteins. 
Supernatants that were boiled or treated with Proteinase K inhibited R. 
microsporus growth (by 97.62%, +/- 1.558, p = 0.0355 and 99.03%, +/- 1.634, p 
= 0.0140, respectively) (Figure 4.2A), suggesting that a secreted heat-stable 
molecule mediates the observed inhibition of R. microsporus germination.  
 
To determine whether the secreted factor is a lipophilic molecule, chloroform 
extractions were performed on P. aeruginosa supernatants to separate the 
hydrophilic and hydrophobic compounds. The organic phase of the supernatant 
did not significantly inhibit spore germination (18% inhibition, +/- 3.058), while the 
aqueous phase maintained its inhibitory action (95.1% inhibition, +/- 0.9559, p = 
0.0079, Figure 4.2B). Therefore, a secreted, heat-stable, water-soluble 
molecule(s) inhibits the growth of R. microsporus.  
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4.3.4 Inhibition of growth is not impacted by removal of R. microsporus 
endosymbiont. The isolate of R. microsporus used in this study has been 
confirmed to contain the endosymbiont Ralstonia pickettii (Itabangi et al., 2019, 
preprint). To determine whether the interaction between P. aeruginosa and R. 
microsporus was modulated by the endosymbiont, we used R. microsporus 
spores that had been treated with 60 μg/ml Ciprofloxacin to remove 
endosymbiont. Cured and parent spores were exposed to P. aeruginosa 
supernatant for 24 hours before measuring fungal growth. P. aeruginosa 
supernatant inhibited endosymbiont positive spores by 88.51% (+/- 7.69%) and 
negative spores by 87.95% (+/- 4.38%) (Figure 4.2C). As treated and un-treated 
spores were both inhibited by the presence of the supernatant, it is unlikely that 
the response was mediated by R. pickettii.  
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Figure 4.2 Inhibitory compound secreted by P. aeruginosa is a hydrophilic, heat-
stable non-protein and is not endosymbiont-mediated. (A) P. aeruginosa 
supernatant was treated with 150 µg/ml Proteinase K or boiled (100˚C for 1 hour) to 
determine whether the inhibitory factor is a heat stable protein (n=6). (B) Chloroform 
extractions were performed to separate aqueous and organic molecules (n=5). (C) R. 
microsporus spores were treated with ciprofloxacin to remove the endosymbiont. Spores 
were exposed to 50% P. aeruginosa supernatant for 24 hours, fungal growth was 
quantified via absorbance (OD600) and normalised to media control (n=3). All data was 
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analysed by a Kruskal-Wallis test with Dunn’s multiple comparisons test (α = 0.05). Data 
represent mean and SEM. ** = p < 0.01. 
 
4.3.5 Inhibition of fungal growth is not due to zinc, copper, or manganese 
restriction. Metal micronutrients are essential for microbial growth and 
pathogenicity, and iron, zinc, copper, and manganese are the most important 
trace metals for the growth of fungi. While bacterial siderophores are primarily 
considered to be iron-binding molecules, they can also non-specifically sequester 
other important micronutrients, and in these cases could be considered 
metallophores (Braud, Hoegy, et al., 2009). While these metals are essential for 
fungal growth, supplementation with zinc, copper or manganese did not rescue 
R. microsporus growth following exposure to P. aeruginosa supernatant (Figure 
4.3). Therefore, the inhibition of fungal growth is via a different mechanism. 
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Figure 4.3 Addition of zinc, copper, and manganese does not rescue R. 
microsporus growth when exposed to P. aeruginosa supernatant. R. microsporus 
spores were exposed to 50% P. aeruginosa supernatant and spiked with increasing 
concentrations of (A) zinc chloride, (B) cupric sulphate, and (C) manganese sulphate for 
24 hours statically at 37˚C. Fungal growth was measured through absorbance (OD600) 
and normalised to media control (n=3, Kruskal-Wallis with Dunn’s multiple comparisons 
test, α = 0.05). Data represent mean and SEM. 
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4.3.6 Addition of exogenous iron rescues R. microsporus growth and 
germination. Mucorales are very sensitive to iron depletion, and deletion of their 
high affinity permease, FTR1, or co-injection with a chelator inhibits virulence in 
vivo (Ibrahim et al., 2007, 2010). Supplementing P. aeruginosa supernatants with 
iron was able to partially restore fungal growth, resulting in 46.2% R. microsporus 
growth at concentrations above 200 µM (+/- 6.660, Fig. 4.4A and C) and an 
insignificant difference as compared to the control.  
 
To confirm that the inhibition of spore germination observed in the co-cultures 
was also attributed to iron restriction, co-cultures of R. microsporus and P. 
aeruginosa were spiked with iron. Germination of R. microsporus was recovered 
at concentrations above 100 µM (41.9% +/- 12.46) (Figure 4.4B), confirming that 
in both scenarios, iron sequestration appears to be the major contributing factor 
in the inhibition of R. microsporus growth.  
 
Iron starvation has been shown to induce apoptosis in R. oryzae after prolonged 
deprivation (Shirazi, Kontoyiannis and Ibrahim, 2015).  Therefore, if spores are 
undergoing iron starvation when exposed to P. aeruginosa supernatant, 
prolonged exposure should decrease survival. To isolate the effects of the 
supernatant, we used 100% P. aeruginosa supernatant to monitor spore survival 
over time. In this condition, the viability of spores was reduced by 82.40% (+/- 
13.44) after 24 hours, and no viable spores were recovered after 120 hours (p = 
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0.0490, Figure 4.4D). This indicates that iron starvation induced by P. aeruginosa 
supernatant can have a strong impact on the survival of R. microsporus.  
 
While the addition of iron increased the growth of R. microsporus, the rescue is 
not complete. To understand whether spore death during co-culture could 
account for the remaining un-germinated spores, R. microsporus was exposed to 
live P. aeruginosa with and without 100 μM FeCl3 for 24 hours before colony 
forming units (CFUs) were plated and counted (Figure 4.4E). The presence of P. 
aeruginosa decreased spore viability by 61.5% (p = 0.0581). When iron was 
added to co-cultures, 56.37% (p = 0.1478) of spores survived, compared to 0-
hour control. While addition of iron increased viability by 17.87% compared to P. 
aeruginosa alone, there were still 43.63% of spores that were killed, despite iron 
treatment. Because of this, we believe that much of the remaining inhibition of 
germination following addition of FeCl3 in live co-cultures (Figure 4.3B) is likely 
due to bacteria-induced spore death independent of iron.  
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Figure 4.4 Growth of R. microsporus spores exposed to P. aeruginosa is rescued 
by addition of exogenous iron. R. microsporus spores were exposed to 50% P. 
aeruginosa supernatant and (A) spiked with increasing concentrations of ferric chloride 
for 24 hours. Fungal growth was measured through absorbance (OD600) and normalised 
to media control (n=3). (B) The ability of iron to rescue R. microsporus germination was 
confirmed in a live co-culture setting, where the addition of exogenous iron increased the 
percent of spores germinated after 24 hours in a dose-dependent manner. This was 
quantified by Callum Clark (n=8). As the addition of iron in 50% supernatant increased 
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overall growth, (C) representative images were collected at 9 hours to confirm ability to 
rescue germination. Scale bar depicts 50 µm. (D) Spore viability in response to 100% P. 
aeruginosa supernatant over time was quantified by counting colony forming units 
(CFUs) every 24 hours for 120 hours (n=3). (E) To understand whether co-cultures 
decreased fungal viability, R. microsporus was exposed to live P. aeruginosa +/- 100 μM 
FeCl3 for 24 hours and colony forming units were counted. All data was analysed by a 
Kruskal-Wallis test with Dunn’s multiple comparisons test on raw data. Data represent 
mean and SEM (α = 0.05). * = p < 0.05, *** = p < 0.001. 
 
4.3.7 The presence of P. aeruginosa supernatant induces an iron-starvation 
response in R. microsporus. Iron starvation has previously been shown to up-
regulate the high affinity iron permease, FTR1, in Rhizopus oryzae (Shirazi, 
Kontoyiannis and Ibrahim, 2015). Therefore, to confirm that R. microsporus is 
undergoing iron starvation in the presence of P. aeruginosa supernatants, the 
expression levels of FTR1 were determined by qRT-PCR. FTR1 was highly 
upregulated (10-fold increase, p = 0.0286) when exposed to 50% P. aeruginosa 
supernatant for 7 hours, as compared to the control (Fig. 4.5C). This further 
validates that R. microsporus is experiencing iron restriction mediated by P. 
aeruginosa supernatant.  
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Figure 4.5 The presence of P. aeruginosa supernatant induces an iron-starvation 
response in R. microsporus. R. microsporus was exposed to 50% P. aeruginosa 
supernatant for 7 hours. Following this, fungal RNA was extracted, quality was confirmed 
via (A) gel electrophoresis, and removal of genomic DNA was confirmed via (B) PCR 
and gel electrophoresis. (C) The expression of the high-affinity iron permease FTR1 was 
quantified by qRT-PCR relative to 18S mRNA (n=4, Mann-Whitney U test). Data 
represent mean and SEM (α = 0.05). * = p < 0.05. 
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4.3.8 Iron-dependent inhibition of Mucorales by P. aeruginosa is not R. 
microsporus species-specific. To delineate whether bacteria-associated iron 
restriction inhibits the growth of closely related Mucorales, we tested the ability of 
P. aeruginosa supernatant to inhibit the growth of R. microsporus var. 
microsporus, R. microsporus var. chinensis, R. delemar, and M. circinelloides 
(Figure 4.6). The growth of all isolates was significantly reduced in the presence 
of P. aeruginosa supernatant [83.85% (+/- 15.23), 98.26% (+/- 1.977), 99.01% 
(+/- 0.8695), and 84.29% (+/- 10.78), respectively], and was significantly rescued 
by the addition of 100 μM of iron [64.36% (+/- 4.450), 41.30% (+/- 10.48), 55.14% 
(+/- 10.01), and 87.54% (+/- 6.219), respectively]. This confirms that the bacteria-
associated inhibition of growth is not an artefact of our R. microsporus clinical 
isolate but is instead a general trait of closely-related Mucorales.  
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Figure 4.6 Iron-dependent inhibition of Mucorales by P. aeruginosa is not R. 
microsporus species-specific. Most experiments in this chapter were performed using 
an R. microsporus clinical isolate. To ensure the inhibitory effect of P. aeruginosa is not 
limited to this isolate, (A) R. microsporus var. microsporus, (B) R. microsporus var. 
chinensis, (C) R. delemar, and (D) Mucor circinelloides were exposed to 50% P. 
aeruginosa supernatant with and without the addition of 100 µM FeCl3. Fungal growth 
was determined at 24 hours by measuring absorbance (OD600) and normalising to control 
(n=3). All data was analysed by a Kruskal-Wallis test with Dunn’s multiple comparisons 
test (α = 0.05). Data represent mean and SEM. * = p < 0.05 (Kousser et al., 2019). 
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4.3.9 Siderophore-deficient P. aeruginosa strains lack the ability to 
suppress germination. Pyoverdine and pyochelin are the two predominate 
siderophores produced by P. aeruginosa, with pyoverdine exhibiting the highest 
affinity for iron and being essential for virulence (Meyer et al., 1996; Braud, 
Hannauer, et al., 2009; Braud, Hoegy, et al., 2009). To identify the role of these 
siderophores in this interaction, fungal growth was quantified in the presence of 
the supernatants from P. aeruginosa strains deficient in either siderophore alone 
or in combination. Growth of R. microsporus was inhibited when incubated with 
culture supernatants from P. aeruginosa strains defective in pyochelin 
biosynthesis (∆pchEF), with growth being rescued by exogenous iron (Figure 
4.7A), suggesting that this siderophore plays a minor role in sequestering iron in 
these experiments. However, R. microsporus germinated in the presence of 
bacterial supernatants from P. aeruginosa mutants defective in pyoverdine 
biosynthesis (∆pvdD) or in pyoverdine and pyochelin biosynthesis 
(∆pchEF∆pvdD) (Figure 4.7A), confirming that, under the tested conditions, P. 
aeruginosa-imposed iron restriction is largely mediated by the secretion of 
pyoverdine.  
 
4.3.10 Pyoverdine is sufficient to inhibit R. microsporus growth. To confirm 
that pyoverdine alone can inhibit R. microsporus growth, spores were exposed to 
exogenous pyoverdine. To ensure a relevant concentration of pyoverdine was 
added, we measured the siderophores present in P. aeruginosa supernatant. 
These supernatants (100%) contained 58.9 µg/ml (+/- 1.194) siderophores, 
making the concentration of siderophores in this assay 29.45 µg/ml, as 50% 
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supernatant was typically used. Therefore, R. microsporus spores were grown in 
the presence of 15 μM (17.4 µg/ml) and 30 μM (34.8 µg/ml) purified pyoverdine 
to resemble siderophore concentrations in the supernatants. Incubation of fungal 
spores with pyoverdine significantly reduced growth (73.8%, +/- 5.503, p = 
0.0022, Figure 4.7B). Therefore, pyoverdine alone is adequate to inhibit R. 
microsporus growth and germination. 
 
Previously, we found that the germination of C. bertholletiae was promoted in the 
presence of P. aeruginosa supernatant, likely due to pH and nutrient changes. 
To determine whether C. bertholletiae was sensitive to the presence of 
pyoverdine, we exposed C. bertholletiae to 30 μM (34.8 μg/ml) and 60 μM (69.6 
μg/ml) of exogenous pyoverdine and compared representative images to R. 
microsporus (Figure 4.7C). The addition of pyoverdine to C. bertholletiae did not 
impact germination or growth after 6 hours, while R. microsporus was strongly 
inhibited. This indicates that either C. bertholletiae is less dependent on iron than 
Rhizopus spp., can use pyoverdine as a xenosiderophore, or that C. bertholletiae 
is more effective at acquiring iron.  
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Figure 4.7 P. aeruginosa-imposed iron restriction is largely mediated via 
pyoverdine. (A) R. microsporus was grown in supernatants from wild type P. 
aeruginosa, strains defective in siderophore biosynthesis, or control media +/- iron. 
Fungal growth was determined via absorbance (OD600) after 24 hours (n = 3). This was 
performed by Sarah Sherrington. (B) R. microsporus spores were incubated in SAB with 
20 μg/ml and 40 μg/ml pyoverdine. Fungal growth was measured through absorbance 
(OD600) and normalised to media control (n = 6). The effect of pyoverdine on R. 
microsporus germination was compared to C. bertholletiae. Spores were exposed to 40 
and 80 μg/ml pyoverdine and (C) representative images are shown after 6 hours. Scale 
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bar = 25 μm. Data was analysed by a Kruskal-Wallis test with Dunn’s multiple 
comparisons test (α = 0.05).  Data represent mean and SEM. * = p < 0.05. 
 
4.3.11 The presence of R. microsporus induces iron stress in P. aeruginosa 
and promotes bacterial siderophore production. The presence of fungi has 
been shown to modulate the expression of bacterial virulence factors (Lopez-
Medina et al., 2015). To determine whether R. microsporus can interfere with P. 
aeruginosa siderophore production, the concentration of siderophores after 24 
hours mono- and co-culture was quantified using a SideroTec Assay kit (Figure 
4.8A). Surprisingly, the concentration of siderophores in mono-cultures in 
SAB/LB was 11-fold lower than in LB (4.99 μg/ml, +/- 5.834, vs 58.9 µg/ml (+/- 
1.194)) suggesting that growth in SAB/LB reduces siderophore production. 
However, in co-cultures, siderophore concentration was increased 10-fold, to 
levels similar to LB supernatant (53.25 μg/ml, (+/- 0.4335) compared to 58.9 
µg/ml (+/- 1.194)) indicative of iron stress. This increase in siderophore 
concentration was not observed in co-cultures containing siderophore deficient 
P. aeruginosa (Fig 4.8B), confirming that the increase in siderophore 
concentration is likely due to increased bacterial rather than fungal siderophore 
biosynthesis.  
 
Pyoverdine is a fluorescent molecule with an excitation at 405 nm (Meyer and 
Abdallah, 1978; Cox and Adams, 1985). Calculating absorbance at this 
wavelength has been used to measure pyoverdine in a solution (Dao et al., 1990; 
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Visca et al., 1992). As the SideroTec kit (Figure 4.8A and 4.8B) measures total 
iron binding compounds within a solution, we wanted to determine whether 
pyoverdine specifically was increased in the presence of R. microsporus. 
Therefore, we measured the absorbance (OD405) of supernatants after 24 hours 
mono- and co-culture at MOIs 1:50 and 1:100 R. microsporus:P. aeruginosa 
(Figure 4.8C). Co-incubation with R. microsporus increased the absorbance by 
approximately 1.7-fold as compared to bacteria only. This suggests that P. 
aeruginosa responds to the presence of R. microsporus by enhancing the 
secretion of pyoverdine.  
 
To further confirm that the presence of R. microsporus increases the production 
of bacterial siderophores, we measured the expression of key genes involved in 
pyoverdine and pyochelin biosynthesis (Figure 4.8F). Following exposure to R. 
microsporus for 7 hours, P. aeruginosa upregulated the expression of pvdS and 
pchA. However, this regulation was lost in the presence of exogenous iron (Figure 
4.8F). These results confirm that during co-culture, the two organisms compete 
for iron, resulting in the upregulation of bacterial siderophore biosynthesis and P. 
aeruginosa outcompeting R. microsporus for iron and inhibiting fungal growth. 
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Figure 4.8 The presence of R. microsporus induces iron stress in P. aeruginosa 
and promotes bacterial siderophore production. (A) Siderophore production 
following mono- and co-culture was measured by using the Siderotec Assay 
(EmerginBio) (n = 3, Mann-Whitney U test). This was performed by Callum Clark. (B) 
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Siderophore production of P. aeruginosa strains defective in siderophore biosynthesis 
was measured by using the Siderotec Assay (EmerginBio) following mono- and co-
culture (n = 3, Mann-Whitney U test, (α = 0.05). This was performed by Callum Clark. (C) 
Fold increase of co-culture supernatant absorbance (OD405) compared to P. aeruginosa 
mono-culture supernatant absorbance is presented (n=4). Following co-culture, P. 
aeruginosa RNA was extracted, and quality was confirmed through (D) gel 
electrophoresis (P. a. = P. aeruginosa, R. m. = R. microsporus, and Fe = iron). Removal 
of genomic DNA was confirmed through (E) PCR and gel electrophoresis (1 = P. 
aeruginosa only, 2 = R. microsporus + P. aeruginosa, 3 = R. microsporus + P. aeruginosa 
+ Fe, and 4 = P. aeruginosa + Fe). (F) The expression levels of PvdS and PchA were 
quantified by qRT-PCR relative to RpoD and normalised to P. a. grown in isolation. Data 
represent mean and SEM. * = p < 0.05. 
 
4.3.12 The concentration of siderophores produced by bacteria correlates 
with inhibition of R. microsporus growth. P. aeruginosa inhibits R. 
microsporus growth through siderophore-mediated iron sequestration. However, 
E. coli, B. cenocepacia, and S. aureus did not inhibit R. microsporus in live co-
culture (Figure 3.16). This was surprising as these bacteria all produce 
siderophores (O’Brien, I, Cox and Gibson, 1970; Courcol et al., 1991; Darling et 
al., 1998). To investigate whether these bacteria can inhibit R. microsporus 
through secreted factors, spores were exposed to E. coli, B. cenocepacia, K. 
pneumoniae, and S. aureus sterile supernatants to determine their ability to inhibit 
R. microsporus growth as compared to P. aeruginosa. P. aeruginosa was the 
only supernatant able to significantly inhibit growth (Figure 4.9A). We then 
measured the amount of siderophores produced after 24 hours growth in LB, to 
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determine whether this lack of inhibition was associated with insufficient 
production of iron binding molecules. There was a negative correlation between 
fungal growth and siderophore production across different bacterial species (p = 
0.0029, Figure 4.9B), suggesting that siderophore-mediated iron restriction may 
be a common mechanism of bacteria to compete with R. microsporus. However, 
the presence of supernatants from E. coli had no effect on fungal growth. This 
was unexpected, as E. coli produces enterobactin, a siderophore with a high 
affinity (1052 M-1) for iron (Carrano and Raymond, 1979). In agreement with this, 
exogenous enterobactin did not inhibit R. microsporus growth (91%, +/- 6.170, 
Figure 4.9C), suggesting that R. microsporus is resistant to enterobactin-
mediated iron sequestration.  
 
 Exogenous enterobactin was added to R. microsporus/P. aeruginosa co-cultures 
to determine if this would provide an advantage to the fungus. However, the 
presence of enterobactin exacerbated the inhibition of fungal growth (Figure 
4.9D), presumably because P. aeruginosa can also utilise enterobactin as a 
xenosiderophore (Meyer and Abdallah, 1978). Because of this, we instead added 
enterobactin to sterile bacterial supernatants. R. microsporus displayed 
increased germination in P. aeruginosa supernatants supplemented with 
enterobactin, although fungal growth was not fully restored (Figure 4.9E), likely 
due to pyoverdine and pyochelin binding the majority of the free iron. Taken 
together, this indicates that R. microsporus may use enterobactin as a 
xenosiderophore, though further investigation is needed to confirm this 
hypothesis. 
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Figure 4.9 Enterobactin does not inhibit R. microsporus growth and can enhance 
germination during exposure to P. aeruginosa supernatant. (A) Fungal growth 
following exposure to P. aeruginosa, B. cenocepacia, S. aureus, and E. coli supernatants 
was determined by absorbance (OD600) and normalised to control. (n=6). (B) The 
concentration of siderophores produced by bacteria was determined by using the 
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Siderotec Assay (EmerginBio) and the correlation between total siderophore production 
and fungal growth was determined by performing a linear regression with Pearson 
correlation (n=3). (C) R. microsporus spores were exposed to varying concentrations of 
purified enterobactin (n=3). Fungal growth was determined by absorbance (OD600) and 
normalised to control. (D) Enterobactin (50 μM) was added to co-cultures of R. 
microsporus and P. aeruginosa (MOI 1:100). (E) Enterobactin was added to 50:50 
SAB:supernatant and incubated with R. microsporus spores. All data was analysed by a 
Kruskal-Wallis test with Dunn’s multiple comparisons test unless indicated otherwise (α 
= 0.05). Scale bars = 20 μm.   Data represent mean and SEM. *** = p < 0.001 (Kousser 
et al., 2019). 
 
4.3.13 The presence of P. aeruginosa supernatant impacts the antifungal 
susceptibility of R. microsporus. To test the impact of polymicrobial 
interactions on antifungal resistance we used media with a higher iron 
concentration to prepare P. aeruginosa supernatants, to overcome iron-
dependent restriction and enable the quantification of fungal growth. 
 
R. microsporus spores were exposed to 50% P. aeruginosa supernatant with 
varying concentrations of fluconazole, posaconazole, and amphotericin B for 24 
hours, 37 °C. Fungal growth was determined by measuring absorbance (OD600). 
Resistance to fluconazole was not impacted by the presence of P. aeruginosa 
supernatant (Figure 4.10A). Our isolate of R. microsporus is resistant to 
posaconazole and growth of control spores was not impacted by the presence of 
this antifungal (Figure 4.10B). However, the addition of 50% supernatant 
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increased susceptibility to posaconazole and fungal growth was decreased with 
the addition of 0.25 μg/ml posaconazole (p < 0.0001, Figure 4.10B). This effect 
was even more striking with amphotericin B. While growth of control spores was 
inhibited with 0.5 μg/ml amphotericin B, upon the addition of the supernatant, 
fungal growth was completely inhibited with only 0.0155 μg/ml amphotericin B (p 
< 0.0001 Figure 4.10C). Therefore, exposure to P. aeruginosa supernatant 
enhances antifungal efficacy independent of iron restriction.  
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Figure 4.10 Release of iron stress identifies a potential role of bacterial 
supernatants in regulating antifungal resistance. R. microsporus spores were 
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exposed to 50% P. aeruginosa supernatants and various concentrations of (A) 
fluconazole, (B) posaconazole, and (C) amphotericin B for 24 hours, 37 °C. Fungal 
growth was measured through absorbance (OD600) Data was analysed using a 2-way 
ANOVA with Sidak's multiple comparisons test (α = 0.05), comparing each concentration 
to 0 μg/ml (n=3). * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. 
 
4.4 Discussion.  
Following the initial observation that P. aeruginosa supernatant strongly inhibited 
the germination and growth of R. microsporus, this chapter aimed to increase 
overall understanding of this interaction. The goals were to characterise the 
inhibitory molecule produced by P. aeruginosa, identify the major mediators in 
this interaction, define the mechanism by which they inhibit fungal growth, and 
begin understanding the impact this relationship could have on clinical outcome.  
 
4.4.1 Inter-kingdom iron competition. As iron availability is known to be a key 
limiting factor in Rhizopus virulence (Ibrahim et al., 2010), and P. aeruginosa 
secretes high affinity siderophores that are hydrophilic small molecules, we 
hypothesised that supernatant-induced iron depletion in the media is the 
inhibitory source. Addition of exogenous iron confirmed this theory as it enhanced 
fungal germination and overall growth in co-cultures and 50% supernatant. While 
the rescue is not complete, in co-cultures we believe the remaining inhibition is 
due to decreased fungal viability, and this is being investigated by other members 
of the group. For the remaining inhibition of supernatant-exposed spores, it is 
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possible that other aqueous pigments, such as pyorubrin and/or pyomelanin are 
also present and affecting fungal growth. While there is no evidence found in the 
literature that shows these pigments mediate polymicrobial interactions, both 
molecules modulate redox homeostasis (Hunter and Newman, 2010; 
Hosseinidoust, Tufenkji and van de Ven, 2013).  
 
P. aeruginosa secretes several iron binding molecules, with pyoverdine being the 
major siderophore with a high affinity for iron. We found that exogenous 
pyoverdine, at concentrations comparable to those secreted by P. aeruginosa in 
our culture conditions, was sufficient to inhibit the growth of R. microsporus. This 
was comparable to levels seen after exposure to the bacterial supernatant. In 
addition, supernatants from P. aeruginosa mutants unable to synthesise the 
major siderophores were less potent, confirming a role for pyoverdine and 
pyochelin in controlling fungal growth. This iron-dependent inhibition of growth is 
also seen between P. aeruginosa and A. fumigatus and P. aeruginosa and C. 
albicans. For instance, P. aeruginosa decreases biofilm production of A. 
fumigatus through the production of pyoverdine (Sass et al., 2018). Furthermore, 
the P. aeruginosa Pf4 bacteriophage inhibits C. albicans and A. fumigatus via 
iron-mediated mechanisms (Penner et al., 2016; Nazik et al., 2017). Taken 
together, this indicates that P. aeruginosa utilises iron restriction as a general 
mechanism for competing with fungi. 
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The presence of fungi has been shown to modulate the expression of siderophore 
biosynthetic genes in P. aeruginosa. For instance, C. albicans was described as 
down-regulating the production of pyoverdine and pyochelin through secreted 
proteins (Lopez-Medina et al., 2015). Conversely, our study has found the 
production of pyoverdine to be increased in response to P. aeruginosa co-
cultured with R. microsporus. This is consistent with a previous study that found 
a decrease in C. albicans metabolism was linked to the enhanced production of 
pyoverdine in mixed species biofilms (Purschke et al., 2012). This highlights the 
dynamic response of P. aeruginosa to fungi, which is likely dependent on the 
individual microenvironment. The fact that the presence of R. microsporus 
enhances the production of siderophores in our system makes the interaction 
between the two organisms more dangerous for an infected host. Pyoverdine 
mediates the production of other virulence factors, such as exotoxin A and 
endoproteases, and increased pyoverdine can enhance overall bacterial 
virulence (Lamont et al., 2002). Furthermore, if this interaction occurs in a burn 
wound environment, the siderophore production will be even more increased, as 
P. aeruginosa upregulates the biosynthesis of pyoverdine when exposed to burn 
wound exudate (Gonzalez et al., 2016). 
 
4.4.2 Enterobactin protects R. microsporus from P. aeruginosa 
supernatant-induced growth inhibition. Despite having an affinity for iron 
higher than pyoverdine, the presence of live E. coli, sterile supernatant, and 
exogenous enterobactin did not significantly impact fungal growth. From this 
work, it is hypothesised that R. microsporus may be able to utilise enterobactin 
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as a xenosiderophore, though further investigation is needed to confirm. 
Mucorales are known to utilise certain bacterial siderophores as sources of iron 
within the host, such as deferoxamine to promote its growth and virulence 
(Boelaert et al., 1993). Unlike deferoxamine, and potentially enterobactin, R. 
microsporus cannot scavenge iron from pyoverdine, which suggests that 
molecules with similar structures may have the potential to be used to control 
mucormycosis. While utilising pyoverdine itself would be problematic due to its 
ability to enhance P. aeruginosa virulence (Lamont et al., 2002), this siderophore 
could provide a starting point for the development of novel iron chelators. Given 
that pyoverdine has also been shown to limit the growth of other invasive fungi, 
such as A. fumigatus (Penner et al., 2016; Sass et al., 2018), molecules based 
on pyoverdine may have wide implications for the treatment of a range of invasive 
fungal diseases. For further speculation regarding enterobactin as a potential 
xenosiderophore, please see Chapter 6. 
 
4.4.3 Bacterial-induced susceptibility to antifungals. Preliminary results from 
this study found that the presence of P. aeruginosa supernatant increases fungal 
susceptibility to both amphotericin B and posaconazole. This is opposite to 
findings in the literature during mixed species biofilms with C. albicans and 
Staphylococcus epidermidis, where bacteria produce extracellular polymers that 
block fluconazole penetration of the biofilm and enhance antifungal resistance 
(Adam, Baillie and Douglas, 2002). Treatment with liposomal or deoxycholate 
amphotericin B can be toxic and lead to harmful side effects, such as renal failure 
(Falci, Da Rosa and Pasqualotto, 2015). Therefore, the ability of P. aeruginosa 
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secreted factors to increase the susceptibility to amphotericin B has important 
clinical implications. Ideally, isolating and synthesising the sensitising compound 
could provide a novel adjunct therapy alongside antifungals and increase 
treatment efficacy. Further studies should determine if mean fungicidal 
concentration of these drugs are altered by P. aeruginosa supernatant, if this 
result continues with live bacteria, and if the response to the supernatant is 
general for different stressors.  
Taken together, these results agree with the current understanding of 
Mucoralean pathogenesis where iron availability is considered essential. Here we 
highlight the ability of surrounding bacteria to control iron availability and the 
dynamic, specialised relationships between fungi and different bacterial species. 
To continue investigating the impact of the interaction between R. microsporus 
and P. aeruginosa on pathogenicity, the next chapter will focus on developing an 
in vivo zebrafish model for co-infection. 
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Chapter 5 : DEVELOPMENT OF A 
ZEBRAFISH MODEL  
 
Parts of this chapter have been previously published: 
Kousser, C., Clark, C., Sherrington, S., Voelz, K. and Hall, R. (2019). 
Pseudomonas aeruginosa inhibits Rhizopus microsporus germination 
through sequestration of free environmental iron. Scientific Reports, 9. 
DOI 10.1038/s41598-019-42175-0 
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5.1 Introduction. 
In the previous chapter we identified P. aeruginosa as inhibiting R. microsporus 
growth through the sequestration of iron. This was confirmed following exposure 
to both supernatants and live bacteria. While this provides information about how 
these organisms interaction in isolation, additional factors inside a host can alter 
phenotypes. To understand the impact of co-infection on the host and determine 
whether in vitro results are physiologically relevant, a zebrafish model was 
developed.  
 
5.1.1 Advantages of the zebrafish model. Mouse and rat models have been 
the gold standard of research into infectious diseases for decades. However, one 
limitation of mammalian models is the inability to observe cellular function during 
disease in a living host. While these models are important for gaining insight into 
infections of an animal that is physiologically similar to humans, zebrafish bridge 
the gap between invertebrates and mammals. There are many advantages to 
using zebrafish over other models, and in many cases zebrafish and mammalian 
models can be used simultaneously to provide a well-rounded understanding in 
disease pathogenesis, whilst abiding to the National Centre for Replacement, 
Refinement, and Reduction of Animals in Research’s (NC3Rs) policy on 
reducing, refining and replacing the need for ethically protected animals in 
scientific research.  
 
Chapter 5: Development of a Zebrafish Model 
 
157 
 
Zebrafish are mostly transparent for the first 2 to 3 weeks of life, though they do 
produce some pigmented spots. Chemical treatment can prevent the formation 
of any pigmented cells (Rosowski et al., 2018). Methods for genetic modification 
of zebrafish embryos are established, and numerous specialised zebrafish lines 
are available, for example larvae with fluorescent or depleted immune cells 
(Harvie et al., 2013). Their transparency and genetic tractability provide a unique 
opportunity to microscopically observe the progression of infection and 
interaction between pathogens and host immune cells.  
 
Furthermore, their small size, high fecundity, and rapid development make them 
an economical and relatively quick method to obtain large quantities of data in a 
short period of time. A single breeding pair can produce hundreds of offspring per 
week, and embryos can be injected as early as 24 hours post fertilisation (hpf). 
They are also able to be anaesthetised and immobilised for long periods of time 
embedded within diffusible agarose, allowing for long-term live cell imaging.  
 
The full zebrafish genome was published in 2013 and displayed extensive 
homology to humans, where it was shown that 70% of human genes have a 
zebrafish orthologue. The zebrafish immune system is surprisingly similar to 
humans, with the largest family of these orthologous genes relating to immunity 
(Howe et al., 2013). Like humans, zebrafish contain both an innate and adaptive 
immune system. The innate immune system develops first, with macrophages 
present at 24 hpf and neutrophils developing around 36 hpf (Herbomel, Thisse 
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and Thisse, 1999). The adaptive branch does not develop until between 4- and 
6-weeks post fertilisation (Willett et al., 1999). Zebrafish respond to invading 
pathogens through the activation of the complement system and subsequent 
production of cytokines, chemokines, and interferons (Stein et al., 2007; 
Bussmann and Raz, 2015). Zebrafish express Toll-like receptors on the surface 
of macrophages to recognise pathogen associated molecular patterns (Jault, 
Pichon and Chluba, 2004) and embryos utilise primitive macrophages and 
neutrophils to engulf and kill pathogens (Herbomel, Thisse and Thisse, 1999; 
Willett et al., 1999). Because of these similarities, zebrafish are ideal models for 
studying the interaction between pathogens and the host’s immune system.  
 
5.1.2 Sites of infection. Although zebrafish do not contain the same organs as 
humans, specific sites have been used to model human infections. This study 
has focused on three injection sites, the hindbrain, yolk sac, and swim bladder.  
 
5.1.2.1 Hindbrain. Models for fungal infections such as Cryptococcus 
neoformans (Davis et al., 2016) and Mucor circinelloides (Voelz, Gratacap and 
Wheeler, 2015) have been developed in the hindbrain as proxies for cerebral and 
disseminated infections, respectively. The hindbrain has also been used to model 
Streptococcus pneumoniae meningitis, with high mortality occurring after 
injection with only 300 bacteria (Jim et al., 2016). Other bacterial infections 
established in the zebrafish hindbrain include P. aeruginosa (Rocker et al., 2015), 
Mycobacterium marinum (Davis et al., 2002), Bdellovibrio bacteriovorus, and 
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Shigella flexneri (Willis et al., 2016). This site allows for the longest monitoring of 
infection, as the hindbrain develops after 24 hpf and fish must be euthanised 
before 5 dpf without extended Home Office licensing (Kimmel et al., 1995; 
HomeOffice, 2017). While primitive macrophages are observed from 24 hpf, 
neutrophils do not develop until 32-48 hpf (Herbomel, Thisse and Thisse, 1999; 
Fehr et al., 2016). This could leave hindbrain-injected embryos more vulnerable 
to deadly infection.  
 
5.1.2.2 Yolk sac. The yolk sac is the food source for embryos until they can begin 
free eating around 4-5 dpf, and it is the place of primitive macrophage 
differentiation (Herbomel, Thisse and Thisse, 1999). This injection site has been 
used to model cancers such as melanoma, prostate, breast, colon, and 
pancreatic (Haldi et al., 2006; Teng et al., 2013; Hill et al., 2018). Limited infection 
studies have utilised the yolk sac. However, recently, injections into the yolk sac 
have been used to model tissue infections of C. albicans and to observe 
dissemination from the tissue into the blood stream (Seman et al., 2018). Yolk 
sac injections are generally performed after 48 hpf, when the yolk membrane is 
less fragile (Stones 2017, personal communication). The yolk sac is highly 
vascularised (Isogai, Horiguchi and Weinstein, 2001), and easy spread to the 
blood stream can be a drawback to using this site if isolated infection is desired. 
 
5.1.2.3 Swim bladder. Because the swim bladder is the only organ exposed to 
air, is lined with epithelial cells, and is transcriptionally similar to human lungs 
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(Zheng et al., 2011), it has been utilised to model pulmonary and mucosal 
infections. For example, swim bladder models have been established for 
intracellular Chlamydia infections of the epithelia (Fehr et al., 2016), C. albicans 
mucosal infections (Gratacap, Rawls and Wheeler, 2013), and M. circinelloides 
pulmonary infections (Voelz, Gratacap and Wheeler, 2015). The swim bladder 
develops after approximately 4 dpf, leaving only 24 hours for infection observation 
with standard Home Office licencing (Kimmel et al., 1995; HomeOffice, 2017). 
Furthermore, some lymphocytes can be found from 4 dpf, though full adaptive 
immunity takes several weeks (Meijer and Spaink, 2011). However, the presence 
of adaptive immune cells could limit the ability to isolate the innate immune 
system in this model.   
 
5.1.3 Zebrafish as a model for mucormycosis. Zebrafish models have been 
invaluable in understanding the interaction between Mucorales and the innate 
immune system. Much like humans, larval models have demonstrated site-
dependent variability in virulence, where M. circinelloides moderately decreases 
viability in the hindbrain of healthy fish and is not deadly in the swim bladder 
(Voelz, Gratacap and Wheeler, 2015). For immunocompromised fish, hindbrain 
and swim bladder injections led to higher mortality (Voelz, Gratacap and Wheeler, 
2015). Macrophages are more vital than neutrophils, and the depletion of 
macrophages increases mortality (Voelz, Gratacap and Wheeler, 2015). Early 
infection results in rapid recruitment of macrophages, where they engulf spores 
and control germination. However, there is a marked lack of oxidative burst and 
the host is unable to kill M. circinelloides. Utilisation of this transparent model 
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displayed the formation of latent granulomas within the fish, suggesting the 
possibility of later remerging infections (Inglesfield et al., 2018).  
 
An adult zebrafish model further assessed the impact of M. circinelloides on 
immune response in a host with a full immune system. Intraperitoneal injection of 
M. circinelloides caused high recruitment of both macrophages and neutrophils 
and the induction of macrophage apoptosis, further confirming the importance of 
the innate immune system in mucormycosis (López-Muñoz et al., 2018). While 
most of the studies involving zebrafish have investigated M. circinelloides, the 
impact of the R. microsporus endosymbiont has recently been explored. There, 
removal of the bacterial endosymbiont, R. pickettii, reduced overall virulence of 
fungal hindbrain infections (Itabangi et al., 2019, preprint), contrary to evidence 
from murine or fly models (Ibrahim et al., 2008).  
 
5.1.4 Zebrafish as a model for P. aeruginosa infections. Infections with P. 
aeruginosa have highlighted the importance of both neutrophils and 
macrophages for immunity against P. aeruginosa infections (Brannon et al., 
2009). Neutrophils are especially important, and fish with only macrophages were 
more susceptible to killing by P. aeruginosa (Clatworthy et al., 2009). 
Furthermore, this model has increased the understanding of P. aeruginosa 
virulence factors, demonstrating an interaction between the bacterial T3SS and 
host phagocytes during infection (Brannon et al., 2009). P. aeruginosa is a 
common pathogen complicating CF and mutations in the zebrafish CF 
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transmembrane conductance regulator enhances susceptibility to infection and 
increases microbial burden of P. aeruginosa (Brannon et al., 2009).  
 
5.1.5 Polymicrobial infections in zebrafish. Most studies involving zebrafish 
infections have focused on mono-infections of pathogens, with polymicrobial 
models slowly emerging. Co-infections in the zebrafish swim bladder have 
provided insight into the interaction between C. albicans and P. aeruginosa. P. 
aeruginosa enhanced C. albicans virulence (Bergeron et al., 2017), which is 
opposite to in vitro work that demonstrated P. aeruginosa inhibiting C. albicans 
growth (Hogan and Kolter, 2002; Hogan, Vik and Kolter, 2004; Morales et al., 
2013).  
 
The impact of primary viral infection on bacterial pathogenesis has also been 
addressed in the zebrafish. Initial injection of sublethal Sindbis virus enhances 
Shigella survival and proliferation, leading to increased bacterial-induced 
mortality (Boucontet et al., 2018).  
 
5.1.6 Limitations of the zebrafish model. Besides the obvious anatomical 
differences between fish and human physiology, there are other limitations that 
should be considered. Firstly, fish antibodies are not widely available 
commercially, making immunological techniques such as Western Blotting or 
ELISA difficult. Also, without extended Home Office licencing, fish must be 
sacrificed after 5 dpf. This can limit experiments involving swim bladder injections, 
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for instance, where the organ only develops after 3-4 dpf. Furthermore, the cross-
talk between the innate and adaptive immune systems cannot be investigated 
using the larval model, as the adaptive immune system does not develop until 4-
6 weeks post fertilisation (Willett et al., 1999). Transparent mutant adult zebrafish, 
known as “caspers” are available and could overcome this problem (White et al., 
2008). While the ability to isolate the innate immune system in vivo is generally 
an advantage, this is a limitation when attempting to carry results forward to 
compare to two-branched immune systems.  
In all, the zebrafish is a powerful model for investigating host-pathogen 
interactions and provides an important mediator between cell culture and 
mammalian models.  
 
5.2 Aim of this chapter.  
The previous two chapters demonstrated the ability of P. aeruginosa to out-
compete R. microsporus for environmental iron in vitro, inhibiting fungal 
germination and growth. This chapter aims to develop a zebrafish model for co-
infection between R. microsporus and P. aeruginosa to understand the impact of 
this relationship on overall virulence and determine whether in vitro and in vivo 
results are consistent.  
 
5.3 Results 
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5.3.1 R. microsporus moderately reduces survival following hindbrain 
injection of healthy zebrafish embryos. To confirm the hindbrain as an 
effective model for studying R. microsporus infections, zebrafish embryos were 
injected with 10, 50, and 100 spores into the hindbrain through the otic vesticle 
(Figure 5.1A). R. microsporus decreased the viability of the larvae in a dose-
dependent manner, with 69% of fish surviving at 96 hpi after injection with 100 
spores (Figure 5.1B). The ability of spores to germinate was confirmed through 
live cell microscopy, where fungal hyphae protruded through the heads of fish 
who were unsuccessful at controlling growth (Figure 5.1C) 
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Figure 5.1 R. microsporus moderately reduces viability in healthy zebrafish 
embryos via hindbrain injection, in a dose dependent manner. R. microsporus 
spores (10, 50, and 100) were injected into the hindbrain of zebrafish embryos at 24 hpf. 
(A) Illustration depicting 24 hpf embryo with hollow needle demonstrating injection site 
through otic vesicle into hindbrain. Image was created with BioRender. (B) Survival of 
larvae was quantified every 24 hours for 4 days. Shown are data pooled from two 
separate experiments with a total of 32, 40, 38, and 42 fish for control, 10, 50, and 100 
spores. Data analysed with Mantel-Cox log-rank test with Bonferroni correction for 
Chapter 5: Development of a Zebrafish Model 
 
166 
 
multiple comparisons, compared to control (α = 0.05). (C) Representative images of 
zebrafish larvae at 2, 16, and 30 hours post infection (hpi). Lower panel depicts calcofluor 
white (CFW) stained spores. Scale bar = 100 μm. * = p < 0.05. 
 
5.3.2 The P. aeruginosa siderophore, pyoverdine, reduces R. microsporus 
virulence in the hindbrain of healthy zebrafish. Pyoverdine was found to be 
the main mechanism controlling fungal growth upon interaction with P. 
aeruginosa in vitro. Co-injection of R. microsporus with pyoverdine (60 μM) in the 
hindbrain (Figure 5.2A) resulted in significant increase in fish survival when 
compared to spores alone (Figure 5.2B) with 89% (+/- 6.377) of fish surviving 
across a 96-hr time course. This demonstrated that the presence of pyoverdine 
is sufficient to reduce host damage caused by R. microsporus infection.  
 
5.3.3 The E. coli siderophore, enterobactin, does not impact R. microsporus 
virulence in the hindbrain. Enterobactin did not impact R. microsporus growth 
in vitro, and fish were infected with R. microsporus in the presence of enterobactin 
to determine if results were reproducible in vivo. Unlike pyoverdine, the addition 
of enterobactin did not increase the survival of the larvae compared to fish 
infected with R. microsporus alone (Figure 5.2C). This suggests that enterobactin 
is unable to sequester iron from R. microsporus, and the ability of pyoverdine to 
enhance host survival is not a general phenomenon. 
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Figure 5.2 The P. aeruginosa siderophore, pyoverdine, reduces R. microsporus 
virulence in a zebrafish model of infection. (A) Representative images of zebrafish 
larvae at 0 hpi. White arrows indicate R. microsporus spores (Calcofluor White stain, 
cyan pseudo-coloured) located within hindbrain compartment. Scale bars = 100 μm. (B) 
Zebrafish were injected in the hindbrain with 50 spores +/- 60 μM pyoverdine and fish 
survival was quantified over time. Shown are data pooled from four separate experiments 
with a total of 87, 80, 80, and 81 fish for control, pyoverdine only, spores only, and spores 
+ pyoverdine, respectively. (C) Zebrafish larvae were injected in the hindbrain with 50 
spores +/- 50 μM enterobactin. Data shown is pooled from two independent experiments 
with a total of 42, 44, 46, 43, and 50 fish for control, DMSO, enterobactin only, spores 
only, and spores + enterobactin, respectively. Data analysed with Mantel-Cox log-rank 
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test with a Bonferroni test for multiple comparisons, compared to control (α = 0.05).  **** 
= p < 0.0001. (Kousser et al., 2019). 
 
5.3.4 P. aeruginosa PA14 inhibits R. microsporus growth via iron 
sequestration. In vitro experiments used P. aeruginosa PAO1, but the following 
zebrafish experiments have used P. aeruginosa PA14. To utilise for future in vivo 
microscopy, fluorescently tagged strains were developed. Several attempts to 
transform P. aeruginosa PAO1 with the plasmid PME6032 to generate a 
cytoplasmic mCherry-expressing strain were unsuccessful. However, PME6032 
was successfully transformed into P. aeruginosa PA14.  
 
To check the ability of P. aeruginosa PA14 to inhibit R. microsporus growth, R. 
microsporus was exposed to 50% PA14 or PAO1 supernatants for 24 hours 
(Figure 5.3). PA14 reduced R. microsporus growth by 96.23% (+/- 0.58%, p = 
0.0171) (Figure 5.3A). This is comparable to PAO1 supernatant, which reduced 
R. microsporus growth by 94.40% (+/- 1.415%, p = 0.0159). Rescue of fungal 
growth with the addition of 50 μM FeCl3 after exposure to PA14 supernatant was 
also confirmed (Figure 5.3B). Therefore, P. aeruginosa PA14 also inhibits the 
growth of R. microsporus through iron restriction, and PA14 was used in the 
following experiments.  
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Figure 5.3 P. aeruginosa PA14 inhibits the germination of R. microsporus through 
iron sequestration. (A) Spores were exposed to 50% supernatants from P. aeruginosa 
PA14 and PAO1 for 24 hours before fungal growth was measured by absorbance 
(OD600). To determine whether this inhibition is iron-dependent, R. microsporus spores 
were exposed to PA14 supernatant +/- 50 μM FeCl3 and germination was visualised 
through live cell imaging (n=4). (B) Representative images of Control (SAB/LB only), 
50% PA14 supernatant, and 50% PA14 supernatant + iron at 10 and 16 hours are shown. 
Scale bar = 25 μm. Data represents mean and SEM. Kruskal Wallis with Dunn's multiple 
comparisons test was used on non-normalised raw data (α = 0.05). * = p < 0.05. 
 
5.3.5 Zebrafish are resistant to swim bladder mono- and co-infections with 
P. aeruginosa and R. microsporus. Zebrafish larvae were injected with 100 R. 
microsporus spores and 10,000 P. aeruginosa cells. Consistent with the 
literature, R. microsporus did not decrease the viability of healthy fish, with 100% 
of larvae surviving after R. microsporus only injection (Figure 5.4A). Similarly, P. 
aeruginosa did not significantly reduce fish viability, with 92.50% of fish surviving 
mono-infection. This is consistent with previous studies that show a low virulence 
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of P. aeruginosa in healthy fish after swim bladder injection (Bergeron et al., 
2017). There was no difference in zebrafish survival between P. aeruginosa 
mono- and co-infection, with 92.86% of fish surviving after co-infection (Figure 
5.4B).  
 
To determine whether the fungi remained viable during the infection, R. 
microsporus, P. aeruginosa, and co-infection with an MOI of 1:100 
(fungi:bacteria) were injected into the swim bladder of 4 dpf zebrafish. After 24 
hours post infection (hpi), larvae were euthanised, homogenised, and the lysate 
was plated onto SAB agar + antibiotics. Viable R. microsporus spores were 
counted and compared to 0 hpi control. For R. microsporus mono-injection, 
93.39% (+/- 20.70%) of spores survived, and 112.30% (+/- 23.19%) of co-injected 
spores survived (Figure 5.4C). Therefore, zebrafish swim bladder co-infection 
with R. microsporus and P. aeruginosa did not impact spore viability. 
Due to the of the lack of pathogenicity of both P. aeruginosa and R. microsporus 
in the swim bladder, other injection sites were explored. 
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Figure 5.4 Zebrafish are resistant to swim bladder infections with P. aeruginosa 
and R. microsporus. (A) Image of 4 dpf zebrafish larvae, white arrow pointing toward 
swim bladder. (B) Zebrafish larvae (4 dpf) were injected into the swim bladder with 
injection buffer only, R. microsporus spores (100), P. aeruginosa PA14 cells (10,000) 
and co-injected. Survival was quantified after 24 hpi. Data presented is pooled from two 
independent experiments with 40, 42, 40, and 42 fish for control, spores only, bacteria 
only, and co-infection. Data analysed with Mantel-Cox log-rank test with a Bonferroni test 
for multiple comparisons. (C) To determine if the presence of P. aeruginosa enhances 
the killing of R. microsporus by host immune cells, 50 spores and 5,000 bacteria were 
injected into the swim bladder and zebrafish were homogenised in triplicate at 0 hpi and 
24 hpi and plated on SAB agar + 60 μg/ml tetracycline, 30 μg/ml gentamycin, and 30 
μg/ml chloramphenicol to determine fungal viability. Colours correspond to points 
belonging to the same biological replicates. One outlier was determined using the Robust 
regression and Outlier removal (ROUT) method and removed. Data analysed using a 
Mann-Whitney U test (α = 0.05). 
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5.3.6 R. microsporus is moderately pathogenic in healthy zebrafish 
embryos via yolk sac injections, while P. aeruginosa is highly virulent. 
Injection into the dorsal end of the yolk sac of 2 dpf zebrafish larvae (Figure 5.5A) 
with 10, 50, 100, 500, and 1000 P. aeruginosa cells resulted in a highly virulent 
infection (Figure 5.5B). After 72 hours, only 15% of fish survived the lowest dose 
of bacteria (10 cells), with 100% mortality after 24 hours injection with 1000 cells.  
This suggests that the bacteria are likely entering the blood stream, killing the 
fish. Injection into the yolk sac of R. microsporus spores mildly reduced viability.  
Survival following injection with 10, 50, and 100 spores is decreased in a dose-
dependent manner, with the highest injection dose leading to 41.18% mortality 
72 hpi.  
 
To observe whether the inoculum was disseminating from original injection site, 
live cell microscopy was utilised. Representative images (Figure 5.5D) depict 
stained R. microsporus spores migrating from the injection site after 5 hours, 
suggesting that organisms injected into the yolk sac easily disseminate.  
While these results indicate that the yolk sac could be an adequate model for 
mucormycosis, the high lethality associated with bacterial injection makes co-
infection impractical at this site. Therefore, the hindbrain injection model was 
explored as a potential site for co-infection. 
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Figure 5.5 R. microsporus is moderately pathogenic in healthy zebrafish embryos 
via yolk sac injections, while P. aeruginosa is highly virulent. (A) Image of 2 dpf 
zebrafish embryo, white arrow pointing towards injection site of yolk sac. Zebrafish were 
injected with a range of (B) P. aeruginosa or (C) R. microsporus cells in the yolk sac at 
2 dpf and the survival of the fish monitored. Data presented is pooled from two 
independent experiments with 35, 40, 40, 35, 40, and 40 fish for the control, 10, 50, 100, 
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500, and 1000 bacteria per fish, and 26, 34, 35, and 34 fish for control, 10, 50, and 100 
spores per fish. (D) To observe dissemination, spores were stained with 250 μg/ml 
calcofluor white (CFW) before live cell microscopy was utilised to observe spore 
dissemination. Representative images are presented. Red circles highlight original site 
of injection. White arrows point to disseminated spores. Survival data was analysed with 
Mantel-Cox log-rank test with a Bonferroni test for multiple comparisons (α = 0.05).  **** 
= p < 0.0001. 
 
5.3.7 P. aeruginosa decreases viability in a dose-dependent manner 
following hindbrain injections of healthy zebrafish embryos. Before 
establishing a co-infection model, zebrafish survival following bacterial mono-
infections was established. Zebrafish were injected in the hindbrain with 10, 50, 
100, 500, and 1000 P. aeruginosa bacteria (Figure 5.6A). A moderately virulent 
infection was established following injection with 10, 50, 100, 500, and 1000 
bacteria, and viability decreased in a dose-dependent manner. After injection with 
1000 bacteria, 67.09% of fish survived at 96 hpi.  
 
It was hypothesised that P. aeruginosa would decrease fungal virulence in vivo. 
Mono-injections with R. microsporus (Figure 5.1) indicated that a high dose of 
spores (100 spores) would be required to reduce zebrafish viability to an extent 
where changes could be observed. In vitro results suggested that an MOI of 1:100 
(R. microsporus : P. aeruginosa) would be required to inhibit R. microsporus 
germination (Figure 3.16). Therefore, 10,000 bacteria would need to be injected 
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into the hindbrain during co-infections. This infection was highly virulent, with only 
2.8% of fish surviving after 24 hours (Figure 5.6B).  
 
Figure 5.6 P. aeruginosa decreases viability in a dose-dependent manner following 
hindbrain injections of healthy zebrafish embryos. To determine the impact of P. 
aeruginosa mono infection, PA14 was injected into the hindbrain with 10, 50, 100, 500, 
and 1000 CFUs/fish (A) Survival was monitored over time. Data shown is pooled from 
four separate experiments with 70, 80, 80, 80, 79, and 79 fish for control, 10, 50, 100, 
500, and 1000 bacteria. (B) To reach adequate bacterial load for future co-infection 
experiments, 10,000 P. aeruginosa cells were injected into the hindbrain and survival 
was quantified over time. Data presented is pooled from two separate experiments with 
31 control fish and 35 fish injected with 10,000 bacteria. Data analysed with Mantel-Cox 
log-rank test with a Bonferroni test for multiple comparisons (α = 0.05).  **** = p < 0.0001. 
  
5.3.8 Co-infection with P. aeruginosa and R. microsporus enhances 
virulence in a zebrafish hindbrain co-infection model. To determine the effect 
of co-infection in vivo, 100 R. microsporus and 10,000 P. aeruginosa were 
injected into the hindbrain (Figure 5.7). Spores alone showed limited virulence, 
with 86.89% of fish surviving after 96 hours. P. aeruginosa was also less virulent 
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than in previous experiments, though 76.67% of fish were still killed after 96 hpi. 
Surprisingly, co-injection resulted in a more highly virulent infection, and 100% of 
fish were killed at 96 hpi. Upon microscopic examination, the fish did not appear 
to die from fungal outgrowth, though further investigation would be needed to 
confirm this observation. This suggests that co-infection with R. microsporus and 
P. aeruginosa enhances bacterial virulence in vivo. 
 
Figure 5.7 Co-infection with P. aeruginosa and R. microsporus enhances virulence 
in a zebrafish hindbrain co-infection model. R. microsporus spores (100) and P. 
aeruginosa PA14 (10,000) were injected into the hindbrain of zebrafish embryos at 24 
hpi. Survival was monitored over time. Data presented is pooled from three independent 
experiments with 51, 60, 61, and 61 fish from control, bacteria only, spores only, and co-
infection respectively. Data analysed with Mantel-Cox log-rank test with a Bonferroni test 
for multiple comparisons (α = 0.05).  *** = p < 0.001. 
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5.4 Discussion.  
5.4.1 Choosing site of infection and validating model.  
This chapter began developing an in vivo zebrafish infection model to test the 
impact of the interaction between R. microsporus and P. aeruginosa on a host. 
The first goal was to analyse different injection sites to determine the optimal 
model for co-infection. Here we confirmed the site-dependent variability of 
Mucorales infection seen in previous zebrafish studies. As found with M. 
circinelloides (Voelz, Gratacap and Wheeler, 2015), injection into the swim 
bladder with R. microsporus did not result in overt infection. Likewise, P. 
aeruginosa did not cause significant mortality following swim bladder infection, 
which is also consistent with the literature (Bergeron et al., 2017). While the time-
course of this study is limited by Home Office licencing regulations (restricted to 
5 dpf), longer incubation with P. aeruginosa or Mucorales has not demonstrated 
increased mortality in healthy fish (Voelz, Gratacap and Wheeler, 2015; Bergeron 
et al., 2017). However, collaborators are currently exploring the impact of R. 
microsporus and P. aeruginosa swim bladder co-infections during extended time-
course experiments.  
 
The hindbrain compartment is the most commonly used site for fungal injections 
in the zebrafish, with established models for candidiasis, aspergillosis, 
cryptococcosis, and mucormycosis (Chao et al., 2010; Knox et al., 2014; Tenor 
et al., 2015; Voelz, Gratacap and Wheeler, 2015). We identified this as the best 
location for co-infection with R. microsporus and P. aeruginosa, due to the dose-
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dependent decrease in viability when exposed to either organism and the ability 
to monitor infections for longer time periods before Home Office licencing requires 
experiment termination. Injection with low (10), moderate (50), and high (100) 
doses of R. microsporus spores provided comparable results to M. circinelloides 
hindbrain infections (Voelz, Gratacap and Wheeler, 2015), confirming our 
technique. Mono-injection with P. aeruginosa into the hindbrain led to a dose-
dependent decrease in viability. However, mortality was lower than seen in 
previous studies, likely due to strain and procedure differences (Rocker et al., 
2015; McCarthy et al., 2017). Zebrafish do not develop neutrophils until 32 to 48 
hpf, and this could account for the extensive mortality with the highest dose of 
bacteria (Lieschke et al., 2001).  
 
While variable, injection with R. microsporus at all sites did not lead to 
considerable death. As most fungal infections occur in immunocompromised 
hosts, it was not surprising that limited mortality was observed with the 
immunocompetent fish used in this study. Depressing zebrafish immune system 
through corticosteroid treatment or depletion of macrophages leads to higher 
mortality following M. circinelloides and A. fumigatus infections (Knox et al., 2014; 
Voelz, Gratacap and Wheeler, 2015). Therefore, co-injection with P. aeruginosa 
and R. microsporus could better establish infection in immunocompromised 
zebrafish larvae. However, high P. aeruginosa virulence in an 
immunocompromised host may be a limiting factor in these experiments.  
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Furthermore, as diabetes is an important risk factor for mucormycosis, a diabetic 
zebrafish model could enhance baseline R. microsporus virulence. While most 
diabetic models use adult fish, a transgenic line has been developed which leads 
to insulin resistance and hyperglycaemia in larvae through disruption of the 
insulin receptors (Yin et al., 2015). Models for diabetic DKA in zebrafish are 
lacking, though treatment with streptozotocin, which has been used to model DKA 
in mammals (Lam et al., 2005), or ketones, such as β-hydroxybutyrate, could be 
promising.  
 
5.4.2 Impact of pyoverdine on R. microsporus virulence in vivo. Through 
utilisation of the zebrafish hindbrain injection model, we confirmed the ability of 
pyoverdine to limit R. microsporus virulence. This is similar to murine 
experiments, where treatment with the iron chelator deferasirox decreased the 
virulence of R. oryzae and enhanced mouse survival (Ibrahim et al., 2007). 
However, there have been reported cases of deferasirox-induced liver toxicity 
(Braga et al., 2017). Furthermore, as adjunct treatment of deferasirox with 
amphotericin B failed clinical trials (Spellberg et al., 2012), there is a need for 
novel iron chelators to treat mucormycosis.  
 
5.4.3 In vivo co-infection model. Based on in vitro observations that P. 
aeruginosa decreases R. microsporus germination, we hypothesised that co-
infection in the zebrafish would decrease fungal virulence. Instead, we observed 
a higher mortality following co-infection, presumably due to P. aeruginosa 
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infection. This is opposite to zebrafish studies involving P. aeruginosa and C. 
albicans where fungal virulence is enhanced in vivo (Bergeron et al., 2017), and 
demonstrates the versatility of this bacterium when interacting with fungi. 
Injecting fish with mutant bacteria unable to secrete pyoverdine or pyochelin 
would help determine whether a fungal-induced increase in these virulence 
factors enhances mortality. Furthermore, co-injections of R. microsporus with 
another bacterial species could indicate whether this is a general phenomenon 
of opportunistic pathogens in the presence of R. microsporus, or if this is specific 
to P. aeruginosa.  
In all, this work provides a unique insight into the potential implications of co-
infection on the host and confirms the importance of studying polymicrobial 
interactions in vivo 
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Chapter 6 : DISCUSSION AND 
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Just as humans live in diverse communities and are rarely alone, no 
microorganism lives in isolation. Because of this, dynamic relationships have 
emerged where microbes have developed specific reactions to the presence of 
certain pathogens. For instance, C. albicans is inhibited or killed when it comes 
into contact with P. aeruginosa (Hogan and Kolter, 2002; Hogan, Vik and Kolter, 
2004), Acinetobacter baumanii (Peleg et al., 2008), or E. coli (Cabral et al., 2018). 
However, when C. albicans meets S. aureus (Schlecht et al., 2015) or S. 
epidermidis (Pammi et al., 2013), the microbes synergise, leading to increased 
bacterial dissemination and more aggressive infections. 
 
Here we have identified the opportunistic Gram-negative bacterium, P. 
aeruginosa, as a novel factor that impacts R. microsporus pathogenicity. This 
interaction was found to be predominantly mediated by iron competition. While 
iron is already known to be a limiting factor in Rhizopus spp. infection, pyoverdine 
is a unique chelator that R. microsporus cannot utilise as an iron source. Further, 
this work gives insight into the complex battle between R. microsporus and P. 
aeruginosa when they meet in the environment or human host. With this 
information, clinicians could better predict disease outcome and understand risks 
associated with co-habitation of these particular organisms. In all, this study 
identified pyoverdine-mediated iron modulation as a novel mechanism by which 
R. microsporus interacts with other microorganisms and reinforced the 
importance of iron in the pathogenesis of these fungi. 
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6.1 Iron competition 
Iron is essential in all lifeforms for biological processes such as oxygen transport, 
DNA synthesis, detoxification, cell growth/division, and electron transport to 
properly function (Abbaspour, Hurrell and Kelishadi, 2014). Iron is generally a 
limiting factor during infection, and as such the host has developed mechanisms 
for sequestering iron and other trace minerals from microbes, termed nutritional 
immunity (Hood and Skaar, 2012). This leads to only 10-24 M unbound iron within 
the human body (Miethke and Marahiel, 2007). Along with pressures from the 
host, microorganisms must compete with other pathogens that are also fighting 
to scavenge iron from host iron-binding proteins. Many pathogenic bacteria and 
fungi have developed effective mechanisms for stealing iron from transferrin, 
including high affinity siderophores and haem oxygenases (Haas, 2014). Our 
study has shown that during the battle between P. aeruginosa and R. 
microsporus, P. aeruginosa siderophores are more efficient at chelating iron than 
R. microsporus. Here, the fungus is not able to scavenge iron from P. aeruginosa 
siderophores, as it can from other bacterial siderophores (Boelaert et al., 1993). 
This results in the significant inhibition of R. microsporus germination in vitro and 
a pyoverdine-mediated reduction in fungal virulence in vivo.   
 
Supplementation with zinc, manganese, and copper alone did not rescue fungal 
growth, even though these are also chelated by pyoverdine and pyochelin (Braud, 
Hannauer, et al., 2009; Braud, Hoegy, et al., 2009).  However, further 
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investigation into the competition between Mucorales and opportunistic 
pathogens for these metals would be interesting. Zinc is essential for nucleotide 
synthesis and germination of Mucorales (Foster and Waksman, 1939; Wegener 
and Romano, 1963). Restriction of this metal inhibits C. albicans virulence by 
decreasing growth (Lulloff, Hahn and Sohnle, 2004) and induces Goliath cell 
formation (Malavia et al., 2017), though C. albicans has developed scavenging 
mechanisms to compete with host zinc sequestration (Citiulo et al., 2012). Zinc 
starvation also increases oxidative stress in Crypotococcus gattii (Schneider et 
al., 2012) and the production of stress-associated proteins in Paracoccidioides 
brasiliensis (Parente et al., 2013). Therefore, zinc competition between R. 
microsporus and P. aeruginosa could manifest in different parameters than 
germination inhibition. Limitation of manganese could also impact R. microsporus 
growth, as manganese is necessary for proper cell wall development of A. niger 
(Kisser, Kubicek and Rohr, 1980) and filamentation of C. albicans (Asleson et al., 
2000). Furthermore, the iron permease, FTR1, is coupled to a copper oxygenase 
during reductive iron uptake (Stearman et al., 1996; Ibrahim et al., 2010). 
Therefore, copper restriction could reduce iron uptake, and perhaps combined 
supplementation of copper with iron would further enhance R. microsporus 
growth. Nevertheless, iron competition, specifically via the siderophore 
pyoverdine, was implicated as the major source of R. microsporus growth 
inhibition in this study.  
 
6.1.1 Speculation regarding germination cessation as a defensive strategy. 
Remaining un-germinated could be a defence mechanism employed by R. 
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microsporus to protect itself against competitors. As dormant fungal spores can 
survive extreme conditions (Dunn et al., 2006), it could be a better strategy to 
wait until conditions are more favourable. Along these lines, perhaps iron 
availability acts as a cue to determine whether the desired nutrients are available 
to thrive. Maybe Mucorales aren’t necessarily inefficient at obtaining iron, but 
decide that without available iron, the conditions will not be adequate to germinate 
and obtain other nutrients. This sensor could also act to warn Mucorales that 
other organisms are present. Perhaps Rhizopus spp. are the most prolific causes 
of mucormycosis because of this ability to more effectively recognise suitable 
conditions for hyphal growth. However, as iron starvation decreases spore 
survival over time (Shirazi, Kontoyiannis and Ibrahim, 2015 and this study), this 
mechanism could be a temporary defensive strategy in early timepoints, or other 
conditions in these experiments could decrease spore viability.  
 
Mucorales are protected against host killing when they remain as spores, but their 
hyphae are vulnerable to neutrophil damage via NETs (Diamond et al., 1978). 
Being aseptate means that hyphal injury is particularly dangerous for the fungus, 
as it is unable to wall off the affected area (Deacon, 2006). Remaining un-
germinated within macrophages reduces killing and allows for intracellular 
persistence (Andrianaki et al., 2018). Mucorales are thought to form granulomas 
within the host (Inglesfield et al., 2018), which is hypothesised to act as a 
reservoir for the emergence of latent infections. This could be a similar defence 
strategy in response to competing pathogens. Perhaps the aggressiveness and 
efficiency of P. aeruginosa’s attack prompts the active decision to halt 
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germination and protect itself. However, this is not entirely successful, as live P. 
aeruginosa and prolonged exposure to supernatants decreases viability.  
 
6.2 Xenosiderophores. 
To overcome nutritional immunity and compete against other microorganisms, 
some pathogens have developed mechanisms for scavenging iron from 
siderophores produced by other bacteria and fungi. For example, Neisseria 
gonorrhoeae does not produce its own siderophores, but instead utilises 
enterobactin and salmochelin which are both produced by E. coli, Salmonella 
spp., and Klebsiella spp., along with host transferrin and lactoferrin (Strange, Zola 
and Cornelissen, 2011). Many fungi such as C. albicans (Heymann et al., 2002), 
C. glabrata (Nevitt and Thiele, 2011), and C. neoformans (Tangen et al., 2007) 
utilise hydroxamate siderophores produced by bacteria and other fungi. P. 
aeruginosa can utilise several siderophores from both bacteria and fungi such as 
deferoxamine (from Streptomycetes spp.), ferrichrome (from Aspergillus spp. and 
Penicillium spp.), and Schizokinen (from Bacillus megaterium) all via the same 
FoxB transporter (Cuív et al., 2007). P. aeruginosa can also use enterobactin 
(Ghysels et al., 2005), aerobactin (from E. coli), and rhizobactin (from Rhizobium 
meliloti) (Cuív, Clarke and O’Connell, 2006) to obtain iron. Therefore, 
xenosiderophore usage is present throughout bacterial and fungal kingdoms and 
is an example of the evolved arms-race against competing community members.  
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Mucorales are no exception to this phenomenon and can utilise deferoxamine as 
a xenosiderophore. Deferoxamine was clinically used as an iron chelator in 
patients experiencing iron overload, usually in hereditary hemochromatosis, beta-
thalassemia,  or following blood transfusions (Mobarra et al., 2016). However, 
these people became uniquely susceptible to mucormycosis (Boelaert et al., 
1993), despite Mucorales’ dependency on available iron (Artis et al., 1982). Under 
these conditions, mucormycosis was induced by ferrioxamine (iron-rich 
deferoxamine) binding to Fob1/Fob2 receptors on the cell surface (Liu et al., 
2015). This project suggests enterobactin, produced by E. coli, as a potential 
novel xenosiderophore for R. microsporus. While the P. aeruginosa siderophore 
pyoverdine strongly inhibited R. microsporus growth, addition of isolated 
enterobactin did not have any effect. This was surprising as enterobactin  has a 
higher affinity (1052 M-1) for iron than pyoverdine (1036 M-1) (Carrano and 
Raymond, 1979). This is in contrast to in vitro studies involving E. coli with C. 
albicans and Aspergillus spp. In these cases, hydrophilic secreted molecules 
from E. coli kills C. albicans (Cabral et al., 2018), and live co-cultures lead to 
inhibition of A. fumigatus and A. flavus growth (Yadav et al., 2005). Furthermore, 
while pyoverdine reduces R. microsporus virulence in a zebrafish hindbrain 
injection model, enterobactin did not have an impact. Investigating the expression 
of Fob1/Fob2 when R. microsporus is exposed to exogenous enterobactin, E. coli 
supernatants, and live E. coli could provide evidence, though if it is a 
xenosiderophore, enterobactin uptake could be mediated by a different receptor 
to deferoxamine.  
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The fact that other bacteria and fungi can form synergistic relationships, such as 
S. aureus and C. albicans  (Schlecht et al., 2015), suggests that E. coli and R. 
microsporus might also work together to enhance pathology in a host. Clinically, 
concurrent E. coli infections and mucormycosis have been reported. Examples 
include diabetic individuals with infections at a surgical site following bowel 
resection (Patel et al., 2010) and following drainage of an abdominal cellulitis 
abscess (Nain et al., 2015). Another case occurred in a patient with non-
Hodgkin’s lymphoma who developed pulmonary mucormycosis with positive E. 
coli cultures following allogenic stem cell transplantation (Peixoto et al., 2014). 
Finally, a person with chronic obstructive pulmonary disorder (COPD) developed 
E. coli sepsis, and mucormycosis was confirmed upon autopsy (Alhassan and 
Thirumala, 2015). In all cases found, E. coli was diagnosed first, and the patient 
ultimately expired. Therefore, xenosiderophore-mediated cooperation between 
Mucorales and E. coli may have serious clinical implications. Future studies could 
involve investigating co-infections in vivo.  
 
While iron availability is a limiting factor in mucormycosis, Mucorales are not very 
efficient at acquiring iron. Perhaps they have ineffective siderophores with a low 
affinity for iron (Thieken and Winkelmann, 1992) because they have developed 
mechanisms to utilise siderophores from bacteria they commonly meet. 
Biosynthesis and secretion of siderophores is a metabolically costly behaviour 
(Griffin, West and Buckling, 2004). Utilising chelators from other organisms could 
be more cost-effective and still provide the necessary nutrients to fuel growth.  
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Ultimately, the ability of pyoverdine to inhibit R. microsporus growth while 
enterobactin induces no effect indicates that Mucorales participate in dynamic, 
species-specific relationships that have evolved into varying responses to 
different bacteria.  
 
6.3 General Mucoralean response to opportunistic pathogens. 
This study has shown a variation in the response of R. microsporus to different 
pathogens. We have shown that R. microsporus is inhibited by the presence of 
P. aeruginosa and K. pneumoniae, while S. aureus, E. coli, and B. cenocepacia 
do not impact germination. This suggests evolved species-specific mechanisms 
for polymicrobial interactions and evidence for further investigation into these 
relationships.  
 
6.3.1 Potential R. microsporus and S. aureus cooperation. S. aureus acts 
synergistically with C. albicans, and binding of S. aureus to fungal hyphae 
promotes deeper penetration of the bacterium into tissues (Schlecht et al., 2015). 
Here, co-culture of R. microsporus and S. aureus resulted in bacterial attachment 
to germinating hyphae. Given that co-infections between S. aureus and 
Mucorales have been reported (Stasiak et al., 2009), it is possible that this 
relationship could promote bacterial dissemination. Further experiments could 
investigate the impact of S. aureus co-infection with R. microsporus in vivo to 
determine if they synergise inside the host. S. aureus commonly colonises the 
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nasal cavity (Kluytmans, Van Belkum and Verbrugh, 1997) and mucormycosis 
most commonly presents in the sinuses (Roden et al., 2005). Clinical correlation 
studies between rhinocerebral mucormycosis and colonisation of S. aureus 
would be interesting to understand if these carriers are more likely to die from the 
fungal infection.  
 
6.3.2 R. microsporus, QSMs, and toxins. Investigating the source of inhibition 
within P. aeruginosa supernatant revealed bacterial QSMs and the toxin 
pyocyanin do not regulate R. microsporus germination. C12 HSL inhibits C. 
albicans filamentation by inhibiting the cAMP pathway (Hall et al., 2011), and the 
lack of total inhibition when exposed to QSMs indicates a different pathway 
regulating R. microsporus germination. While C12 HSL inhibits Aspergillus spp., 
the mode of action of is unknown (Briard et al., 2019). Germination of A. 
fumigatus is not regulated by the PKA-dependent cAMP pathway, and is instead 
thought to be mediated by ras/MAPK signalling (Osherov and May, 2000). 
Therefore, it is possible that C12 HSL could act on this pathway in A. fumigatus. 
As C. albicans filamentation is also regulated by MAPK signalling (Monge et al., 
2006), it would be worth investigating whether cAMP or ras/MAPK signalling are 
involved in Mucoralean polymicrobial interactions. Farnesol, the QSM produced 
by C. albicans, delays germination but does not completely inhibit. Because 
farnesol autoinhibition is also regulated by cAMP (Davis-Hanna et al., 2008), it is 
possible that live cell imaging of spores exposed to P. aeruginosa QSMs could 
reveal delayed germination, which is eventually overcome before endpoint 
measurement. As QSMs act as an inter- and intra-species communication 
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mechanism, the ability of R. microsporus to overcome high concentrations of 
QSMs could indication an evolutionary defence. It would be interesting to see if 
this is a general trait of Mucorales, and if not, whether this correlates with rate of 
clinical infections.  
 
R. microsporus is also resistant to pyocyanin. This is surprising, as C. albicans, 
C. tropicalis, C. neoformans, A. fumigatus, and A. niger are all sensitive to 
pyocyanin (Abdul-hussein and Atia, 2016), and phenazines are known to 
modulate redox homeostasis (Briard et al., 2015; Hall et al., 2016). The 
accumulation of intracellular ROS occurs during R. delemar hyphal growth 
(Sephton-Clark et al., 2018). This indicates that ROS generation is a natural part 
of Mucoralean germination, and perhaps this explains why R. microsporus is 
resistant to pyocyanin. Further work could investigate ROS production in R. 
microsporus during pyocyanin exposure to understand the impact on oxidative 
stress in Mucorales. 
Taken together, this study has demonstrated the ability of R. microsporus to 
participate in polymicrobial interactions with other opportunistic pathogens, and 
these relationships are variable, dynamic, and specialised. 
 
6.4 Impact of polymicrobial interactions on the host.  
Polymicrobial interactions can have a devastating impact on the progression of 
infectious diseases in a host. For instance, co-infection with P. aeruginosa and 
A. fumigatus in CF is associated with a more severe outcome and poorer 
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management of disease (Reece et al., 2017). Furthermore, the presence of fungi 
within a polymicrobial chronic wound promotes stable, cross-kingdom biofilms 
and are associated with slower healing and necrosis (Kalan et al., 2016). 
Therefore, understanding the impact of co-infection with R. microsporus and P. 
aeruginosa on host response and outcome was important to understand the 
clinical relevance of this interaction.  
 
6.4.1 Comparing human and zebrafish iron-sequestering proteins. 
Nutritional immunity is a host defence used to restrict essential metal nutrients 
from pathogens to prevent their successful growth (Weinberg, 1975). This is a 
common phenomenon amongst vertebrates, where metals are tightly 
sequestered in the serum and within tissues bound to specific proteins (Hennigar 
and McClung, 2016). Using the Basic Alignment Search Tool (BLAST), Danio 
rerio and Homo sapiens were found to contain homologous proteins related to 
nutritional immunity, making the zebrafish a valid model to study the relationship 
between R. microsporus and P. aeruginosa in vivo (Table 6.1, Altschul et al., 
1990). These proteins included the iron-transporter transferrin, the 
oxygen/carbon dioxide transporter haemoglobin, the phagosome associated 
metal transporter NRAMP1 (natural resistance associated macrophage protein 
1), and the iron storage protein ferritin (Hood and Skaar, 2012). These similarities 
suggest that both organisms utilise similar mechanisms to restrict iron from 
microorganisms. As this study determined that the interaction between R. 
microsporus and P. aeruginosa was mediated by iron competition, zebrafish were 
a valid model for co-infection with R. microsporus and P. aeruginosa. 
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Table 6.1 Homology of nutritional-immunity related proteins in Homo sapiens and 
Danio rerio using the BLAST. (Altschul et al., 1990) 
Name Percent Similarity 
Transferrin 42% 
Haemoglobin alpha subunit 54% 
NRAMP1 70% 
Ferritin 79% 
 
6.4.2 Enhancement of virulence in a co-infection model. Co-infection in a 
zebrafish hindbrain injection model revealed enhanced larval mortality when both 
species were present. Lack of evident fungal growth and limited mortality from 
the injection with spores alone indicated that the increased death during co-
infection was likely attributed to bacterial pathogenicity. This agrees with in vitro 
co-culture data which demonstrated an increased expression of pyoverdine and 
pyochelin biosynthetic genes and enhanced siderophores in supernatants. 
Pyoverdine is important for pathogenicity of P. aeruginosa (Meyer et al., 1996) 
and can modulate virulence by regulating the production of toxins such as 
exotoxin A and endoproteases (Lamont et al., 2002). Therefore, it is possible that 
the presence of R. microsporus in the zebrafish increases the virulence factor 
production of P. aeruginosa and enhances host mortality. Clinically, the presence 
of C. albicans can increase risk of P. aeruginosa infection (Azoulay et al., 2006). 
We predict this could be similar when R. microsporus is present. In these 
scenarios, increased P. aeruginosa virulence would be a by-product of microbial 
competition.  
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As P. aeruginosa inhibits R. microsporus germination in vitro, we speculate that 
the presence of both microbes within a wound, for example, could mask fungal 
presence and enhance P. aeruginosa pathogenicity (Figure 6.1). This is opposite 
to zebrafish co-infections with P. aeruginosa and C. albicans, where P. 
aeruginosa enhances fungal germination and virulence in vivo (Bergeron et al., 
2017). In a murine model, C. albicans decreases the virulence and bacterial 
burden of P. aeruginosa by reducing the biosynthesis of pyoverdine and 
pyochelin (Lopez-Medina et al., 2015).  
Together, our results and evidence from the literature indicate a dynamic 
relationship between P. aeruginosa and different fungal species, where P. 
aeruginosa forms cooperative or competitive relationships depending on the 
situation and the fungus involved. Furthermore, it highlights the importance of 
siderophores in infection scenarios and the enhanced aggressiveness of 
polymicrobial infections.  
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Figure 6.1 Proposed clinical scenario where R. microsporus enhances P. 
aeruginosa virulence. (A) A wound becomes infected with P. aeruginosa. P. 
aeruginosa secretes a plethora of molecules, including pyoverdine (blue spheres). 
Pyoverdine binds any available iron (grey spheres) in the area. (B) If R. microsporus 
spores (large spheres) enter the wound from the environment, there is no iron available, 
and the spores do not germinate. (C) However, the presence of R. microsporus 
enhances P. aeruginosa pyoverdine production which leads to enhanced virulence factor 
production and poorer patient prognosis. Not to scale. 
 
6.4.3 Antifungal resistance. Interestingly, exposure to P. aeruginosa 
supernatant cultured under iron replete conditions increased R. microsporus 
sensitivity to amphotericin B and posaconazole, which are first-line and salvage 
therapies, respectively, for mucormycosis (Spellberg and Ibrahim, 2010). 
Susceptibility to amphotericin B varies between species and strains (Vitale et al., 
2012), and the resulting high concentrations and prolonged treatment can lead to 
nephrotoxicity (Fanos and Cataldi, 2000). In our study, the growth of R. 
microsporus was inhibited upon exposure to very low concentrations of 
amphotericin B (0.0155 μg/ml) when treated with P. aeruginosa supernatant. 
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Furthermore, treatment with supernatants induced posaconazole susceptibility, 
even though this strain was initially resistant to posaconazole. Amphotericin B 
creates pores in the fungal cell membrane after binding to ergosterol (Finkelstein 
and Holz, 1973) and posaconazole inhibits ergosterol synthesis (Hof, 2006). 
Therefore, it is possible that compounds present in the P. aeruginosa supernatant 
weaken the cell membrane themselves, enhance antifungal binding to membrane 
targets, or increase the drug activity after binding. Furthermore, recent studies 
have suggested that oxidative stress induced by amphotericin B attributes to the 
fungicidal activity in A. fumigatus (Shekhova, Kniemeyer and Brakhage, 2017). 
Perhaps the supernatant increases R. microsporus sensitivity to ROS. Identifying 
the factor(s) within the supernatant that enhances antifungal sensitivity could lead 
to novel adjunct therapies, reducing the dosage of amphotericin B or 
posaconazole needed to control infection. It is unclear as to whether the 
supernatant is inducing sensitivity to general stressors or specifically to 
antifungals, and this needs further experimentation.  
Altogether, preliminary data indicates that patient management and host outcome 
could be impacted by co-infection with R. microsporus and P. aeruginosa.  
 
6.5 Clinical implications: patient management.  
Beyond the previously discussed implications of this research, we propose a 
hypothetical clinical model (Figure 6.2). In our theorised model, a patient has a 
wound that becomes infected with P. aeruginosa. As the bacteria multiply, they 
secrete various metabolites, toxins, and molecules, including pyoverdine (Figure 
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6.2A). If this were a burn wound, pyoverdine production would be even greater, 
as biosynthesis is enhanced when exposed to burn wound exudate (Gonzalez et 
al., 2018).  Pyoverdine binds any available iron within the area, and if R. 
microsporus spores come into contact with the wound, germination would be 
inhibited due to lack of iron (Figure 6.2B). However, if the wound is treated with 
antibiotics and the P. aeruginosa is successfully removed, the spores no longer 
have the bacterial pressure (Figure 6.2C). This could lead to fungal germination 
and an aggressive secondary infection (Figure 6.2D). There is an example in the 
literature of the opposite occurring, where antifungal treatment of a C. albicans 
infection led to a P. aeruginosa infection (Nseir et al., 2007). This is evidence that 
the pressures of microbial competition can control infection, and release of these 
pressures can result in secondary infection. 
 
6.6 Future work. 
6.6.1 Host-pathogen interactions. The zebrafish infection model is a powerful 
system for investigating host response to infections and could be utilised more 
extensively to examine P. aeruginosa and R. microsporus co-infections. Future 
experiments could measure changes in macrophage/neutrophil recruitment to the 
infection site in mono- versus co-infections. It would also be prudent to develop 
a technique for determining whether R. microsporus germinates within the 
zebrafish hindbrain during co-infection. Confocal microscopy has been used to 
determine in vivo filamentation of C. albicans (Brothers, Newman and Wheeler, 
2011). However, acquiring fluorescent Mucoralean spores is difficult due to lack 
of genetic manipulability, though techniques are improving for M. circinelloides 
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and R. delemar with the development of CRISPR-Cas9 systems (Nagy et al., 
2017; Binder et al., 2018; Vellanki et al., 2018; Bruni et al., 2019).  Determining 
changes in genes associated with germination could be a promising avenue. 
Transcriptional regulation of genes associated with hyphal growth have been 
studied and provide promising targets to molecularly identify germination, such 
as actin and delta-9 desaturase expression (Sephton-Clark et al., 2018).  
 
As most mucormycosis occurs in immunocompromised individuals, co-infections 
following corticosteroid treatment of the fish could be a better model for 
understanding the impact on a host. Glucocorticoid treatment reduces pro-
inflammatory transcriptional changes and neutrophil migration in zebrafish 
(Chatzopoulou et al., 2016). M. circinelloides mounts a more aggressive infection 
following dexamethasone treatment (Voelz, Gratacap and Wheeler, 2015), and 
R. microsporus is likely similar. It would also be interesting to investigate how the 
use of antibiotics or antifungals impacts co-infection outcome, and previous 
studies have demonstrated the ability of antibiotics added to the water to reduce 
bacterial burden in zebrafish (Fehr et al., 2015). Ideally, development of 
mammalian co-infection models would occur following zebrafish characterisation. 
 
The fungal cell wall is the first point of contact with the host immune system and 
cell wall components can modulate host response (Wang, Aisen and Casadevall, 
1995; Jawhara et al., 2012; Wagener et al., 2014). The presence of cell wall chitin 
in early timepoints following exposure to P. aeruginosa supernatant was 
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investigated in this study, where we found a decrease in total chitin which was 
likely associated to decreased spore swelling. Examining the impact of P. 
aeruginosa on β-glucan, melanin, and chitosan could give further clues into how 
this relationship affects the interaction between R. microsporus and the host. 
 
Further experiments investigating host-pathogen interactions could include in 
vitro phagocytosis assays with co-culture or supernatant-treated spores to 
observe changes in macrophage or neutrophil ability to engulf spores. As 
treatment with P. aeruginosa supernatants is predicted to alter cell membrane 
sensitivity to antifungals, perhaps spores would be more sensitive to intracellular 
killing by phagocytic cells. Furthermore, looking at changes in cytokine 
expression in vitro and comparing this to in vivo expression in the zebrafish model 
could further indicate alterations in host inflammatory response during co-
infection. 
 
6.6.2 Relationships with opportunistic bacteria. While this study focused on 
the impact of P. aeruginosa on R. microsporus virulence, future work could further 
investigate the response of P. aeruginosa to the fungus, looking at any changes 
in growth and viability, and the expression of other virulence factors beyond 
pyoverdine and pyochelin, such as exotoxin A, pyocyanin, proteases, as well as 
the expression of contact-dependent secretion systems like T3SS and T6SS.  
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While we hypothesise a cooperative relationship between R. microsporus and S. 
aureus and/or E. coli, further investigation into these relationships are warranted. 
Time-lapse microscopy would help observe whether the presence of the bacteria 
impacts the speed of R. microsporus germination, and histological studies of 
mammalian models could indicate changes in bacterial or fungal tissue 
penetration. Zebrafish models could be used to observe bacterial dissemination 
during co-infection. Furthermore, as concurrent aspergillosis and mucormycosis 
have been described in the literature (Gupta et al., 2014; Pouvaret et al., 2019), 
investigating the interaction between these invasive fungal pathogens would be 
an interesting, clinically relevant avenue. As Mucorales are ubiquitous 
environmental organisms, there are countless organisms that would warrant 
investigation into polymicrobial relationships. Through increased awareness of 
Mucorales and of the potential for polymicrobial interactions to exacerbate 
disease, perhaps data regarding co-isolations will increase and clinically relevant 
targets of Mucoralean polymicrobial research will become clearer. 
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Figure 6.2 Hypothetical clinical model of P. aeruginosa and R. microsporus interaction. In this scenario, (A) A wound becomes 
infected with P. aeruginosa. P. aeruginosa secretes a plethora of molecules, including pyoverdine (blue spheres). Pyoverdine binds any 
available iron (grey spheres) in the area. (B) If R. microsporus spores (large spheres) enter the wound from the environment, there is no 
iron available, and the spores do not germinate. (C) Antibiotic treatment would remove P. aeruginosa (D) With the iron-dependent pressure 
removed, R. microsporus could germinate, penetrate surrounding tissues, and lead to aggressive infection. Not to scale.  
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6.7 Concluding remarks  
Mucormycosis is a devastating infection with an unacceptably high mortality rate 
and a lack of effective treatment options. Here we have identified a novel 
mechanism for iron starvation, and further confirmed Mucorales’ dependency on 
environmental iron for full virulence. Through this, our work has identified a 
potential starting point for the development of new chelation therapies. We have 
also demonstrated the importance of studying the interactions between 
microorganisms, and how these relationships can impact pathogenicity. While 
Mucorales might be lying dormant within a niche, it could still have strong effects 
on the virulence of other organisms who might sense it and respond aggressively. 
Further, treatment of an overt P. aeruginosa infection might release siderophore-
mediated growth inhibition and leave a patient vulnerable to secondary fungal 
infection.  
 
We live in a world filled with microorganisms that are forming their own community 
structures, complete with competitive and cooperative relationships. As human 
communities can impact those surrounding them, microbial relationships strongly 
influence the health of their hosts. When these quiet relationships become overt, 
humans can suffer. While the acknowledgement of the impact of polymicrobial 
interactions is growing, increasing the awareness of these relationships in the 
medical field is paramount to gaining a holistic understanding of infectious 
disease.  
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The world is not in your books and maps, 
it’s out there   
 
Gandalf 
The Lord of the Rings 
J. R. R. Tolkien
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